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Abstract 
4 
 
Embryonic stem cells (ESCs) are known for their unique property to be maintained almost 
indefinitely in an undifferentiated, proliferating state with the potential to give rise to all types of cells. 
Current established protocols for the culture and differentiation of ESCs are cumbersome and inefficient 
involving three stages: a) maintenance or expansion of undifferentiated ESCs, b) spontaneous 
differentiation through formation of embryoid bodies (EBs), and c) dissociation of the EBs and replating 
leading to the terminal differentiation to the desired lineages. One of the major challenges in the use of 
ESCs for cell therapy is controlling their differentiation pathways. Optimal culture conditions and 
requirement as well as precise differentiation mechanisms and cellular interactions within EBs are still 
not well characterised resulting in sub-optimal control of homogenous differentiation especially due to 
the formation of all three germ layers. Attempts on developing an efficient culture protocol have been 
widely reported in order to overcome the limitations. Recent research approaches have shown that 
treatment with conditioned medium derived from HepG2, a human hepatocarcinoma cell line enhances 
the formation of multipotent mesodermal progenitors from ESCs. This promotes a greater control of ESC 
differentiation in a lineage-specific fashion possibly resulting in efficient haematopoietic differentiation. 
In this study, we have developed an integrated, single step bioprocess for ESCs hematopoietic 
differentiation that: a) uses HepG2-conditioned medium (HepG2-CM), that stimulates mesoderm 
formation, b) facilitates three dimensional (3D) culture through encapsulation of undifferentiated ESCs 
in hydrogels, c) bypasses EB formation, and d) involves culture in a rotating wall vessel bioreactor that 
does not require passaging of the cells and is scalable and automatable. In conclusion, this thesis reports 
the development of a novel culture system for the efficient single-step haematopoietic differentiation of 
ESC resulting in a reproducible, scalable, high-intensity culture system of mESCs for ex-vivo blood 
manufacture.  
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1.0 INTRODUCTION 
Blood is one of the most essential tissues that help sustain the welfare of the human body, by 
maintaining homeostasis, fighting infections, and supplying oxygen and nutrients and removing carbon 
dioxide and metabolites required for the survival of all organs. It is constituted by different cell types, 
each with specialized function. In order to ensure that these cells are continuously replenished due to 
their limited life span, the human body responds through an elegant feedback system called 
haematopoiesis, which in the adult body takes place mainly in the bone marrow. The main purpose of 
haematopoiesis is to maintain and produce the different types of progenitor stem cells that eventually 
differentiate into all mature blood cells. The average human body generates and replenishes about 
5x10
11
 blood cells per day as a result of natural turnover. When this process malfunctions it originates 
different types of blood-related malignancies such as anaemia or leukaemia. 
One of the best established clinical therapies nowadays that might be used as a life-saving way 
to overcome several clinical problems such as massive bleeding for patients who had trauma or surgery 
or may also used to treat disease derived from haematopoietic malfunction such as anemia, sickle cells, 
and thrombocytopenia is blood transfusion. This depends on the availability of donor material and is 
hindered by supply shortages and safety screening of the blood collected. Specifically, despite the fact 
that more than 80 million units of whole blood are collected worldwide every year, problems with 
insufficient supply and deficient screening of transfusion-transmitted infections make this still a 
particular concern in developing and transitional countries. Furthermore, immune incompatibility and 
ageing blood cells themselves remain critical issues that may impact negatively on patient outcomes. In 
response to these concerns, the ex vivo manufacture of blood cells from stem cells represents an 
alternative way to continuously provide the clinic arena with sufficient quantities in a safer manner for 
transfusion. Recent researches efforts have focused on enhancing the numbers of red blood cells (RBCs) 
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expanded from stem cells as enucleated are well-characterised, have a low expression of human 
leukocyte antigen molecules and are the most common cell type in the blood. 
Stem cells are a logical alternative source for blood cells due to the unique potential to develop 
into many different cell types in the body during early life and growth. Research was primarily focused 
two types of stem cells; (1) embryonic stem cells (ESCs) and (2) non-embryonic “somatic” or “adult” 
stem cells. ESCs are described as a type of undifferentiated cells derived from a 3.5 day embryo 
implantation in mouse and 5 day for human that are capable of dividing without differentiating for a 
prolonged period in culture, which develop into different types of cells and tissue from the primary germ 
layers. In contrast, somatic or adult stem cells are defined as relatively rare undifferentiated cells found 
in many organs and tissues with a limited capacity for both self renewal and differentiation.  Such cells 
vary in their differentiation capacity, which it is usually limited to cell types in the organ of origin. One of 
the most effectively used adult stem cell in both research and clinical applications is haematopoietic 
stem cells which can be obtained from different sources such as the bone marrow, cord blood and 
peripheral blood. These cells are known to have a special potential to differentiate into all of the cell 
types that compose the blood. 
Early on, production of RBCs in vitro used hematopoietic stem cells (HSCs) as the starting 
material. These resident stem cells in the bone marrow have a dual capability of self renewal and 
differentiation into the committed blood progenitors. These properties are thought to depend upon 
specific microenvironments which house the HSCs in the marrow, the so-called stem-cell niches. The 
bone marrow niches are formed by few types of specialized cells which include bone marrow stromal, 
subendoosteal osteoblasts, and sinusoidal endothelial cells.  Though this approach offered promising 
results due to the ease of controlling the differentiation process, HSCs have a limited availability and 
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expansion capacity. In order to overcome this hurdle and translate this concept into a clinical 
application, identifying a cell source with “unlimited” expansion capability becomes crucial. 
Recently, embryonic stem cells (ESCs) have been explored as a potential source of HSCs because 
of their unique pluripotency and self-renewal properties that distinguish them from adult stem or 
progenitor cells, which have the limitations described above. Considering their unique combined 
potential of virtually unlimited expansion and pluripotency, ex vivo manufacture of RBCs from ESCs 
could potentially provide the clinically relevant numbers of RBCs for use in transfusions. However, some 
of the major challenges are to control the differentiation pathway of ESCs purely into RBCs and to 
develop automatable and scalable bioprocesses.  
Methods currently known to be able to direct the differentiation of ESCs towards a specific 
lineage of interest are: (i) embryoid body (EB) formation; (ii) co-culture with accessory cells; and (iii) 
culture with extracellular matrix proteins. Recently, efforts towards the large-scale production of 
erythroid cells from ESCs have been employing these techniques to highly reduce the percentage of 
unwanted cellular lineages in the final product, pointing to the potential feasibility of such an approach. 
Therefore, this thesis intends to be a stepping stone in providing an overview of some of the current 
challenges faced by engineers and clinicians alike in generating RBCs from ESCs, while providing 
potential solutions that could bring a significant contribution for the future of pluripotent stem cell-
derived therapeutics and regenerative medicine. 
The outline of this thesis will be as follows: Chapter 2 will provide the literature review by 
introducing the problems and clinically urgent requirement for blood supply, the advantages and 
disadvantages of current practises which normally applied clinically, brief information on the process of 
blood formation in human body, new approach on producing hematopoietic stem cells from different 
sources of adult stem cells and embryonic stem cells (which included pros and cons of each types of cells 
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sources), brief studies on differentiation process started with early formation of germ layer occurs in 
vivo during embryogenesis followed by blood cells differentiation from ESCs in vitro, current 
differentiation approach which highlighted on the EB formation technique and the use of condition 
medium from human Hepatocarcinoma cel line, HepG2,and ended with 3 dimensional (3D) culture 
application using alginate encapsulation and rotating wall vessels bioreactor.  
Chapter 3 will summarise the critical requirements in ESC bioprocessing for RBC production and 
establish the overall aim and objectives of the thesis. Chapter 4 will present the experimental methods 
and materials used for ESC and HepG2 culture, encapsulation in hydrogels, and bioreactor utilisation as 
well as the methods employed in cellular analysis. Chapters 5 and 6 focus on characterisation and 
optimisation studies for in vitro erythropoiesis of mESCs using HepG2-conditioned medium (HepG2-CM) 
with standard 2 dimensional (2D) culture technique. Specifically, chapter 5 demonstrates the use of 
HepG2-CM as an alternative strategy for directing and enhancing the mesoderm differentiation from 
mESCs. The main purpose of this chapter is to use ‘embryoid-like’ colonies (ELCs) formation step on 
methylcellulose semi-solid medium for hematopoietic differentiation, which focused on the 
enhancement of erythroid progenitor colonies formation using HepG2-CM. Chapter 6 aims at the effect 
of HepG2 CM treatment on mESCs culture followed by terminal differentiation towards hematopoietic 
differentiation without undergoing  the standard EB formation step, which resulted in the spontaneous 
differentiation of cardiogenic lineage on specified methylcellulose semi-solid hematopoietic 
differentiation medium.  
This stage is followed with works on 3 dimensional (3D) cultures, by introducing the alginate 
hydrogel encapsulation technique and the use of rotating wall vessel (RWV) bioreactor for 
hematopoietic differentiation, which described in chapter 7. Chapter 7 summarise the results from 3D 
encapsulated mESCs cultured in alginate hydrogel beads for hematopoietic differentiation including the 
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spontaneous cardiomyogenic differentiation after the enhancement with HepG2 CM and cultured in the 
RWV bioreactor. Final thoughts regarding the findings from this thesis as well as future works are 
summarized and concluded in Chapter 8. 
Table 1. Scientific objectives for chapters 5, 6, and 7. 
Chapter Scientific objectives 
Chapter 5 2D mESC hematopoietic differentiation with ELCs formation steps using HepG2-CM 
Chapter 6 2D mESC spontaneous cardiogenic differentiation bypassing ELCs formation steps using 
HepG2-CM 
Chapter 7 3D mESC hematopoietic and spontaneous cardiogenic differentiation from the 
enhancement by HepG2 CM and cultured in a RWV bioreactor. 
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2.0. Clinical Needs For Blood Supply 
 
The requirement for blood is of critical significance. Advances in haematology, such as bone 
marrow transplant, anti-coagulation therapy and chemotherapy, resulting from progress in clinical 
procedures and the increase in blood disorders, have lead to a high demand for blood needs that 
exceeds the current available supply.  Although 80 million units of blood are collected every year, blood 
shortage is still remains as a global issue. This problem becomes worse amongst developing countries, 
where 82% of the world’s population lives when only 39% of world donations are collected in these 
regions (Timmins and Nielsen 2009). The limitation of blood supply is faced only amongst low and 
medium income countries. The same problem has also been reported in the developed countries such 
as the U.S.A. and it has caused at least a 7% postponement of elective surgeries in the hospital due to 
the blood inventories shortage. Furthermore, additional issue on the safety and screening standards of 
the blood collected has been critically discussed when at least six million units of donated blood went 
unscreened for virus-transmitted disease such as H.I.V., hepatitis B and C and syphilis between year 
2001 and 2002. This fact has caused more fears amongst all the world’s population when the safety of 
blood donor products cannot be guaranteed even in the most advanced and wealthy nations (Timmins 
and Nielsen 2009). 
 
2.1. Current Techniques For Blood Supply 
2.1.1. Blood Transfusion 
 
Despite the fact that many controversial issues have been seriously reported on blood 
transfusion, this practice still remains as one the most successful therapeutic acts in modern medicine. 
Blood transfusion is commonly defined as a process of transferring blood from donor to recipient which 
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can either be autologous (i.e. the blood donor and the transfusion recipient are identical) or 
homologous (i.e. allogeneic, where the blood is transfused into someone different than the donor) 
(Lippi, Mercadanti et al. 2010). Blood transfusion is an essential cellular therapy because it might be life-
saving in several situations such as massive bleeding (e.g. in patients with defects of primary and 
secondary haemostasis, after trauma and surgery) or as prolonged quality-of-life therapies in patients 
with chronic anaemic disorders (e.g. haemolytic disease such as sickle-cell disease (Figure 1)). Blood 
transfusion may also be used to treat a severe anaemia or thrombocytopenia caused by a blood disease 
(Lippi, Mercadanti et al. 2010).  Although the need for blood transfusion is widespread, there is a major 
imbalance between demand and supply of donors. Along with other limitations of traditional blood 
transfusion (i.e. the problem with blood type analysis and cross-match test, the limited preservation 
time, the immunomodulation to the recipient and the risk of pathogen transmission), it has lead a way 
in research for scientists to develop suitable alternative for donated blood (Mountford, Oliver et al. 
2010).  
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Figure 1. Normal and Sickle Red Blood Cells 
(adapted from http://www.nhlbi.nih.gov/health/dci/Diseases/Sca/SCA_WhatIs.html) 
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2.1.2. Blood Substitutes 
 
Ongoing research efforts have been developed over the past decades focusing on generating 
“artificial blood” that mimic most functions of biological blood which could also provide a better 
solution than blood transfusion. Several attempts were made to obtain a suitable blood substitute which 
involved the development of polymerized haemoglobin solutions, haemoglobin-based oxygen carriers, 
perflurocarbons and allosteric modulators of haemoglobin (Lippi, Mercadanti et al. 2010). Although 
these substitutes have some important clinical advantages, including sterilization of viral and bacterial 
contaminations, the possibility of storage at room temperature, longer half life and lack of RBC antigens, 
both their safety and real clinical efficacy have been seriously questioned (Sullivan, Jagannath et al. 
2008). Some of perfluorocarbon molecules cannot provide a sufficient peripheral tissue oxygenation at 
the conventional alveolar oxygen partial pressure and their oxygen transport capacity must be artificially 
increased. The other issue with haemoglobin–based oxygen carriers is related to life-threatening 
vasoconstrictor reactivity due to the scavenging of endogenous nitric oxide which has been associated 
with the onset of few organ malfunction including myocardial ischaemia, gastrointestinal dysfunction 
and alteration of some biochemical and haematologic parameters. Whilst the allosteric modulators of 
haemoglobin display a very short half life (approximately from three to six hours), they require a high 
volume of infusion and can caused organ malfunction which is a given side effect of renal dysfunction 
and arterial dissaturation(Lippi, Mercadanti et al. 2010). 
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Figure 2. Types of Blood Substitutes (adapted from http://en.domotica.net/Blood%20substitutes) 
 
2.0.3. Blood-Derived Stem Cells 
 
In response to these concerns, production of blood cells from stem cells has been proposed as 
another alternative source due to their special capacity to self-renew, differentiate and repopulate a 
host in vivo (Lippi, Mercadanti et al. 2010; Mountford, Oliver et al. 2010; Slukvin 2010). They have a 
different hierarchy of potency ranging from totipotent (differentiating into a cell types including 
placenta), pluripotent (differentiating into cells of the three germ layers; ectoderm, mesoderm and 
endoderm, but not trophoblastic cells), multipotent (differentiating into cells of more than one type but 
not necessarily into all the cells of a given germ layer) to unipotent (differentiating into one type of cell 
only e.g. muscle or bone)(Placzek, Chung et al. 2009). Recent studies on blood production from stem 
cells mainly focused on generating a common progenitor of blood cells called the haematopoietic stem 
cells (HSCs), which in adults, resides in the stem cell niche of the bone marrow (Panoskaltsis, Mantalaris 
et al. 2005; Mountford, Oliver et al. 2010). Haematopoietic stem cells transplantation has become one 
of the potential cures for various types of blood-related malignancies, disorders, leukaemia and 
34 
 
anaemia. This process involves the transplantation of blood stem cells deriving from the bone marrow, 
peripheral blood or umbilical cord blood (Breems and Lowenberg 2007; Pant and Copelan 2007; Haspel, 
Kao et al. 2008). Though the procedure is still considered somewhat high risk due to the many possible 
complications such as graft-versus-host disease (G.V.H.D), HSC transplantation offers a potential cure or 
long-term remission for many different types of haematological conditions (Noel, Bruniquel et al. 2008; 
Toubai, Hirate et al. 2008; Blade, Rosinol et al. 2010). In vitro expansion and differentiation of HSCs have 
therefore been investigated to increase the cell numbers available thus increasing the chances for a 
successful transplantation. Use of expanded HSCs for treatment of blood types diseases or for post-
chemotherapy patients has shown success in various cases (McNiece, Jones et al. 2000; McNiece and 
Briddell 2001; Bradley and Cairo 2005). However, mechanisms controlling HSC fates in vitro are still 
poorly understood and not well defined; the operation of a bioprocess that ensures quality and 
consistency of in vitro manipulated HSC products for clinical applications is therefore still difficult to 
achieve. Research efforts continue to further the characterization of these complex bioprocesses in 
order to improve yield and quality of the cellular product that will meet high clinical standards (Lim, Ye 
et al. 2007; Placzek, Chung et al. 2009). 
 
2.2. Haematopoiesis 
2.2.1. Processes Involved During Haematopoiesis 
 
Haematopoiesis is a dynamic process that requires the replenishment of about 5 × 10
11
 blood 
cells for the average adult per day (Pallister and Watson 2011). As blood circulates in the body, it helps 
to transport gases, nutrients and waste products, prevent bleeding by forming blood clots and form an 
efficient immune defence system against a variety of foreign infectious agents. Blood cells in 
circulation have a short lifespan varying from a few days to several months. As blood cells die, the 
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human body responds through an elegant feedback system, to ensure that blood is continually 
replenished. This process is called haematopoiesis and it takes place primarily in the bone marrow of 
healthy adults (Edwards et al. 2002).  The primary function of haematopoiesis is to generate various 
forms of stem cell progenitors which lead to all mature blood cells. This complex and highly regulated 
process comprises of self-renewal, proliferation, commitment, differentiation and cell death (Lim, Ye et 
al. 2007).  
Bone marrow and its haematopoietic inductive microenvironment (H.I.M) are known as the site 
of haematopoiesis which provide a complex sinus network consisting of stromal cells, bone cells, growth 
factors, extracellular matrix (E.C.M) and residing haematopoietic cells (Panoskaltsis et al. 2005; Abboud 
and Lichtman, 2001). The bone marrow stroma is made up by stromal cells, macrophages, endothelial 
cells and adipocytes, provide structure to the H.I.M and secrete growth factors that are key initiators of 
many haematopoietic cell functions such as homing, cell adhesion, proliferation and differentiation 
(Figure 3) (Panoskaltsis et al. 2005; Abboud and Lichtman, 2001). E.C.M macromolecules, secreted by 
the stromal cells, include proteoglycans, collagen and adhesive proteins such as laminin and fibronectin, 
which help to localize growth factors and the haematopoietic cells to their specific functional three-
dimensional (3-D) micro-environmental niches. At these sites, a well-balanced physical, chemical and 
cellular microenvironment enables regulated processes to occur through a series of cell-to-cell and cell-
to-matrix interactions (Abboud and Lichtman, 2001). 
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Figure 3. The Schematic Drawing of Bone Marrow Cellular Environment Indicating The Stem 
 Cell Niche and Maturational Niches Towards The Sinusoid. (adapted from Panoskaltsis, 2005). 
 
2.2.2. Haematopoietic cells 
 
All matured blood cells are developed from common precursor cells that are produced 
principally in the bone marrow which are called haematopoietic stem cells (Figure 4) (Edwards et al. 
2002). They are distinguished by their unique properties of self-renewal (i.e. capable to produce a 
lifetime supply of mature blood cells for the host) and multipotency (i.e., ability to differentiate into 
different types of blood cells, each with a specific and often distinct function) (Quesenberry and Colvin 
2001). Blood cells are composed with highly-specialized cells which include erythrocytes (red blood 
cells), leukocytes (white blood cells) and thrombocytes (platelets) (Ryan, 2001). Erythrocytes represent 
as the most abundant type of blood cells. They are biconcave circular enucleated cells; normally show a 
pinkish-brown colour in the presence of iron-containing pigment haemoglobin that has a distinct affinity 
to oxygen. Their main function is to carry oxygen from the lungs to the tissues and transport carbon 
dioxide from the tissues back to the lungs. This type of blood cells is produced in the bone marrow 
under the controlling influence of the renal hormone erythropoietin. After entering the bloodstream, 
they have a life-span of approximately 120 days before being broken down in the reticulo-endothelial 
system (Ryan 2001).  
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Figure 4. The process of haematopoiesis. (Adapted from Kaufman and Anderson 2003) Lineages: 
B/CFU = burst/colony forming unit, GEMM = granulocyte-erythrocyte macrophage and monocytes,  
Ba = basophil, Eo = eosinophil, Meg = megakaryocyte, E = erythrocyte, NK = natural killer cell. 
 
Another component of blood cells is leukocytes which occupy less than 1% of the total blood 
volume (Ryan 2001). In mammals there are at least five types of white cell in the circulating blood. 
Unlike erythrocytes, leukocytes have retained their nuclei. The cell is therefore made up of a nucleus 
and cytoplasm. They are produced in the bone marrow and lymphatic tissue. Leukocytes consisting 
largely of granulocytes, monocytes and lymphocytes, vary in the shape of their nucleus and the presence 
of granules in their cytoplasm. Granulocytes such as neutrophils have irregular shaped/segmented 
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nucleus while basophils and eosinophils are distinguished by features in their cytoplasmic granules. 
Lymphocytes usually have a circular/oval nucleus with little/no presence of cytoplasmic granules and 
can vary significantly in sizes, ranging from 10 to 20 μm (Ryan 2001). Monocytes are the largest blood 
cells and measure around 15-22 μm (Ryan 2001). The nucleus of a monocyte can be round, kidney-
shaped or indented and generally stain lighter than other leukocytes. Leukocytes are cells of the 
immune system. Cells such as neutrophils fight against bacterial infection whilst basophils and 
eosinophils participate in various inflammatory reactions. B- and T-lymphocytes produce antibodies and 
cytokines to neutralise bacteria and viruses, whilst monocytes/macrophages usually engage in 
phagocytosis, engulfing dead cells and foreign materials as they protect the body against infection. 
Thrombocytes (platelets) are small cell fragments deriving from megakaryocytes. They are produced in 
the bone marrow and contain enzymes and other biologically active substances (mediators). Their 
function is to respond to any vascular wall damage by gathering together at the site of injury to form an 
initial temporary platelet plug and releasing their contents into the blood. The released contents of 
platelets are largely responsible for the subsequent coagulation process by activating the blood clotting 
mechanism that results in the permanent deposition of a fibrin clot at the site of damage, preventing 
further bleeding (Ryan 2001). 
 
2.2.3. Factors Required For Haematopoiesis 
 
Haematopoiesis is a complex process regulated by multiple factors. Haematopoiesis occurs in 
specialised tissue sites called haematopoietic niches which play important roles for the maintenance and 
differentiation of stem and progenitor cells (Kim 2010). The bone marrow stem cell niche is one example 
of haematopoietic niches which provide a low oxygen environment (hypoxic condition) which are 
suitable for haematopoietic stem cells to maintain their quiescent and self-renewing identity (Kim 2010). 
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The marrow stem cell niche is composed of various cells and their products which positively and 
negatively regulate the process. Key regulatory cells include osteoblasts, chemokine-expressing reticular 
cells and vascular endothelium cells (Kim 2010). Signals from the sympathethic nervous system and 
osteoclasts regulate the haematopoietic stem cell migrate from the bone marrow through the 
regulation of critical cell homing and specific retention factors (Kim 2010).  A number of molecular 
pathways including Wnt, calcium-sensing receptors, angiopoietin 1, Tie-2 and extracellular matrix 
components are involved in the process to finely control the stem cell niche (Kim 2010). Although 
incompletely understood, these pathways are thought to be involved not only in maintenance of stem 
cell niche but also in renewal and differentiation of haematopoietic stem cells within the niche (Kim 
2010). Various cells produce haematopoietic cytokines such as stem cell factor (S.C.F), notch ligands, 
bone morphogenic proteins, transforming growth factor β, thrompopoietin (T.P.O), fibroblast growth 
factors and insulin-like growth factors 2 which maintain and regulate the primitive hematopoietic stem 
cells (Kim 2010). Other cytokines, such as granulocyte colony stimulating factors (G-CSF), interleukin-3 
(IL-3), IL-7, erythropoietin (EPO), granulocyte macrophage (GM)-CSF, and macrophage (M)-CSF, play 
important roles in the differentiation of haematopoietic stem and progenitor cells to committed cell 
lineages (Kim 2010).  
 
2.3. Cell Sources For Blood Production 
 
                       Cell used in blood production can be derived from numerous sources including primary 
tissues as well as cell lines. The ideal properties are non-immunogenic, highly proliferative (large 
numbers of expansion usually required), easy to harvest and able to differentiate into specific cell types 
with specialized function. Both autologous and allogenic cells have being considered as cell sources, 
including adult progenitor cells, adult stem cells, and embryonic stem cells.   
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2.3.1. Adult Progenitor Cells 
 
  The main source of adult progenitor cells is the tissue itself which collected from adult tissues 
such as bone marrow and peripheral blood. Scientists have come across a population of cell named 
multipotent adult progenitor cells (MAPC) when they accidently identified a rare population of cells that 
has special properties to proliferate without obvious signs of senescence and have a broad 
differentiation ability in vitro and in vivo unlike most adult somatic stem cells (Geraerts and Verfaillie 
2009). This suggests that MAPC are derived from a population of cells that either has active telemorase 
in vivo or that is highly quiescent in vivo and therefore have not yet incurred telomere shortening in 
vivo. MAPC can be cultured from bone marrow of human and animals such as mice and rats in vitro 
(Geraerts and Verfaillie 2009). Although the isolation of MAPC remains technically demanding, the 
maintenance of established cell lines in their differentiated form has become significantly less 
demanding. The challenge in MAPC isolation is that cells with morphological and phenotypic features of 
MAPC can only be detected in bone marrow cultures after several population doublings. Scientists still 
have not yet determined if MAPC exist as such in the freshly isolated bone marrow or if this cell 
phenotype is focused just via the culture process. Besides, it is difficult to control culture conditions that 
affect isolation of MAPC, which include cell density, CO2 and O2 and cell density, among others (Geraerts 
and Verfaillie 2009).  
 
 
 
 
 
 
41 
 
2.3.2. Adult Stem Cells 
 
                       Adult stem cells are a type of stem cells that can be found in almost all adult tissues 
examined including brain, dental pulp, muscle, bone marrow, skin and pancreas. Ideally, they are 
defined as clonogenic cells where a single adult stem cell generates a line of genetically identical cells 
which then give rise to all appropriate, differentiated cell types of the tissue in which they reside 
(Melton and Cowen 2009). These cells share the same potential as normal stem cell, in order to divide or 
self-renew indefinitely and generate all the cell types of the organ from which they originate as directed 
by appropriate inducers with limited expansion. The adult stem cells could be multipotent (such as 
haematopoietic stem cells (HSCs) giving rise to all blood cells and adherent stromal/mesenchymal stem 
cells (MSCs) that give rise to bone, fat, cartilage and muscle) or unipotent (such as progenitor cells) 
(Melton and Cowen 2009). The progenitor cells in foetal or adult tissues which are usually regarded as 
“committed” cells have the ability to divide and give rise to fully differentiated cells along a particular 
cellular development pathway. Although their populations are rare in body, their primary function of 
maintaining the steady state of a cell’s function especially in replacing the cells that die because of injury 
or disease so-called haemaostasis is well-explained (Melton and Cowen 2009).   
                          There are few sources of blood forming-adult stem cells which originally come from (i) 
bone marrow-derived haematopoietic stem cells (HSCs),  (ii) peripheral blood-derived HSCs, and (iii) 
umbilical cord blood-derived HSCs. The marrow is a primary source of haematopoietic stem cells that 
can be isolated from the tissue itself and that when re-introduced in vivo are capable of differentiating 
into various blood-forming stem cells, stromal stem cells and mature blood cells (Figure 5) (Pant and 
Copelan 2007).  When bone marrow derived-HSCs are observed in culture, there are large increases in 
the number of cells often harvested. This usually reflects an increase in the differentiation of cells to 
progenitor cells that can give rise to different lineages of blood cells but have limited self-renewal 
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ability. Due to the ability to generate a larger number of cells from a very small number of precursors in 
culture, these cells have been considered as attractive clinical approach for the older population 
(Krause, Theise et al. 2001).  
                       However, obtaining the HSC from bone marrow involves an invasive procedure which the 
process include anaesthetizing the donor, puncturing a bone (i.e. a hipbone) and drawing out the bone 
marrow cells with a syringe. In addition, the putative HSCs from the bone marrow are in fact found in 
low numbers (about 1 in every 100,000 cells) in the adult patient and a highly heterogeneous population 
with only a very limited proportion of cells being capable of differentiation into the haematopoietic 
lineage (Krause et al. 2001). Moreover, in a clinical setting, their potential to proliferate and 
differentiate down to specific cell lineages diminishes with the patient age. If the capacity of the 
continuous self-renewal is taken strictly into consideration as the defining criterion for stem cells, only 
an extremely low proportion of the bone marrow-derived HSCs can be considered as true stem cells 
(Krause et al. 2001). This would give a major challenge in the development of isolation and purification 
protocols.  
                            
Figure 5: Haematopoietic and Stromal Cell Differentiation From Bone Marrow  
(adapted from http://stemcells.nih.gov/info/scireport/chapter4.asp#figure3) 
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                         Peripheral blood is another source of HSCs for clinical transplantation due to the fact that 
they contain a small number of stem and progenitor cells circulating in the bloodstream (Figure 6). 
Recently, researchers have found that they can coax the cells to migrate from marrow to blood in 
greater numbers by injecting the donor with specific small signalling protein molecules called cytokines 
(Cutler and Antin 2001).  This method giving a better solution to the patients in terms of harvesting the 
cells and is easier on the donor with minimal pain and without using anaesthesia.  Besides, the 
peripherally harvested cells contain twice as many HSCs as stem cells taken from bone marrow and 
engraft more quickly, offering fast recovery time for the patients (Lickliter, McGlave et al. 2000; Horwitz, 
Negrin et al. 2001).  However, of the cells collected, only 5 to 20 percent are true HSCs, other cells 
present include heterogeneous populations of stem cells, progenitors and white blood cells of various 
degrees of maturity (Lickliter, McGlave et al. 2000). Although harvesting HSCs from peripheral blood are 
easy and can be used directly from the same patient but their self-renewal capability is still limited. This 
remains a major challenge for scientists as the mechanism underlying HSCs “plasticity” or pluripotency is 
still not yet fully understood. 
                       Umbilical cord blood offerings a rich source for HSC as it has been shown to have sufficient 
amount of haematopoietic progenitor cells to support blood formation and can be obtained off-the-
shelf (Figure 6).  Umblical cord blood stem cells have recently gained in popularity due to the reduced 
risk in immune rejection and graft-versus-host disease (G.V.H.D) occurrences but also ease of collection 
and wider availability of usage for minorities (Noel, Bruniquel et al. 2008; Toubai, Hirate et al. 2008). 
However, cord blood stem cells are limited by the volume and number of cells available in a single cord 
blood unit. Furthermore, it has also been reported that in vitro expansion of HSCs from umbilical cord is 
restricted to a small number of passage due to rapid aging and loss of multipotency (Bradley and Cairo 
2005). In terms of the clinical haematology work, these reasons would limit their usefulness in 
autologous cell-transplantation therapy for the treatment of haematopoietic malignancies.  Although 
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there is a substantial amount of research work being conducted on these cells to search ways to expand 
the number of HSCs and compare their biological properties with bone marrow stem cells, research data 
have not conclusively shown qualitative differences in the differentiated cells produced between this 
source of HSCs and peripheral blood and bone marrow (Bradley and Cairo 2005).  With all the limitations 
and insufficient number of HSC contributes towards the use of embryonic stem cells (ESC) as another 
option for blood formation from stem cells.    
 
             
Figure 6. Types of Resources Blood-Forming 
Adult Stem Cells. (a) Bone Marrow; (b) Peripheral Blood; (c) Umbilical Cord Blood   
(adapted from http://health.allrefer.com/health/bone-marrow-transplant-bone-marrow-
aspiration.html ; http://healthguide.howstuffworks.com/peripheral-artery-disease-and-intermittent-
claudication-in-depth.html; http://health.allrefer.com/pictures-images/percutaneous-umbilical-cord-
blood-sampling-series-2.html ) 
 
2.3.3. Embryonic Stem Cells (ESCs) 
 
                         The use of ESCs as a potential cell source for clinical application, specifically for blood 
forming cell-based therapies has been suggested very recently. It has been shown that it is possible to 
generate most, if not all, precursors to many different blood cells from ESCs with some addition of the 
right growth factors in in vitro culture (Kaufman, Lewis et al. 1999; Chen, Lewis et al. 2003).   Although 
the cells product yielded from ESCs have not yet achieved the “gold standard” for clinical application, 
(a) (b) (c) 
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but recent studies have shown that they are able to produce long-term HSCs which has been 
successfully transplanted into lethally irradiated mice to reconstitute long-term haematopoiesis (Wang, 
Yates et al. 2005). This recent finding proved the fact that HSCs derived from ESCs are more capable of 
self-renewal and offer a promising solution for the high expansion of cell numbers in culture as 
compared to adult HSCs sources. Although the issue on teratomas formation has became their main 
limitation, several strategies have been conducted in research practices to enhance the safety of ESCs 
for potential clinical use including by differentiating them into specific cell types followed by sorting 
process with flowcytometry for further purification to reduce their ability to cause tumours (Krishnan et 
al. 2010). Besides, ESCs are predicted to be inherently safer than induced pluripotent stem (IPS) cells, 
another potential cells source for unlimited expansion property because they are not genetically 
modified with genes such as c-Myc that are linked to cancer and highly expressed in IPS cells 
(Varlakhanova, Cotterman et al. 2010). With respect to the recent findings, they have lead to the idea of 
deriving well-characterized ESC lines that posse genetically identical background to the patients, which 
could reduce the risk of donor-host rejection.  
                      ESCs are defined as pluripotent stem cells derived from the inner cell mass in the very early 
stage of developing embryos (Thomson, Itskovitz-Eldor et al. 1998). Recent outcomes on the potential of 
using ESCs in clinical studies has been extensively highlighted owing to their outstanding unique 
capacities, specifically for prolonged self-renewal abilities that could be used to solve the cell expansion 
problem (Mitjavila-Garcia, Simonin et al. 2005; Yates and Daley 2006; Siti-Ismail, Bishop et al. 2008). 
Other qualities include the differentiation capacity of these cells into all the cells types forming the 
origin of three germ layers (endoderm, mesoderm and ectoderm) as proven by injecting them into a 
blastocyct and showing the interesting production of chimera offspring in which all the tissue are 
arbitrarily formed (Heng, Cao et al. 2004). These characteristics of ESCs allow them to be one of the 
most useful cell sources for tissue engineering and regenerative medicine. The first derivation of 
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pluripotent mouse ESCs (mESCs) was reported over 25 years ago and the derivation of human ESCs 
(hESCs) was also proposed about 7 Years later (Hirai, Umegaki et al. 2002; Prelle, Zink et al. 2002; Keller 
2005). mESCs are maintained in the undifferentiated (and pluripotent) state in the presence of the 
leukaemia inhibitory factor (LIF) without feeder cells whilst hESCs are cultured in basic fibroblast growth 
factor (bFGF) with feeder cells or conditioned media. Those chemical and humoral factors are used to 
sustain ESCs self-renewal activity in culture (Evans and Kaufman 1981; Martin 1981; Thomson, Itskovitz-
Eldor et al. 1998). On the withdrawal of the factors, proliferation continues but differentiation is induced 
and stem cells do not persist beyond a few days.  
                     
Figure 7. Derivation of Embryonic Stem Cells (adapted from 
http://journals.cambridge.org/fulltext_content/ERM/ERM7_19/S1462399405009804sup002.pdf) 
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                         ESCs can be cultured for extended periods without loss of their pluripotent capacity due to 
the fact that they spend most of their time in the S phase and less time in the G1 check point in the cell 
cycle. This allows them to synthesise DNA, which do not require any external stimulus to initiate DNA 
replication unlike differentiated somatic cells (Evans and Kaufman 1981; Martin 1981). 
Many techniques have been used to detect undifferentiated ESCs in vitro that normally have been 
developed based on the cell surface antigens, in vitro developmental capacity or expression of genes 
associated with the properties of undifferentiated ESCs. These includes a series of stage-specific 
embryonic antigen-4 (SSEA) and tumour rejection antigen-1 (TRA-1), cluster of differentiation 9 (CD9), 
alkaline phosphatise activity, and octamer binding factor 3/4 (Oct 3/4) (Scholer, Ciesiolka et al. 1991; 
Keller 1995). Studies have shown that Oct 3/4 is the most established marker used for detection of 
undifferentiated ESCs (Yeom, Fuhrmann et al. 1996). This marker is normally expressed exclusively in 
blastomeres, pluripotent early embryo cells and germ-line lineage cells. Expression of Oct3/4 has been 
shown to be essential for the initial development of pluripotential property in the inner cell mass cells in 
vivo and also in ESCs in vitro (Nichols, Zevnik et al. 1998). In addition, this marker plays important roles 
in activating or inhibiting a host of target genes that maintaining ESCs in a proliferative and non-
differentiated stage.  
                    Down-regulation of the Oct 3/4 marker resulted in differentiation into both primitive 
ectodermal and trophectodermal cells, which normally occur during the gastrulation stage in vivo 
(Palmieri, Peter et al. 1994). However, recent studies have suggested that maintenance of Oct 3/4 
expression needs to be further defined due to the fact that it is no longer sufficient to sustain the 
pluripotent phenotype. It has been shown that different level of Oct 3/4 expressions separate the ESCs 
fate into three stages.  A significant increase of the Oct 3/4 expression, lower than two-fold results in 
differentiation towards embryonic ectoderm and mesoderm whilst repression of Oct 3/4 expression 
induces loss of pluripotentcy and dedifferentiation into trophectoderm (Niwa, Miyazaki et al. 2000). 
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Hence, a critical threshold of Oct 3/4 expression that maintains ESC self-renewal is remain to be 
elucidated.    
                        In vitro culture of ESCs differentiation give rise into all three embryonic germ layers 
(ectoderm, mesoderm and endoderm) followed by specialization into many cell types via embryoid body 
(EB) formation periods (Takahashi, Lord et al. 2003; Dang, Gerecht-Nir et al. 2004). In contrast to adult 
progenitor and adult stem cells, ESCs are able to divide continually in culture whilst maintaining their 
ability to generate any cell type desired provided with the proper signal and cultured in the appropriate 
environment.  EB formation is one of the most robust methods to induce ESCs for spontaneous 
differentiation forming a spheroid tissue-like colony (Dang, Gerecht-Nir et al. 2004). Studies have shown 
that EB differentiation recapitulate the aspects of the early embryogenesis following the sequences of 
the lineage commitment events  (Keller 1995).  In vitro ESCs-culture has been proposed as a model to 
reflect the development of embryo in vivo which has been established through the formation of a 
complex three dimensional spherical like shape colonies where the interaction between cell-cell and 
cell-matrix are thought to play an important role in the three embryonic germ layers development and 
their derivatives (Keller 1995; Itskovitz-Eldor, Schuldiner et al. 2000).                   
                     Several in vitro culture methods have been adopted for the EB culture practice which 
includes three basic methods, namely, suspension culture in bacterial-grade dishes, culture in hanging 
drops, and culture in methyl cellulose semi-solid media (Kurosawa 2007). Suspension culture in 
bacterial-grade dishes has been used for liquid suspension culture of ESCs as the simplest way to induce 
EB formation (Wang, Clark et al. 1992). Seeded ESCs naturally stick to each and form aggregates without 
any shaking when suspended on the low attachment grade plates. This method allows ESCs to aggregate 
spontaneously resulting EBs tend to be heterogeneous in their size and shape due to the probability that 
ESCs encounter each other accidentally in culture (Bratt-Leal, Carpenedo et al. 2009). It is important to 
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form EBs in a uniform and reproducible manner as it has been studied that the heterogeneously sized 
EBs will rapidly lose any synchrony in differentiation (Keller 1995).   
                     In contrast to the suspension culture, EB formation using hanging drop culture provides 
better culture conditions for generating homogeneous cell aggregates from a predetermined number of 
ESCs (Hopfl, Gassmann et al. 2004). The rounded bottom of a hanging drop allows the aggregation of 
ESCs via gravity. The number of ESCs aggregated in a hanging drop can be controlled by varying the 
number of cells in the initial call suspension to be hung as a drop from the lid of a petri dish. However, 
this method is highly time consuming and not easily amenable to scaling up due to many manual 
handling procedures and also showed the additional limitation in manipulating the small volume of 
medium without disturbing the EBs (Kurosawa 2007). Therefore, methylcellulose culture offers another 
option that also allows reproducible formation of EBs from single ESCs. When ESCs are seeded into 
semisolid methylcellulose media, they tend to remain single, isolated by the matrix of methylcellulose 
and these single ESCs will develop into aggregates (Kurosawa 2007). 
                    As compared to suspension culture, methylcellulose culture allows the resulting EBs not to 
randomly coalesce into very large structures in the matrix of methylcellulose which giving an advantage 
in controlling the size of EBs formed. Besides, this culture method also allows a direct microscopic 
observation of forming EBs in methylcellulose as it is difficult to observe the colonies formed within the 
hanging drop culture using microscope (Kurosawa 2007). Although the handling of semi-solid 
methylcellulose dilution by pipette is not easy, it has been proved that methylcellulose culture has been 
used extensively for the study of haematopoietic differentiation of ES cells, because haematopoietic 
cells can be efficiently generated in the differentiation system via EBs formed by this culture technique 
(Keller, Kennedy et al. 1993). The high frequency of haematopoietic cells formed in methylcellulose 
culture might be due to a local accumulation of factors in the matrix of methylcellulose surrounding EBs, 
giving a better environment for haematopoietic differentiation that mimic bone marrow extracellular 
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matrix condition (Weiss and Orkin 1996). Considering  the fact that it is important to direct the EB 
differentiation towards the lineage of interest, many recent studies have focused on the length of EB-
culturing periods as related to the correlation with the in situ process of the post implantation 
development (Keller 1995). For example, it has been reported that mesodermal and ectodermal 
precursors appear to be formed in the early stage of EB maturation whereas some endodermal cell 
types may be beneficially affected in more extended culturing time when most of the EBs have cavitated 
and become cyctic (Abe, Niwa et al. 1996).  
                       Although recent research efforts have given and proven many successful outcomes using 
the ESC-based technique, limitation to control their differentiation (even though relatively robust 
techniques have been proposed to maintain the developmental potential of ESCs in vitro) still remain to 
be elucidated (Thompson, Clarke et al. 1989; Reubinoff, Pera et al. 2000). Current established protocols 
for the differentiation of embryonic stem cells (ESCs) using EB formation are still physically ineffective 
and cumbersome due to the fact that it is fragmented and laborious procedures. Furthermore, optimal 
culture conditions and requirements as well as precise differentiation mechanisms and cellular 
interactions within EBs are still not well characterized, resulting in the sub-optimal control of 
homogenous differentiation especially due to the formation of all three germ layers. In addition, 
cavitation within EBs results in a loss of available cell numbers which reduces the yield and quality of the 
cellular product outcomes (Hwang, Randle et al. 2006). Considering the fact that it is important to 
produce a homogeneous population in the targeted cell differentiation from ESCs for clinical practice, 
several experimental standards have been suggested in order to prove in vitro and in vivo efficacy 
(animal model), to have a safety test (teratoma formation) and to negate the innate rejection 
mechanism of the human body (immune rejection) (Zandstra and Nagy 2001). Further study is necessary 
to examine the tumorigenic potential of the long-term ESCs transplants.  
51 
 
                    Ethical issues involving ESCs isolated from the destruction of an embryo have become the 
main concern among modern society globally.  Derivation of induced pluripotent stem (IPS) cells from 
skin cells with specific gene modification offers a desirable alternative in that they possess the major 
benefits of ESCs with less controversial issues and less immune rejection problems (Si-Tayeb, Noto et al. 
2010). However, there are still some complications faced when dealing with IPS cells which remain from 
the side effects of using viral vectors in the gene transfection process that are not supposedly to be 
neglected (Yamanaka 2007). Prior to clinical needs on developing a desirable source of pluripotent stem 
cells, many research efforts have focused on developing various methodologies to derive ESCs towards 
specific lineage effectively. These include some involvement of cytokines, growth factors and chemical 
reagent that could be introduced in order to direct stem cell differentiation in vitro which also can be 
combined with the three-dimensional culture system  (Heng, Cao et al. 2004).     
 
2.4. Differentiation Process For Blood Formation From ESCs. 
2.4.1. In vivo Development of The Embryonic Germ Layer 
 
                 The following stages normally involved during embryogenesis, include 1) cleavage (vigorous 
cellular division of the fertilized eggs); 2) morula (formation of a spherical mass of the cells); 3) 
blastocycst (cavity development in the spherical mass of the cells); 4) gastrulation (formation of three 
germ layers; endo-, ecto- and mesoderm, that leads to differentiation towards all the cell types of the 
body) (Figure8) (Tam, Williams et al. 1993; Tam and Loebel 2007).   Studies have focused more on the 
stage of the blastocyst which contained an inner cells mass composed of pluripotent cells surrounded by 
the trophectoderm and the primitive endoderm. Subsequently, having severe biochemical signalling 
exchanges between them, the inner cell mass differentiates to the epiblast (also called primitive 
ectoderm in the late stage of epiblast) and primitive endoderm (Rathjen, Lake et al. 1998).  The further 
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development process of the primitive endoderm resulted in the formation of two different types of 
endoderm, namely, parietal endoderm and visceral endoderm. The visceral endoderm, which localized 
in the anterior region during the gastrulation stage, plays an important role in regulating the 
developmental procedures. 
                       Prior to gastrulation, the primitive ectoderm in the late stage of epiblast is lined over the 
distal visceral endoderm layer and vigorously exchanges various biochemical signals (Tam and Loebel 
2007). The developmental process moves to the next phase entering the gastrulation stage. During this 
stage, the posterior cells of the epiblast migrate into the space between the epiblast and the visceral 
endoderms are ready for the formation of the primitive streak along the posterior axis of the embryo 
(Lawson and Schoenwolf 2003). Haemangioblast, the precursor of the mesoderm and endoderm is 
derived whilst the primitive streak is positioned. At the same time, ectoderm is also ready to be 
generated from the epiblast cells which have not migrated through the primitive streak (Tam and Loebel 
2007). It is believed that blood cells are developmentally originated from the mesodermal lineage. 
Therefore, many researchers have focused more on the development process of mesoderm in vivo in 
order to have a better understanding on the process of haematopoiesis.   
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Figure 8. The Process of Embryogenises Occur In Vivo In Brief (adapted from Tam and Loebel 2007). 
 
2.4.2. In vitro Blood Differentiation From ESCs 
 
                       Considering the facts that the in vitro sequences of lineage commitment event in ESC 
differentiation exhibit the same process that closely mimics the embryogenesis development in vivo 
(Keller 1995b), EB-based techniques have been successfully used as a model to study the in vitro 
formation of the embryonic germ layers.  However, certain limitations especially on their inability to 
precisely control the differentiation is still the main problem as the competition among the three germ 
layers formed (endo, ecto and mesoderm) would normally occurred during the developmental process 
resulting in the heterogeneity of the cell population in the EBs (Hwang, Randle et al. 2006). Recent 
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studies have put more interest on the investigation of the activation or direct transfection of the variety 
of transfeciption factors which normally are expressed in the inner call mass of the blastocyct. This 
fundamental step is important to provide such information for selections of the growth factors and their 
appropriate antagonists which are involved during the developmental process prior to the ESCs 
differentiation towards mesodermal lineage  (Loebel, Watson et al. 2003).  
                     Many research efforts have shown that specific differentiation of ESC towards the 
mesodermal lineage can be controlled by a few factors which include the induction of Transforming 
growth factor beta (TGF-β) proteins, the use of Bone Morphogenic Proteins (BMPs) and activins and the 
regional coordination of canonocal Wnt and Nodal pathways (Watabe and Miyazono 2009). Recent 
studies have also highlightened the important roles of BMP4 and activin A in the generation of a 
primitive-streak-like population from ESCs leading to the formation of mesodermal cells (Liu 1999). 
Further research works have shown that in addition of BMP4 and haematopoietic cytokines such as 
Stem cell factor (SCF) and Interleukin-3 (IL-3) during early haematopoietic development generates the 
modulation of proliferative and differentiative adult haematopoietic progenitors (Keller, Kennedy et al. 
1993; Zhu and Emerson 2002; Pina and Enver 2007; Kassouf, Chagraoui et al. 2008). Moreover, it has 
also been reported that a lack of gene expression such as C-kit and Gata-2 delays the early 
haematopoietic differentiation and the inactivation of BMP4 in mouse model has shown low 
mesodermal differentiation (Keller, Kennedy et al. 1993; Zhu and Emerson 2002).    
                  The development of the mesodermal population, which have been induced by the addition of 
BMPs during ESC-differentiation showed a highly expression of Brachyury-T followed by Foetal liver 
kinase-1 (Flk-1) gene expression (Park, Afrikanova et al. 2004). The combination of BMPs and activin 
induces the dominant generation of posterior primitive streak progenitors. The addition of activins 
activates the Nodal pathway which induced the expression of Foxa2 and Goosecoid (Watabe and 
Miyazono 2009). Furthermore, it has also been shown that the subsequent formation of the definitive 
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endoderm (anterior streak) or mesoderm (posterior streak) normally depended on the concentration of 
activins. Recent studies have shown that the inhibition of Wnt/β-catenin during early stage of ESC 
differentiation resulted in the deficiency of haematopoietic stem cells produced, having the long-term 
growth and maintenance problem (Murry and Keller 2008). Therefore, it is believed that the induction of 
mesodermal derivatives from ESCs is also correlated with Wnt signalling systems.  
                     The differentiation method using a co-culturing system allows ESCs to have a direct physical 
contact and to share paracrine factors with different cell types mimicking the natural developmental 
environments (Trounson 2006). Current ESCs protocols have shown that the co-culture system can also 
be used as one of the self-renewal maintenance method for ESCs in culture. Several types of somatic 
stromal cells have been used to promote co-culture environment such as mitotically inactivated murine 
fibroblasts, human foetal fibroblast (Richards, Fong et al. 2002) and bone marrow stromal cells (Cheng, 
Hammond et al. 2003). Application of the co-culture technique in culture is known to provide various 
signals secreted by the visceral endoderm promote the activation of mesodermal development although 
the exact pathways to be proven are still obscure.  
                     The use of Visceral endoderm-like cell (END2) in ESCs differentiation has been reported 
recently, resulting in the production of the activins and BMPs signals in culture due to the concept that 
this cells type occurs in vivo in the adjacent mesoderm (Mummery, Ward et al. 2002). Further studies on 
ESCs haematopoietic differentiation demonstrated that co-culturing mESCs with OP9 stromal cells and 
EB formation provided potent stimuli for haematopoietic differentiation and enhanced the 
haematopoietic progenitor colonies formation (Keller, Kennedy et al. 1993; Sakamoto, Tsuji-Tamura et 
al. 2010).  Moreover, recent studies have focused on using primary bone marrow derived cells and 
murine foetal liver derived cells for in vitro ESCs haematopoietic differentiation as it has been proved 
that using co-culture technique with those cells promote better maturation of red blood cell enucleation 
process (Lu, Feng et al. 2008; Ma, Ebihara et al. 2008). However, a potential problem from the co-culture 
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system is the formation of heterokaryons due to the close physical contact between the cells that may 
cause fusion of different cell types (Heng, Cao et al. 2004). Furthermore, there could be a high risk of 
pathogen transmission occurring during the culture process that contaminates the cells harvested.  
                      Recent works on using the conditioned medium form human hepatocarcinoma cell line, 
HepG2 by Rathjen et al. (1999) have suggested an idea of the ESCs transition to a novel cell population 
in vitro which ideally considered as the second pluripotent stage holding similar behaviour to epiblast in 
vivo (Figure 9) (Rathjen and Rathjen 2001). Moreover, similar studies have shown that the bioactive 
components of HepG2-conditioned medium (HepG2-CM) have been verified as an equivalent to the 
signals relevant with the pre-gastrulation embryo or expressed by visceral endoderm-like cell that 
possess the similarities of liver cell line and visceral endoderm biochemical reaction (Rathjen and 
Rathjen 2001; Rodda, Kavanagh et al. 2002). After the treatment with HepG2-CM, EB suspension culture 
progresses in the absence of visceral endoderm in that they initially have been affected by exogenous 
visceral endoderm-like signals. This results in the formation of multipotent mesodermal progenitors at 
the expense of ectoderm during in vitro embryogenesis (Lake, Rathjen et al. 2000). Therefore, the use of 
HepG2 treatment can be usefully applied in culture step to enhance the formation of mesoderm 
formation as well as direct the differentiation towards ESCs haematopoietic differentiation.    
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Figure 9. Derivation of The Mesoderm Layer from ESCs Using HepG2-CM 
(adapted from (Lake, Rathjen et al. 2000)) 
 
2.5. Three-dimensional bioprocess for in vitro blood formation 
 
                    Clinical applications using ESCs derivatives remains technically challenging. Current 
established protocols for the culture and differentiation of embryonic stem cells (ESCs) utilize two-
dimensional (2-D) tissue culture flasks/dishes. This culture method is cumbersome and inefficient for  
large-scale production. Although in theory ESCs can be expended indefinitely, traditional 2-D ESCs 
culture method is still facing a few common problems including labour-intensive, time-consuming 
nature and surface area availability for culture which result in a limited amount of cells to be harvested 
in vitro (Placzek, Chung et al. 2009). In addition, 2-D culture condition would also limits the three-
dimensional (3-D) interaction between ESCs and extracellular matrix or other neighbouring cells as 
normally exist in vivo (Polak and Mantalaris 2008). Therefore, it is important to create a 3-D culture 
environment in order to provide a better culture condition that mimics in vivo condition for the 
effectiveness of ESCs maintenance, expansion and differentiation in vitro.  
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                       One of the major concerns on promoting 3-D cell culture is the development of efficient 
nutrient supply for the in vitro generation of the living tissues. Recent research works using 3-D culture 
environment normally focus on the cell viability, metabolic activity and other physiological reaction 
(Ishaug-Riley, Crane-Kruger et al. 1998; Holy, Shoichet et al. 2000). Due to this reason, it is suggested 
that common culture practice especially on feeding the cells regularly is impractical to apply on the 3-D 
cells/matrix hybrids.   Several factors that affect the growth of cells in 3-D culture have been high 
lightened which include: (1) the complex inter-linkage of nutrients, metabolites and other 
environmental factors within the immediate cellular environment (King and Miller 2007); (2) lactate and 
ammonia that affect pH level (Cormier, Zur Nieden et al. 2006); and (3) oxygen tension that influences 
cellular metabolism such as consumption and production rate of glucose and lactate  (Powers, Millman 
et al. 2008). Therefore, the idea of developing a novel 3-D bioprocess for culturing ESCs appear to be a 
promising approach to overcome those limitations from the conventional 2-D culture system as stated 
above. 
                 The materials used in standard cultures which are involved in the 3-D system, include scaffolds 
or micro carriers and bioreactor applications. A bioreactor is defined as a controllable and reproducible 
culture device that provides cell/tissues in a mechanically active environment. Applications on 
bioreactors are believed to be able to circumvent the few culture problems specifically on the spatial 
gradients of physicochemical parameters which are normally caused by mixing limitation and difficulties 
in controlling the medium supplements at the optimal level. These factors are important in order to 
develop an effective culture condition for ESCs differentiation towards the targeted specific lineage of 
interest and to produce a scalable and reproducible system (Czyz and Wobus 2001; Chao, Xi et al. 2009). 
In addition, bioreactors provide a better cultivation process for the engineered tissues which improved 
the overall structural integration including construction size, cellularity and molecular composition(Pei, 
Solchaga et al. 2002; Dang, Gerecht-Nir et al. 2004) by enhancing mass transport of nutrients 
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(Obradovic, Carrier et al. 1999; Radisic, Yang et al. 2004) and growth factors provided in culture (Pei, 
Seidel et al. 2002; Pearson, Sroczynska et al. 2008). 
 
2.5.1. Application of Three Dimensional Scaffolds in Tissue Engineering 
 
                   The initial theory of using tissue engineering application in cell culture works is to create a 
three-dimensional environment by seeding the cells on a 3-D scaffold that is usually composed of 
synthetic polymers or naturally-derived biomaterials. The scaffold is designed to promote the tissue 
development from the cells seeded on or within the scaffold. With regards to the safety issue on using 
tissue-engineered constructions clinically, many specific requirements have been proposed on choosing 
the right materials for making the scaffolds. Several aspects have been highlightened which include the 
biocompatibility, temporal mechanical support, controlled degradation and interstitial fluid flow for 
adequate mass transports etc. (Elisseeff, Puleo et al. 2005). Recent research efforts have focused on 
using 3-D culture for ex vivo maintenance, expansion and differentiation of haematopoietic cells and 
blood progenitors which were developed to mimic the stem cells niches in bone marrow. Numerous 
studies have led to the development of a list of materials that could be used for the above reasons with 
current clinical availability which include porous hydroxyapatite, poly (lactic-co-glycolic acid; PLGA) and 
nanofibers scaffolds (Berthold, Haibel et al. 2007; Ma, Chan et al. 2008; Blanco, Mantalaris et al. 2010). 
Further works on the ex vivo studies of haematopoietic stem cells have shown that the material 
properties could affect the expansion and differentiation of these cells in culture.                  
                         Additionally, several types of biomaterial have had their structures modified with the 
addition of certain types of amino acids and adhesive peptide domains prevalent in the proteins of ECM. 
It showed that cellular growth and responses in the 3D configuration appear to resemble that in the in 
vivo system  (Tan, Liu et al. 2010). Furthermore, recent works have shown that a lack of exogenous 
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growth factors also did not inhibit the ability of haematopoietic stem cells in maintaining the multi-
lineage differentiation in the 3-D configuration. Studies have shown that multiple cellular functions are 
affected by various surface properties of the polymeric scaffolds such as hydrophibicity, complex 
structure, various charges and chemical compositions (Hollinger and Battistone 1986; Puleo and Bizios 
1992; Rezania and Healy 2000). This leads to the idea of producing a novel scaffold material with bio-
mimetic properties that would maintain high cellular viability and mimic the ECM roles, specifically on 
adhesion, migration, proliferation and also differentiation (Liu and Roy 2005). However, the problem of 
harvesting the cells from the scaffolds remain as the main issue because it is not a straight-forward 
process and may cause damage to the cells which may reduce the viability or achieve only partial 
dissociation. 
 
2.5.2. Encapsulation of Alginate Hydrogel 
 
             The fundamental theory of applying tissue engineering approaches in cell culture works is to 
remodel the seeded cells within 3-D porous structure into tissue-like structures  (Mooney and Mikos 
1999).  However, it is known that most polymeric scaffolds are typically processed under severe 
conditions which normally produced using toxic reagents. Furthermore, it is considered to be relatively 
difficult to incorporate a variety of factors important on the scaffold to improve the cell growth in order 
to mimic the in vivo condition. Besides, it is also not easy to distribute the cells homogenously in the 
solid porous structure practically (Chia, Leong et al. 2000; Uludag, De Vos et al. 2000; Bienaime, Barbotin 
et al. 2003) (Drury and Mooney 2003). Therefore, the idea of using a class of hydrated polymer materials 
namely hydrogels have been employed as an alternative material of making scaffolds in order to 
overcome the existing problems with the solid-type scaffolds.  
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                       Several advantages of using hydrogel in culture works have been listed as follows: 1) 
biocompatibility which defined as a low undesirable immune response; 2) controllable biodegradability; 
3) low mechanical stress or frictional irritation on the surrounding tissue due to the soft and pliable 
nature; 4) convenient modulation of physical and chemical properties for adequate application to any 
case of surgery; 5) high permeability for transport of nutrients and metabolites; 6) homogeneous cell-
distribution in the three-dimensional structure (Chia, Leong et al. 2000; Uludag, De Vos et al. 2000; 
Bienaime, Barbotin et al. 2003). During the gelling process of forming hydrogel, cell can be encapsulated 
resulting in a small bead formation. The advantage of using this method is that cells can be surrounded 
by a small amount of a physiologically relevant matrix. This bead containing cells can be cultured and 
can be potentially transplanted into body as remain in the encapsulated shape. This approach offers a 
good strategy for tissue engineering application specifically for cell delivery system. Despite the facts 
that hydrogels have low mechanical properties, they provide a mechanical integrity by developing a 
matrix for accelerated tissue formation. It is believed that the chemical and physical properties of 
hydrogel scaffolds could be altered to improve tissue development as compared to other types of 
biomaterials (Elisseeff, Puleo et al. 2005). 
                      Alginate material has been widely used in many research works for tissue engineering 
application and it has also been proven to promote macromolecular structure formation as resembled 
the ECM formation in vivo (Glicklis, Shapiro et al. 2000; Leor, Aboulafia-Etzion et al. 2000). Alginate is 
produced from brown seaweed, which specifically described as a water soluble linear polysaccharide 
composed of 1-4 linked α-L-guluronic and β-D-mannuronic acid residues block. With a presence of 
multivalent cations, usually divalent Ca
2+
, Ba
2+
 or Sr
2
 turning alginate solution into hydrogel formation 
(Smidsrod 1975). Ca2+ and those cations normally take part in the interchain binding between the 
blocks of guluronic residues in alginate strands and forming a 3-D network of a hydrogel. This network, 
namely “egg-box” model, which is represented by solid circle depicting calcium ions positioned between 
62 
 
consecutive guluronic acid residues (V-shaped structures). At the same time consecutive mannuronic 
acid residues are depicted by the curves which take place at the end of the “egg box” (Figure 
10)(Simpson, Stabler et al. 2004). 
                
Figure 10. A Schematic Diagram Represent The “Egg-Box” Model in Low and High CaCl2 Concentration 
(adapted from (Simpson, Stabler et al. 2004). 
 
                  Although the arrangements of polysaccharides blocks would have some changes between the 
peripheral layers and the beads centre, this well-structured gel composed of macromolecular 
construction supports the orientation and regular geometric structure throughout the gel network. The 
different structure of gel network for a Ca-alginate gel bead is shown by Figure 10 (Bienaime, Barbotin 
et al. 2003). Formation of a microcosm structure with heterogeneous layers resulted from each Ca-
alginate bead production which can be described in detail as follows; very dense gel sectors (superficial 
crust and subsurface); strong, medium and weak gelled zones and regions with micro fractures, cavities, 
shafts, and shafts clusters. During the gelling process of Ca-alginate hydrogel formation, the process is 
briefly described as follows; The first step starts with the formation of the superficial crust acting as a 
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spherical belt that tightens the gel bead progressively; The second step follows with a reduction of the 
gel bead volume with water expulsion (syneresis), resulting from the reaction-diffusion process between 
alginate macromolecules and calcium cations; The third step continues by the movement of alginate 
molecules that have not reacted yet with calcium, which moved from the bead centre to the boundary 
of the reaction front that attracts by the accumulation of calcium cations; The fourth step ends all of the 
process forming a cascade of reaction-diffusion mechanism that triggers the formation of micro 
fractures, shafts, shafts clusters and cavities (Figure 11).   
                        The rearrangement of the internal part of alginate molecules occurred during the reaction-
diffusion process of gelation. It is believed that the movement of alginate molecules contributes to the 
movement of cells from the centre to the surface of the forming gel bead when they are cultures in the 
alginate solution.  It has shown that the growth and expansion of cells would be achieved in a soft gel 
network of the hydrogels as it provides spaces within the construction. In other points, a hard gel 
network, which is close to the surface area of the bead, is recommended for a distinction between 
external and internal circumstances of the beads that provides an isolated and independent vehicle of 
the cells with desirable permeability. Several parameters control the gel densities, porosity, presence of 
cavities and shafts such as alginate solution concentration, ionotropic cation concentration, 
temperature, stirring and impurities content (Bienaime, Barbotin et al. 2003). Interestingly, it has been 
shown that bead production could be achieved with a highly reproducible rate when the same 
conditions and reagent concentration are used. Recent research works have also demonstrated that 
alginate and gelatine could be used to overcome the inert nature of alginate which increased the bead 
integrity. It has been found that normal alginate hydrogel structure tends to lose Ca
2+
 cations after 
prolonged culture. With the addition of gelatine, the alginate hydrogel structure could be improved 
specifically on enabling the cell-mediated contraction and packing of the scaffold material (Awad, 
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Wickham et al. 2004). The alginate/gelatine matrix and embedded cells interaction would contribute to 
their morphological and physical behaviour. 
                                       
Figure 11. A Schematic Diagram Shows The Different Gel Network Structures of A Ca-alginate Gel Bead 
(adapted from (Bienaime, Barbotin et al. 2003)). 
 
2.6. The Development of Three-Dimensional Bioprocess for Blood Production From ESCs. 
 
                      The requirement of producing a three-dimensional tissue substitute is not only dependant 
on the biological consideration but also the technical development of culture strategies involving the 
bioreactor system (Ratcliffe and Niklason 2002). Conventional culture practices are concerned only on 
biological aspects such as an adequate source of proliferative cells with appropriate biological functions 
and a protocol of expanding cells for maintaining the tissue-specific phenotype. For the improvement of 
the culture techniques, a well-defined scale-up platform is necessary (Rungarunlert, Tar et al. 2010).  
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2.6.1. Bioreactors Application on Haematopoietic Differentiation of ESC.  
 
                      Recently, novel scenario methods for the bioprocess of ESCs in hydrodynamic conditions 
created by bioreactor culture systems using stirred suspension systems (spinner flasks) have currently 
been used to achieve ESC expansion in a large scale and also effective to generate differentiation of 
many cell types including blood cells from ESCs (Fridley, Fernandez et al. 2010). Their use allows for 
continuous monitoring and control of the physical and chemical environment which is difficult to 
achieve by traditional methods.  In addition, micro-carriers have also been introduced in a stirred system 
to influence ESC adhesion because it is difficult for ESCs to have initial agglomerations in a suspension 
state (Fok and Zandstra 2005). Dang et al. in 2004 demonstrated mESCs and human ESCs encapsulated 
in agarose hydrogel with serum culture condition particularly for a clinical adaptability using a stirred 
tank bioreactor and showed an effective expansion expansion and differentiation into haematopoietic 
cells. 
                      This method resulted in high cell numbers that could be obtained by more cellular 
aggregations bridging on the bead surfaces but it appeared that the size of agglomeration is in huge 
variances. Recently, centrifugation of ESCs within round-bottomed 96-well plates was also attempted to 
induce ESC-aggregations more rapidly but it still requires individual processing and manipulating of the 
resulting EBs (Ng, Davis et al. 2005). Although the use of stirred bioreactors in tissue engineering is very 
well-known, several disadvantages remain on this system. The problem mainly focused on the flow 
environment created by the impeller renders them inappropriate due to the shear stress (Placzek, 
Chung et al. 2009; Rungarunlert, Tar et al. 2010). A low rate of paddle-impeller stirring results in cell 
clumping in aggregation supporting EB cultures that leads to lower mass transport to the cells whilst 
high rates of paddle-impeller stirring can be harmful for the cells. Consequently, an optimal fluid velocity 
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promoting the suitable shear stress for the cell type during the culture process is critical  (Rungarunlert, 
Tar et al. 2010).  
                      Cells in a conventional stirrer are exposed to hydrodynamic shear stress resulting in damage 
to the cells. Another approach for controlling EB agglomeration employs a rotating wall vessel (RWV) 
bioreactor system which is comprised of a slow turning lateral vessel (STLV) and a high respect rotating 
vessel (HARV)(Placzek, Chung et al. 2009; Rungarunlert, Tar et al. 2010). This system has been developed 
by National Aeronautics and Space Administration (NASA) in the US to physically stimulate the gravity-
free environment in the outer space. Initially, the behaviour of mammalian cells within this micro-gravity 
environment were investigated in order to predict the health conditions of astronauts in space. 
Nowadays, bioprocess engineers adopted this technology to overcome the limitations from using the 
impeller type of bioreactor (Hammond and Hammond 2001). The advantages of these bioreactors are as 
follows: (1) horizontal rotation is characterized by extremely low fluid shear stress; (2) fluid-filled culture 
vessels are equipped with membrane diffusion gas exchange to optimize oxygen levels and (3) 
membrane area to volume of medium ratio is high, thus enabling efficient gas exchange  (Rungarunlert, 
Tar et al. 2010). Studies have shown that the type of rotating vessel had significant impacted on the 
process of EB formation and agglomeration. EBs formed small aggregates with no necrotic centers in 
STLV whilst EBs of extensive cell aggregation with large necrotic centers are formed in HARV. For this 
reason, researchers have suggested that the culture condition in SLTV is suitable for the efficient 
productivity in term of EB’s maturity (Gerecht-Nir, Cohen et al. 2004). Fridley et al. in 2010 compared 
different types of culture condition which include stirred tank bioreactors and the STLV system for EB 
formation and haematopoietic differentiation of mESCs. Interestingly, the study showed the expression 
of specific haematopoietic genes were significantly more upregulated in the STLV cultures than in 
spinner flasks. Although mESCs grown in a STLV bioreactor showed higher quality of EBs and enhanced 
differentiation, unexpectedly, this system presented the slowest growth rate and lowest final cell 
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concentration and survival potential. This finding can be accountable to the specific type of STLV 
bioreactor used which has a limitation of oxygen mass transfer (Yirme, Amit et al. 2008).    
 
2.6.2. High Aspect Rotating Vessel Bioreactor 
 
                     The HARV bioreactor is another alternative culture system that shows promise in addressing 
the shortcoming of conventional cell culture apparatus for 3-D culture (Figure 12) (Hammond and 
Hammond 2001). This system has been widely used in the culture of cells seeded on scaffolds or 
microcarriers or without scaffolds in mesoderm-mediated differentiated cells such as in cartilage, bone 
and heart muscle tissue formation in vitro. Similar with STLV systems, the HARV bioreactor is designed 
to optimize the production of laminar flow and minimize the mechanical stresses on the cell aggregates 
in culture by minimizing shear and turbulence. These conditions are conducive to the formation of 
aggregates or adherence of cells to substrates such as microcarriers and extracellular matrix (ECM). As 
cells proliferate and reorganize, they can form 3-D structures that resemble native tissue. The 
sedimentation of 3-D cell aggregates in the vessel confers additional benefits in terms of mass transfer, 
the constant movement of aggregates in the media insures that nutrient and oxygen and waste transfer 
will not be limited by diffusion as they are in static culture systems. Oxygenation is provided by a 
permeable silicon rubber membrane through the stationary inner cylinder, allowing the passive 
exchange of gases to and from the medium whereas the outer cylinder is impermeable and rotates at a 
controlled rate. The free falling of the microcarrier inside the bioreactor as a result of gravity can be 
balanced by the centrifugal forces due to the rotation of the outer-cylinder thus establishing suspension 
culture environments for microcarriers (Hammond and Hammond 2001).  
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Chapter 3.       
Goal and Objectives 
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3.0 Goal and Objectives 
The ex vivo expansion and differentiation of ESCs towards the hematopoietic lineage require 
defined culture systems that can be optimally controlled in order to meet the high clinical standards. 
Conventional protocols for two-dimensional (2-D) cultures of ESCs involve three stages: a 
maintenance/expansion phase, an embryoid body (EB) formation phase and finally the terminal 
differentiation to the desired cell lineage(s). However, differentiation of ESCs in 2-D cultures is 
fragmented, has low output numbers of differentiated cells, and is time- and labour- intensive. Optimal 
culture conditions and requirements as well as the precise differentiation mechanisms and cellular 
interactions within the formed EBs still lack proper characterization, resulting in sub-optimal control for 
a homogenous differentiation, especially due to the formation of all three germ layers. Furthermore, 
cavitation on the EBs ensues in loss of available cell numbers.  
The overall goal of this thesis is to overcome these obstacles and meet the needs of stem cell 
and cell culture bioprocesses by developing an integrated, single-step bioprocess that (1) utilises 
conditioned medium (CM) derived from HepG2, a human hepatocarcinoma cell line that has been 
previously shown to stimulate preferentially the mesoderm layer and (2) utilises encapsulation of 
undifferentiated mESCs to by-pass the EB formation step, doesn’t require the passaging of cells and 
involves culture in a rotating wall vessel bioreactor. Currently, EB formation is the most established 
technique for lineage-restricted differentiation of ESCs. It results in the generation of the three germ 
layers, namely ectoderm, endoderm and mesoderm, which are on the origin of all the different cell 
lineages. However, EB formation presents several problems, specifically due to the inherent 
heterogeneity of the cell population and their committed differentiation to unwanted lineages. 
Therefore, it is important to control spontaneous differentiation of ESCs in culture as well as to ensure 
the quality of cells and improve the differentiation efficiency, which requires that proper cues are 
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delivered to the cells in order to direct differentiation of the ESCs to the specific lineage of interest. 
Herein, we present an efficient method for enhanced mesodermal differentiation of mESCs resulting in 
the production of hematopoietic cells using conditioned medium from the HepG2 cell line. Through this 
approach, we aim at studying the effect of HepG2 CM and promoting better mesodermal differentiation 
of mESCs as well as enhancing hematopoietic differentiation in conventional 2-D methylcellulose-based 
culture media.  
The high demand for large-scale production of cell masses in cell-based clinical technologies is 
necessary for the high regulation of ESCs differentiation, requiring the use of a robust and efficient 
experimental 3-D in vitro culture system that can mimic the in vivo physiological environment. Its 
novelty lies on the fact that the 3-D culture system proposed is suitable for the expansion and 
differentiation of ESCs by facilitating close cell-cell interactions. We propose to implement a 3-D alginate 
encapsulation technique with HepG2 CM and a bioreactor for generating a dynamic 3-D cultivation 
system that may result in a new robust protocol for the hematopoietic differentiation of mESCs. 
Specifically, we aim at using alginate encapsulation and a bioreactor to define the 3D in vitro 
erythropoiesis of undifferentiated mESCs, and demonstrate the success of using the above 3D culture 
methods in enhancing mESCs hematopoietic differentiation, which could then easily be applied in vitro 
for the effectiveness and efficiency of 3-D differentiation culture methods. We look forward to be able 
to prove that the combination of HepG2-CM and 3D culture environment can enable the direct 
formation of haematopoietic cells, especially from the erythroid lineage and by-passing the EB 
formation step. This idea of producing a robust 3-D cell culture system that is suitable for mESCs 
differentiation will involve: (1) the development of a reproducible, controlled and dynamic 3D 
environment for hematopoietic differentiation; (2) the characterization and optimization of 
hematopoietic differentiation within encapsulated mESCs and a bioreactor for scaling up 3D 
hematopoietic differentiation of mESCs; and (3) the establishment of a single-step culture protocol for 
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the 3D hematopoietic differentiation of mESCs, integrating traditional mESCs culture protocols through 
the encapsulation of undifferentiated mESCs within alginate beads and supported by an automated 
perfusion bioreactor. The successful evaluation of these three components will allow a better 
understanding of the defining culture parameters for the production of clinically-relevant mature cells 
through the culture of mESCs in an integrated bioreactor culture system. 
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Chapter 4.   
Materials and Methods 
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4.0. Materials 
4.1. Culture media 
4.1.1. Mouse ESCs (mESCs) Maintenance Medium 
High glucose Dulbecco’s Modified Eagles Medium (DMEM) without sodium pyruvate (Gibco, 
Invitrogen, Paisley, UK) was supplemented with 10% foetal bovine serum (FBS; Gibco), and 100 units/ml 
penicillin and 100 µg/ml streptomycin, 2 mM L-glutamine (all supplied by Gibco), 0.1 mM β-
Mercaptoethanol (Sigma-Aldrich, Poole, UK) and 1000 U/ml of Leukaemia Inhibitory Factor (LIF) 
(Chemicon, Millipore Upstate, Hampshire, UK)  
4.1.2. HepG2 Maintenance Medium 
High glucose DMEM without sodium pyruvate was supplemented with 10% FBS, 2 mM L-
glutamine and 100 units/ml penicillin and 100 µg/ml streptomycin (all supplied by Gibco) 
4.1.3. Pre-differentiation Medium 
High glucose Iscove’s Modified Dulbecco’s Medium (IMDM) with sodium pyruvate was 
supplemented with 15% FBS, 2 mM L-glutamine, 100 units/ml penicillin and 100 µg/ml streptomycin (all 
supplied by Gibco), 1mM Sodium Pyruvate , 0.1 mM Non-Essential Amino Acids, 100 µM 
monothioglycerol (MTG; all supplied by Sigma), 1000 U/ml LIF (Chemicon). 
4.1.4. Primary Differentiation Medium 
High glucose IMDM with sodium pyruvate (Gibco) was supplemented with 1% basic methyl-
cellulose (Stem Cell Technologies, Sheffield, UK), 15% FBS (Gibco), 2mM L-Glutamine (Gibco), 150 µM 
MTG (Sigma), and 40 ng/ml mouse stem cell factor (mSCF; R and D Systems, Abingdon, UK).   
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4.1.5. Feeding Differentiation Medium 
Primary differentiation medium was supplemented with 160 ng/ml mSCF, 30 ng/ml mouse 
interleukin (mIL)-3, 20ng/ml human (h) IL-6, and 3 U/ml h erythropoietin (EPO; all supplied by R&D 
Systems).     
4.1.6. Hematopoietic Differentiation of Colony-Forming Unit (CFU) Medium 
Hematopoietic differentiation medium were prepared using IMDM (Gibco) supplemented with 
15% FBS (Gibco) , 2mM L-Glutamine (Gibco), 150 mM MTG (Sigma), 1% BIT (1% BSA, 10 mg/ml Insulin, 
and 200 mg/ml Transferrin; Stem Cell Technologies, Sheffield, UK), 150 ng/ml mSCF, 30 ng/ml mIL-3, 30 
ng/ml hIL-6, 3U/ml hEPO (all supplied by R and D Systems), and 1% basic methylcellulose medium (Stem 
Cell Technologies). 
 
4.2. Cell Culture Methods 
4.2.1. mESC Maintenance  
mESCs cell line (E14 thioguanine resistance ; E14Tg2α, ATCC, Middlesex, UK) was routinely 
cultured and passaged on tissue culture flasks (VWR International Ltd., Leicestershire, UK) coated with 
0.1% gelatine (Sigma) and incubated in a humidified water-based incubator set at 37
0
 C and 5% CO2. 
Undifferentiated stage of mESCs (>passage 20) were passaged every 2 or 3 days and fed everyday with 
fresh mESCs maintenance medium. In order to passage the cells, mESCs were detached from the flasks 
using 0.05% (v/) trypsin-ethylenediaminetetraacetic acid (Trypsin-EDTA; Gibco), which added into the 
culture flasks after medium aspiration and a single wash with pre-warmed 1X PBS (Gibco). The cells 
were treated with Trypsin-EDTA for 2-3 minutes at 37
0
 C before adding the mESCs maintenance medium 
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to stop the reaction of Trypsin-EDTA after the cells detachment process. The process were continued 
with centrifugation step at 1280 rpm for 5 minutes to collect the cells pellet before re-suspending the 
cells with fresh mESCs maintenance medium to proceed the culture process.  
4.2.2. HepG2 Culture and Conditioned Medium Collection 
Human hepatocarcinoma cell line (HepG2; ATCC HB-8605) were cultured on tissue culture flasks 
at 37
0
 C in a 5 % CO2 humidified water-based incubator. HepG2 cells were passaged every 3 or 4 days 
and fed every 2 days with HepG2 maintenance medium. In order to passage the cell, HepG2 cells were 
treated with 0.25 % Tripsin-EDTA for 5 minutes at 370 C and the Tripsin-EDTA reaction were stopped 
with addition of HepG2 maintenance medium. The cell pallet was obtained after the centrifugation 
process at 1280 rpm for 5 minutes. The cells were resuspended in fresh HepG2 maintenance medium to 
proceed the culture process. 
HepG2-conditioned medium were prepared as in the same way of our previous works described 
by Hwang et.al (2006). Basically, a density of 5.0 x 10
4
 cell/cm
2
 HepG2 cells were seeded on tissue 
culture flasks and the culture were fed with HepG2 maintenance medium. In order to prepare for the 
conditioned medium collection, the culture medium was not changed for the following 4 days. The 
process continued with medium collection and filter-sterilisation step using 0.22 µm filter unit (VWR 
International Ltd) followed by supplementing the filtered medium with 0.1 mM β-mercapthoethanol 
(Sigma) and stored at -20
0
 C prior to use. HepG2 conditioned medium (CM) was formulated by mixing 
50% of fresh mESCs growth medium with 50% of the medium collected from HepG2 cells as described 
above, and subsequently with addition of 1000 units/ml of LIF in the mixture (Rathjen et al. 1999). 
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4.2.3. Pre-differentiation Stage of mESCs For 2-Dimensional (2-D) Culture System 
For control group, undifferentiated mESCs were cultured on coated tissue culture flask with 
0.1% gelatin (Sigma) and maintained in maintenance medium as previously reported. For experimental 
group (HepG2-conditioned medium treated mESCs; CM-mESCs), undifferentiated mESCs were cultured 
for 3 days in HepG2 CM and standard mESCs maintenance medium in a 1:1 ratio in tissue culture flasks 
coated with 0.1% gelatin as described above. mESCs in both groups were harvested by using 0.25% 
Trypsin-EDTA (Gibco) and were centrifuged after 48 hours cultured in maintenance media as previously 
described, prior to the start of the in vitro hematopoietic differentiation procedure. Cells then were re-
suspended in the pre-differentiation media and the live cells were counted using erythrosine B red stain 
exclusion assay for the viability test.  
4.2.4. ‘Embryoid-like’ colonies (ELCs) Formation in Primary Differentiation 
A cell suspension containing 3 x10
3
 cells/mL of control pre-differentiated mESCs and CM-mESCs 
groups was prepared and the cells were plated on low-adherence 35 mm Petri dish (VWR International 
Ltd, Leicestershire, UK) with semi solid media containing 1% basic methyl-cellulose (Stem Cell 
Technologies, Sheffield, UK), 15% FBS (Gibco), 2mM L-Glutamine 200 mM (Gibco), 150 µM MTG (Sigma) 
and 40 ng/mL  murine stem cell factor (mSCF) (R and D Systems, Abingdon, UK) in IMDM (Gibco). On day 
7, an amount of 160 ng/mL mSCF, 30 ng/mL murine interleukin (mIL)-3, 20 ng/mL human (h)IL-6, and 3 
U/mL human erythropoietin (hEPO; all from R&D Systems) was added. The cultures were incubated at 
37 
0
C under 5% CO2 in a humidified incubator wherein ‘embryoid-like’ colonies (ELCs) were formed. 
4.2.5. Hematopoietic Colony Forming Unit (CFU) Assay  
Control and CM-mESCs groups of eight-day-old ELCs were harvested and trypsinized to prepare 
a cell suspension containing 2 x 10
5
 cells/mL which were then cultured in hematopoietic differentiation 
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medium containing IMDM (Gibco) supplemented with 15% FBS (Gibco), 2mM L-Glutamine 200 mM 
(Gibco), 150 µM MTG (Sigma), 1% BIT (1% BSA, 10 µg/mL Insulin, and 200 µg/mL Transferrin; Stem Cell 
Technologies), 150 ng/mL mSCF, 30 ng/mL mIL-3, 30 ng/mL hIL-6, 3U/mL hEPO (all from R and D 
Systems) and 1% basic methylcellulose medium (Stem Cell Technologies). Cell suspensions were plated 
on low-adherence 35 mm Petri dishes (VWR International Ltd.) and cultured for an additional 14 days at 
37 
0
C under 5% CO2 in a humidified incubator. Resultant colonies were scored and counted using 
standard criteria for burst forming unit-erythroid (BFU-E), colony forming unit-erythroid (CFU-E), colony 
forming unit-granulocyte macrophage (CFU-GM), and colony forming unit granulocyte erythroid 
macrophage (CFU-GEMM; all colonies identified based on Stem Cell Technologies Hematopoietic 
Manual). Cells were collected following the 7-14 day secondary differentiation period and then 
subjected to morphological and gene expression studies. 
4.2.6. Encapsulated mESCs within Alginate Hydrogel Beads in 3-Dimensional (3D) Culture System 
Prior to mESCs alginate encapsulation, a mixture solution composed of 1.1% alginate acid 
(Sigma) and 0.1% gelatin (all dissolved in PBS, pH 7.4) was prepared and was filter-sterilised using 0.22 
mm filter unit as described in our previous study by Randle et.al (2007). A number of 1 x 10
7
 cells/ml 
(20,000 cells/bead) was counted and was resuspended in alginate-gelatin solution mixture. The cell-sol 
solution was passed through a peristaltic pump (Model P-1, Amersham Biosciences, Buckinghamshire, 
UK) and was dropped in a solution prepared for cross-linking hydrogel, which composed of 100 mm 
calcium chloride (CaCl2; Sigma) and 10 mm N-(s-hydroxyethyl) piperazine-N-(2-ethane sulfinic 
acid)(HEPES; Sigma) at pH 7.4. A flow rate of a peristaltic pump was empirically confirmed to produce 
proper single using a 25-gauge needle (Becton Dickson, Oxfordshire, UK) and a drop height was about 15 
mm. Prior to those processes, all tubes were autoclaved and sterilized with 1M of NaOH (Sigma) for 30 
minutes and were washed three times with sterile phosphate buffer saline (PBS; Gibco). The droplets 
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containing cells were gelled immediately on contact with the Ca2+ solution as a shape of bead 
(approximate diameter size: 2.3mm), and then remained in the gently stirred solution for 5 minutes at 
room temperature. The beads were washed three in PBS and placed into the mESC maintenance 
medium or HepG2-CM respectively regarding to the experimental group arrangement. 
4.2.7. High Aspect Ratio Vessel (HARV) Bioreactor  
The HARV (Cellon, Bereldange, Luxembourg) also known as a rotating wall bioreactor, was 
developed by Synthecon Ltd, USA in connection with the National Aeronautics and Space Administration 
(NASA) programme to study tissue and cellular engineering in a low-shear, non-turbulent environment. 
It has a large radius-to-depth ratio (40mm x 50mm) providing a substantial surface on the rear face for 
gas exchange through a gas-permeable membrane. The medium is 50 ml. The culture vessel itself is a 
disposable, sterile, clear plastic circular unit with two sampling or injection Lure lock ports and a half 
inch drain or fill port. Input media or beads were performed through the fill port and air bubble removal 
was undertaken through the Lure valves daily. The HARV units were attached to a rotator base which sat 
in a humidified incubator and were controlled by an external electrical unit.          
4.2.8. Alginate Beads Dissolution Buffer 
A sterile depolymerisation buffer was used to dissolve the beads that consisted of Ca2+ -
depletion solution with 50 mm tri-sodium citrate dehydrate (Fluka, UK), 77 mm sodium chloride (BDH 
Laboratory supplies, UK) and 10 mm HEPES (Sigma, UK). These ingredients were dissolved in PBS (Gibco, 
UK). The beads with medium were washed twice before adding the dissolving solution. Later, the beads 
were incubated at 37
0
C for about 5 minutes while stirring gently. The solution that contained dissolved 
beads was centrifuged at 1250 rpm for 5 minutes and the cell pellet was washed once with PBS (Gibco, 
UK) followed by centrifugation at 1000 rpm for 3 minutes.  
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4.3. Analysis of cells output    
4.3.1. Erythrosin-B Exclusion assay for Cellular Growth 
Cellular growth and cell viability were evaluated at each passage during the culture. Cells were 
manually counted using a haemacytometer under the Leica DM-IL inverted phase microscope (Leica). 
Cell viability was determined by a dye-exclusion method using Erythrosin-B stain solution (ATCC) which 
stains only dead cells reddish-pink. Fold expansion, defined by the increase in total cell numbers from 
the starting population, was one of the main criteria that guided the differentiation studies.  
4.3.2. Live and Dead Assay 
Viability of cells in culture flasks and inside hydrogels were evaluated using LIVE/DEAD Viability/ 
Cytotoxicity Kit (Invitrogen). Briefly, membrane-permanent 3’,6’-Di(O-acetyl)-2’,7’-bis[N,N-
bis(carboxymethyl) aminomethyl] fluorescein, tetraacetoxymethyl ester (calcein AM) is cleaved in live 
cells by esterases to yiled cytoplasmic green fluorescence, whereas membrane-impermanent ethidium 
homodimer-1 (EthD-1) labels nucleic acids of membrane-compromised cells with red fluorescence. Prior 
to the experiment, 2D-flask culture cells were grown on sterile 4 or 8 well chamber slides (VWR 
International) as both confluent and sub-confluent monolayers, while 3D-sample beads were collected 
and washed with PBS (Sigma). A concentration of 4 mM EthD-1 and 2 mM calcein AM solution diluted in 
PBS was added to the chamber-slide cells and the PBS-washed beads. Both samples were incubated at 
37 
0
C with gentle shaking for about 30 minutes in the dark. A negative control was conducted using 100 
% methanol (VWR International) for 5 minutes in place of PBS. After Incubation, the solution was 
aspirated and a small amount of PBS was added to the beads to prevent dehydration. Samples were 
visualised on the fluorescence Olympus BX51 microscope (Olympus, Essex, UK) and the image were 
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captured using the F-view unit (Soft Imaging System GmbH, Munster, Germany) with U-MNIBA3 (FITC) 
and U-MWIY2 (Texas Red) filters. 
4.3.3. Cell Proliferation Assay (MTS Assay) 
The capacity of mESCs to proliferate in each medium was compared by using the Cell Titer 96 
Aqueous One Solution Reagent MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium] assay (Promega, UK) to assess the metabolic activity of mESCs in a time-
course study, as per manufacturer’s instructions. The experiment was run in 24-well tissue culture 
polystyrene plates (VWR International Ltd.) coated with 0.1%  gelatin (Sigma) for at least 30 min. 
Gelatin-coated 24-well plates were seeded with 3x10
4
 cells/cm
2 
and cultured for 1, 2, 3, 4, and 5days in 
each primary differentiation culture medium. The cells/beads were incubated with MTS solution for 3 
hours. Following the process, an amount of 100mL of the solution from each treated samples was 
transferred into a separate 96-well plate and read at 490nm using an enzyme-linked immunosorbent 
assay (ELISA) reader (ELx808, BIO-TEK, USA).  
4.3.4. Immunocytochemical Staining 
Immunocytochemical staining was generally done according to following protocol throughout all 
experiment. Prior to the experiment, 2-D flask culture cells were grown in 4 or 8 well chamber slides and 
were fixed for 20 minutes in 4% paraformaldehyde (PFA; VWR International) followed by washing in 
PBS. The process was followed by permeablisation step with 0.2% Triton-X-100 (VWR International Ltd.), 
incubated for 45 min at room temperature. The samples were sequentially incubated with 3% blocking 
goat serum (Santa Cruz Biotechnology, Heidelberg, Germany) for 30 min at room temperature in 0.05% 
bovine serum albumin (Sigma), with 0.01% NaN3 (Sigma) in PBS as primary diluents. Prior to the staining 
process, the primary and secondary antibodies were diluted with primary and secondary diluents 0.05% 
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bovine serum albumin in PBS) respectively to prepare working solution and all antibodies used as listed 
in Table 2. Following the blocking process, the samples were incubated with primary antibody at 4 
0
C 
overnight before treating them with secondary antibodies for 1 hour at room temperature in the dark. 
The samples were then washed with PBS and mounted using Vectashield with 1.5 mg/mL 40,6 
diamidino-2-phenylindole (Vector Laboratories, Peterborough, UK).  
Table 2. List of Antibodies For Immunocytochemistry Staining 
 
                                                              Immunostaining Dilutions 
Antigen Primary Secondary Blocking Serum 
Oct-4 1:80 Rabbit polyclonal 
(Santa Cruz Biotech) 
1:80 goat anti-rabbit FITC 
(Santa Cruz Biotech) 
3% Normal goat 
serum (Santa Cruz 
Biotech) 
SSEA-1 
 
 
a-actinin 
(sarcomeric) 
1:200 Mouse 
monoclonal (Santa 
Cruz Biotech) 
1:100 Mouse 
monoclonal (Sigma-
Aldrich) 
1:200 Goat anti-mouse Texas 
red (Santa Cruz Biotech) 
 
1:64 Goat anti-mouse IgG FITC 
(Sigma-Aldrich)  
3% Normal goat 
serum (Santa Cruz 
Biotech) 
3% Normal goal 
serum (Santa Cruz 
Biotech) 
 Immunostaining antibodies for Erythropoiesis   
CD71 
 
TER-119 
 
FITC Rabbit anti-mouse CD71 
polyclonal (Assay Biotech) 
PE Rat Anti-Mouse TER-119/Erythroid 
Cells  (Biolegend) 
FITC Rabbit IgG Isotype Control 
(Assay Biotech) 
PE Rat IgG2b, κ Isotype Control 
(Biolegend) 
 
 
FITC, fluorescein isothiocyanate; PE, phyto-erythrin; PeCy5, phyto-erythrin Cyno-5 
4.3.5. Flowcytometry Antibodies Analysis 
Cultured cells were stained with antibodies as listed in Table 3 and were analysed via flow 
cytometry using the Epics-Altra (Beckman Coulter, UK) flow cytometry, equipped with a 488 nm Argon 
(Ar) laser. Prior to mESCs antibodies staining, alginate beads containing cells cultured in 3-D condition 
were dissolved using alginate dissolving buffer for about 5 minutes in order to collect the colonies of 
cells. Those colonies were then resuspended using small needle and syringe with slightly mechanical 
forces in order to obtain single cells.   A number of 0.5-1.0x10
6
 cells/mL were counted and were 
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suspended in Flowcytometry (FC) buffer containing PBS (Gibco) with 2% FBS (Gibco) and 0.1% sodium 
azide (Sigma). The samples were directly incubated with antibodies as listed in Table 2 at 4 
0
C for 30 
minutes. After staining, cells were washed twice with PBS prior to analysis. If fixation is required, cells 
were normally fixed in 0.2% para-formaldehyde (PFA) solution and stored in 4 
0
C for 24 hours prior to 
analysis. Data acquisition using the Epics-Altra is typically performed immediately or within three days 
following fixation, and a total number of 30,000 un-gated events was recorded for each sample. Data 
analysis and offline colour compensation for the FITC-PE and PE-FITC fluorescent panels were performed 
using WinList (Verity).  
Table 3. List of Antibodies For Flowcytometry Analysis 
 Antibodies for Flowcytomery Analysis on Erythropoiesis  
CD71 
 
TER-119 
 
FITC Monoclonal Rat Anti-Mouse 
CD71 (BD Pharmingen) 
PE Monoclonal Rat Anti-Mouse TER-
119/Erythroid Cells (BD Pharmingen) 
FITC Rat IgG1, κ Isotype Control (BD 
Pharmingen) 
PE Rat IgG2b, κ Isotype Control (BD 
Pharmingen) 
 
 
FITC, fluorescein isothiocyanate; PE, phyto-erythrin; PeCy5, phyto-erythrin Cyno-5 
 
4.3.6. Clonogenic Ability (CFU Assay For Hematopoietic Progenitors) 
In vitro clonogenic assays for the erythroid progenitors (colony-forming unit-erythroid; CFU-E 
and burst-forming unit-erythroid; BFU-E), granulocyte-macrophage progenitors (colony-forming unit 
granulocyte-macrophage; CFU-GM), and multi-lineage progenitors (colony-forming unit-granulocyte-
erythroid-monocyte-macrophage; CFU-GEMM) cells were assessed using methylcellulose-based media, 
Es-Cult M3120 (Stem Cell Technologies) which is supplemented with recombinant mouse SCF (150 
ng/ml), recombinant mouse IL-3 (30 ng/ml), human IL-6 (30 ng/ml), and human-EPO (3 U/ml) (all from R 
and D System). A number of 1-5 x 10
5
 cells/ml cells were seeded into 35 mm culture plate (VWR 
International) and the seeding densities are optimised according to the clonogenic ability of the cells as 
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recommended by the manufacturer’s technical manual (Stem Cell Technologies). All assays were 
performed in duplicates. Numbers and types of hematopoietic colonies were scored after 14-16 days of 
incubation period in a fully humidified chamber at 37 
0
C.            
4.3.7. Wright-Giemsa Staining 
Morphology of the cultured cells was observed on a cytospin. A cell suspension of 1x10
6
 cells/ml 
was prepared in PBS and 100ml of the cell suspension was loaded into a well in the cytospin 
cytocentrifudge set. Cells were spun for 3 minutes at 100g. The cuvette and filter in the cytospin 
cytocentrifudge set was then gently removed to avoid any damage to the fresh cytospin and the slide 
was air-dried for 5-10 minutes in preparation for immunocytochemistry. Cells were stained with Wright-
Giemsa stain (Sigma-Aldrich) in a Coplin jar via dip-method for nuclear-cytoplasmic differentiation. 
Slides were dipped for 10 seconds in Wright-Giemsa stain and subsequently dipped in deionised (DI) 
water for approximately 2 minutes to wash the stain.     Cells were visualised on the Olympus BX51 
microscope (Olympus UK Ltd) and images were captured using the DP50 camera (Olympus UK Ltd). 
Fluorescence microscopy was also used to verify the expression levels and distribution of cellular surface 
antigens for antibodies staining as described in flowcytometry antibodies staining above. The F-view unit 
(Soft Imaging System GmbH), a high resolution cooled CCD digital camera was used for capturing images 
in fluorescence microscopy.    
4.3.8. Gene and Protein Expression Studies 
4.3.8.1. RNA Isolation and Quantification from mESCs 
Sample of mRNAs from the mESC-cultured cells were extracted by using RNeasy kit (Qiagen, 
West Sussex, UK), according to the manufacturer’s instruction. Harvested cells were firstly disrupted in 
buffer RLT added with 1% β-Mercapthoethanol and homogenised in a Qiashredder spin column, 
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centrifuged at maximum speed for 2 minutes. Ethanol was then mixed to the cell lysate to promote 
binding of RNA to RNeasy membrane. Total RNA that bound to the membrane column was washed 
twice with Buffer RW1 before ethanol was removed using buffer RPE. RNA was then eluted in a 1.5 ml 
collection tube using RNase-free water. RNA quantification was performed on a UV spectrometer and 
the A260/A280 ratio of greater than 1.70 is required to ensure the quality of RNA sample.      
4.3.8.2. cDNA Formation By Reverse Transcriptase (RT) and Gel Electrophoresis 
Total mRNA was reversed transcribed into complementary DNA (cDNA) using the Reverse 
Transcription System (Promega, Southampton, UK) following the manufacturer’s recommendations with 
some modification. Briefly, Mastermix for cDNA synthesis was prepared with 1µg of RNA adding 5mm 
MgCl2, 1 mM of 2’-deoxynucleoside 5’-triphosphate (dNTP) mixture, 1 unit/µl recombinant RNasin 
ribonuclease inhibitor, 5 units/µl AMV reverse transcriptase and 0.5 mg/µl random primers in a total 
volume of 20 µl per reaction. The RNA samples were heated at 70 0C for 10 minutes, briefly centrifuged 
and cooled on ice for 5 minutes. After the mastermix was added to RNA samples, they were incubated 
at 25 
0
C for 10 minutes, and then reverse was performed at 42 
0
C for 40 minutes followed by 
denaturation at 90 
0
C for 5 minutes and a cooling step at 4 
0
C for 5 minutes. 
An amount of 50 µl of cDNA samples containing the mastermix, 1x Green Go Taq PCR Buffer 
which contained 1.5 mM MgCl2, 0.2 MM dNTP mixture, , 0.2 mM each primer (sense and anti-sense), 
1.25 unit of Go Taq DNA polymerase, and DNase free water (all supplied by Promega) were amplified 
with the following PCR conditions; Taq polymerase activation, 95 
0
C for 2 minutes; denaturation, 94 
0
C 
for 30 seconds; annealing temperature (AT)for 30 seconds, 72 
0
C for 60 seconds; followed by final 
elongation step at 72 
0
C for 5 minutes. The RT-PCR products were analysed and visualised via agarose 
gel electrophoresis for separation and visualisation. Agarose gel was made by mixing 1.5g of agarose 
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agar with 100 ml of 1x TBE solution, dissolved in a microwave with addition of 10 mg/ml of EtBr (10 
µg/ml) just before being casted to solidify. The process followed by transferring the solidified gel to the 
electrophoresis system. A DNA reference sample consisting of 5 µl of 100 bp DNA ladder and 1 µl of 
Blu/Orange loading dye was made up. Samples were loaded quickly into each well in the gel and 
subjected to electrophoresis at 95 V for 50 minutes. Gel was visualised in a gel-documentation system 
with ultra-violet light (Gene Flash, Syngene Bio Imaging). The information of specific PCR conditions is 
indicated on Table 4.  
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Table 4. List of Polymerase Chain Reaction (PCR) Primers 
Genes Forward 5’-3’ Reverse 5’-3’ Length (bp) PCR Cycles 
Pluripotency  
Oct-4 TGTGGACCTCAGGTTGACT CTTCTGCAGGGCTTTCATGT 181 27 
Rex-1 CGTGTAACATACACCTCCG GAAATCCTCTTCCAGAATGG 129 27 
Primitive ectoderm   
FGF-5 AGTTTCCAGTGGAGCCCTTC AATTTGGCACTTGCATGGA
G 
236 31 
Endoderm    
Gata-4 CTCCTACTCCAG CCCCTACC GTGGCATTGCTGGAGTTAC
C 
         571 30 
α-feto 
protein 
CCTTGGCTGCTCAGTACGA
CAAGG 
CCTGCAGACACTCCAGCGA
GTTTC 
299 27 
Mesoderm    
Brachyury-T AAGGAACCACCGGTCATCG CGTGTGCGTCAGTGGTGTG
TAATG 
321 27 
Flk-1 CCTGGTCAAACAGCTCATC
A 
AAGCGTCTGCCTCAATCACT 599 30 
Goosecoid ATGCTGCCCTACATGAACG
T 
CAGTCCTGGGCCTGTACATT 516 32 
Ectoderm    
Sox-1 GCACACAGCGTTTTCTCGG ACATCCGACTCCTCTTCCC 388 30 
Nestin CGGCCCACGCATCCCCCATC
C 
AGCGGCCTTCCAATCTCTGT
TCC 
259 27 
Early hematopoietic progenitors    
Gata-2 
 
c-kit 
 
TGCAACACACCACCCGATA
CC 
GCTCATAAATGGCATGCTC
CAGTGT 
CAATTTGGACAACAGGTGC
CC 
GAAGTTGCGTCGGGTCTAT
GTAAAC 
336 
 
458 
 
35 
 
35 
 
Myeloid- erythroid    
c-myb GAGCTTGTCCAGAAATATG
GTCCTAAG 
GGCTGCCGCAGCCGGCTGA
GGGAC 
522 35 
SCL 
 
TAGCCTTAGCCAGCCGCTC
G 
GCGGAGGATCTCATTCTTGC 277 35 
Erythroid 
Gata-1 
 
βH1-globin 
 
β-major 
globin 
 
 
ATGCCTGTAATCCCAGCACT 
TTTGCACACTTGAGATCATC
TC 
ATGGTGCACCTGACTGATG
CTG 
TCATGGTGGTAGCTGGTAGC 
GGTCTCCTTGAGGTTGTTCCA
TG 
GGTTTAGTGGTACTTGTGAGC
C 
581 
 
610 
 
447 
35 
 
30 
 
30 
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House keeping 
GAPDH CATCACCATCTTCCAGGAGC ATGCCAGTGAGCTTCCCGTC 500 27 
 
 
4.8.3.3. Protein Extraction From mESCs  
mESCs cultured cells were collected for Western Blot analysis. Cells were centrifuged into a cell 
pellet and stored at -80 
0
C till analysis. Frozen cells were lysed in 150 µl of cold RIPA lysis buffer (Santa 
Cruz Biotechnology, Heidelberg , Germany), incubated at 4 
0
c for 30 minutes and centrifuged 10,000 
RPM for 5 minutes to pellet the cell debris. Protein-containing supernatant was collected for protein 
quantification. 
4.8.3.4. Protein Quantification 
Total amount of protein was quantified using BCA
TM
 Assay Kit (Pierce Biotechnology). The BCA 
quantification method is based on the reduction of Cu
2+
 ions to Cu
1+
 by proteins in an alkaline 
environment which causes the formation of a blue-coloured complex. The highly sensitive and selective 
colorimetric reagent, BCA, reacts with the Cu1+ cation to form a BCA/copper complex which exhibits a 
strong linear absorbance at a wavelength of 562 nm. Bovine serum albumin (BSA) was used as a known 
protein standard and diluted at various concentrations in PBS from 0-500 mg/ml to create a standard 
curve. An amount of 25 µl of each sample is loaded onto a 96 well plate followed by mixing with 200 µl 
of BCA working reagent. Plates were covered and incubated in an orbital shaking incubator at 37 
0
C for 
30 minutes and then read on a microplate reader at a wavelength of 560 nm. Protein concentration in 
each sample was quantified against the BSA standard curve.  
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4.8.3.5. Sample Preparation 
From each sample, 40 µg of proteins were loaded onto each lane of the gel in sodium dodecyl 
sulphate polycrylamide gel electrophoresis (SDS-PAGE). Protein samples were mixed with 2x SDS-PAGE 
sample buffer which consisted of 0.125 M Tris-HCI at pH 6.8, 4% SDS, 20% glycerol, 10% β-
mercapthoethanol and 0.005% bromophenol blue. The sample mixture was heated at 95 
0
C for 10 
minutes for protein denaturation and placed in ice prior to gel loading. A protein ladder consisting of a 
range of protein from 40-200kDa was included in each gel. 
4.8.3.6. SDS/PAGE and protein blotting 
SDS-PAGE gels were prepared individually using the gel assembly kit for a 10-well gel. A 12.5% 
resolving gel made by mixing 4.8 ml of resolving buffer, 4.16 ml of Protogel acrylamide mixture (National 
Diagnostics), 1 ml 0.9% ammonium persulfate (APS; VWR International Ltd.) and 15 µl of TEMED (N, 
N,N’, N’ tetramethyl-ethylenediamine; VWR International Ltd) and gently poured into gel assembly, 
allowing it to polymerise for 15-20 minutes. The gel is finished off with a staking gel layer and allowed to 
further polymerise for about 45 minutes. The stacking gel consists of 2.03 ml stacking buffer, 0.6 ml 
Protogel acrylamide mixture, 0.3 ml of 0.9% APS and 8 µl of TEMED. One-dimensional SDS-PAGE was 
performed in the EC120 mini vertical gel electrophoresis   unit (Thermo Electron) and a constant voltage 
of 110 V was initially applied for 15 min or till the sample passes the stacking gel before a constant 
voltage of 150 V was applied for another 45 min or until the dye reached the bottom of the gel. Gels are 
allowed to equilibrate in 1x transfer buffer for 30 min before they are blotted onto 0.2 μm nitrocellulose 
membranes. Protein blotting was performed in the C140 Mini Blot Module (Thermo Electron) at a 
constant current of 30 mA for 50 min. The blotted membrane was then air-dried for at least 1 hr at room 
temperature prior to immunostaining. 
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4.3.8.7. Western blot Analysis 
Western blot analysis of listed antibodies in Table 5 was used to assess erythrocyte maturation 
determined by its expression at the protein level. GAPDH (Abcam) was used as the housekeeping gene. 
Undifferentiated mESCs were used as negative controls for all proteins of interest. Protein membranes 
were then incubated overnight at 4
o
C in the primary antibody and 1 hr at room temperature for the 
secondary antibody. Details of primary and secondary antibodies dilution for each type of antibody used 
in this thesis was listed in Table 5. Proteins were detected using the SuperSignal West Pico 
chemiluminescent substrate (Pierce Biotechnology), a highly sensitive enhanced chemiluminescent 
substrate for detecting HRP on immunoblots. Western blot images were captured in the Dyversity gel-
documentation system (SynGene) using the Genesnap program (SynGene). 
Table 5. List of Antibodies For Western Blot Analysis  
 
                                        Western Blot Dilutions  
Gata-1 1:200 Rabbit polyclonal 
(Abcam) 
1:10000 Goat polyclonal IgG 
HRP (Abcam) 
5% Non-fat mik 
solution 
ζ-globin 1:200 Rabbit polyclonal 
(Abcam) 
1:10000 Goat polyclonal IgG 
HRP (Abcam) 
5% Non-fat mik 
solution 
β-major 
globin 
1:200 Chicken 
polyclonal (Abcam) 
1:10000 Goat polyclonal IgG 
HRP (Abcam) 
5% Non-fat mik 
solution 
GapDh 1:20000 Rabbit 
polyclonal (Abcam) 
1:10000 Goat polyclonal IgG 
HRP (Abcam) 
5% Non-fat mik 
solution 
       FITC, fluorescein isothiocyanate; HRP, Horseradish peroxidase 
4.4. Statistical analysis 
Samples for the quantitative analyses were measured in duplicate. Error bars on all graphs 
represent the standard deviation (SD) of the mean. Each comparable value from each group was 
statistically analysed with analysis of variance (ANOVA) for each proper case at a level of significance of 
p<0.05 or p<0.001 (single or double asterisks respectively).  
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Chapter 5. 
In vitro Haematopoietic Differentiation 
of mESCs  Through ‘Embryoid-Like 
Colonies’ (ELCs) Formation. 
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5.0. Introduction 
ESCs are induced to spontaneously differentiate in vitro through formation of embryoid bodies 
(EBs), tissue-like spheroids cultivated in suspension culture (Heng, Cao et al. 2004). EB formation 
recapitulates some aspects of early embryogenesis, including the formation of a complex three-
dimensional (3D) arrangement wherein cell-cell and cell-matrix interactions support the development of 
the three embryonic germ layers, mesoderm, ectoderm and endoderm. Following EB formation, cells 
are returned to adherent culture conditions in order for directed differentiation to occur (Hwang, 
Randle et al. 2006; Kurosawa 2007; Tian and Kaufman 2008; Placzek, Chung et al. 2009).  
EB-based methodologies have contributed many advantages to the advanced study of 
mammalian developmental processes. However, the main limitation of ESC-based technologies is to 
obtain a homogenous population of any desired lineage cells due to the spontaneous differentiation 
into the three germ layers is not controlled (Dang, Kyba et al. 2002; Hwang, Randle et al. 2006). 
Furthermore, the EB-differentiation method also requires a complex culture process and experimental 
intervention. The standard culture process for ESCs in vitro is fragmented and laborious which normally 
involves three steps: pluripotency maintenance, EB formation and specific lineage differentiation 
(Thompson, Clarke et al. 1989; Reubinoff, Pera et al. 2000; Polak and Mantalaris 2008). The 
development of a novel bioprocess appears to be crucial to improve the shortcomings of the current 
ESC-cultured methodologies.  
Blood is derived from mesoderm in direct competition with spontaneous angiogenic and 
cardiomyogenic differentiation (Tian and Kaufman 2008; Shiraki, Higuchi et al. 2009). In order to 
recapitulate the process of blood formation from mesoderm in vitro, ESCs are allowed to form EBs for 
approximately five-eight days followed by terminal haematopoietic differentiation through the use of 
various supplements and cytokines  (Kaufman, Lewis et al. 1999; Srivastava, Kaushal et al. 2006; 
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Medvinsky, Taoudi et al. 2008). The current approaches for EB mediated haematopoietic differentiation 
are summarized in Table 5. 
Table 6. Current Approaches For In Vitro EB Mediated Haematopoiesis 
Haematopoietic differentiation 
culture strategy 
Cells Culture System References 
EB formation with growth factor 
cocktail 
mESCs 2D (Irion, Clarke et al. 
2010) 
EB formation with growth factor 
cocktail 
mESCs 2D (Zhou, French et al. 
2010) 
EB formation mESCs 3D in spinner tank and 
rotary microgravity 
bioreactor 
(Fridley, Fernandez et 
al. 2010) 
EB formation with growth factor 
cocktail 
 
hESCs 2D (Lu, Feng et al. 2007) 
EB formation, co-culture with OP9 
cells and growth factor cocktail  
hESCs 2D (Ji, Vijayaragavan et al. 
2008) 
EB formation, D4T endothelial cell-
conditioned medium and growth 
factor cocktail 
hESCs 2D (Kennedy, D'Souza et al. 
2007) 
EB formation, co-culture with OP9 
cells and growth factor cocktail  
hESCs 2D (Chang, Nelson et al. 
2006) 
EB formation with growth factor 
cocktail 
mESCs 2D (Srivastava, Kaushal et 
al. 2006) 
EB formation, co-culture with OP9 
cells and  growth factor cocktail 
mESCs 2D (Zhang, Park et al. 
2005) 
EB formation mESCs 3D on biomemetic scaffoflds (Liu and Roy 2005) 
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 Serum-free cultures for haematopoietic differentiation and the production of functional 
nucleated red blood cells (RBCs) have been achieved (Kennedy, D'Souza et al. 2007; Lu, Feng et al. 2008). 
However, these methods have all used EB formation and co-culture with feeder cells or conditioned 
media. Non-EB cultures of haematopoietic cells derived from ESCs can also be achieved with co-culture 
using stromal cells (Hiroyama, Miharada et al. 2008; Ji, Vijayaragavan et al. 2008; Lu, Feng et al. 2008). 
Although co-culture provides microenvironmental cues for differentiation of ESCs, the method also has 
pitfalls including problems in separating the feeders from the differentiated cells and the possible 
formation of heterokaryons within the culture (Heng, Cao et al. 2004). Recombinant cytokines are used 
for more defined culture conditions for the controlled differentiation of mesoderm from ESCs. However, 
this method is costly and can, paradoxically, lead to multiple lineage development due to the redundant 
action of cytokines and morphogens, such as BMP and Activin (Hwang, Randle et al. 2006; Medvinsky, 
Taoudi et al. 2008). Alternatively, conditioned media (CM) from the culture of differentiated somatic 
cells is a cheaper option which contains soluble factors, albeit largely undefined, that direct ESC 
differentiation into mesoderm in vitro (Rathjen, Lake et al. 1999; Mummery, Ward-van Oostwaard et al. 
2003; Heng, Cao et al. 2004; Hwang, Randle et al. 2006).  
Recent studies on the development process in vivo have focused on the formation of primitive 
ectoderm, which is located close to the distal visceral endoderm layer in the late stage of epiblast.  
These two layers provided a vigorous biochemical signaling exchange which plays important roles in 
formation of all the germ layers during a subsequent gastrulation stage (Tam and Loebel 2007). Studies 
on liver cell lines have reported that the use of conditioned medium from the cells has shown some 
similarities on the biochemical signals with the pre-gastrulation embryo or visceral endoderm-like cell 
lines (Rathjen and Rathjen 2001; Rodda, Kavanagh et al. 2002). Studies by Rathjen et al. have reported 
that conditioned medium from HepG2 cell line caused the transition of ESCs to another type of cell 
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population in vitro which still maintained their pluripotency property (Rathjen, Lake et al. 1999). This 
type of cells showed similar properties corresponding to epiblasts in vivo, which known as early 
primitive ectoderm (Rathjen and Rathjen 2001). Interestingly, early inducement of mESCs culture with 
HepG2-conditioned medium (HepG2-CM) resulted in selective formation of multipotent mesodermal 
progenitors during EB formation in suspension culture (Rodda, Kavanagh et al. 2002). This finding has 
potentially shown the feasibility of controllable ESC differentiation programmed towards lineage-
specific fashion during ESCs differentiation.     
Our group has previously demonstrated that conditioned media obtained from cultures of 
hepatocarcinoma liver carcinoma cell line, HepG2, with characteristics similar to visceral endoderm, 
enhanced mesoderm formation from mESCs with EB formation(Hwang, Randle et al. 2006). Visceral 
endoderm (VE) is an early organizer which secrets signaling molecules that specify cell fate during 
embryogenesis. The similarities between liver carcinoma cell lines and visceral endoderm has led to the 
suggestion that HepG2 CM reiterates visceral endoderm-like signalling in this system (Rathjen, Lake et 
al. 1999; Hwang, Randle et al. 2006). Differentiation of mESCs cultured in HepG2 CM resulted in a 
restricted repertoire of cell types comprised of mesoderm and parietal endoderm providing an efficient 
method for enriched mesoderm formation in vitro. Herein, we extend our studies of directed mesoderm 
differentiation from mESCs using HepG2 CM and present an efficient method for the development of 
the haematopoietic lineage.  
5.1. Objectives 
 The focus of this chapter are: 1) to establish a new protocol that enhanced the production of 
haematopoietic differentiation from mESCs using HepG2 CM with standard 2 dimensional (2D) culture 
system and 2) to optimize the production of erythroid progenitor colonies with ELCs-differentiation 
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method on methylcellulose semi-solid culture medium that could improved the differentiation process 
of mESCs compared to the conventional EB formation step.  
5.2. Experimental Plan 
Previously, our group has demonstrated that HepG2-CM induced early differentiation of mESCs 
to a specific cell type with a gene expression similar to primitive streak/nascent mesoderm transient-
stage cells which showed positive expression of primitive streak/nascent mesoderm marker (Hwang et 
al. 2006). Herein, we address whether the mESCs-treated with HepG2 CM (CM-mESCs) are capable to 
differentiate into haematopoietic lineage efficiently.   
One experimental group and one control group were set up as shown in Figure 12. The 
experimental group consisted of CM-mESCs culture which had undergone an eight-day ‘embryoid-like’ 
colonies (ELCs) formation period using the primary differentiation medium followed by a further 
fourteen days of culture in the haematopoietic differentiation medium, as previously described. The 
control group consisted of normal mESCs culture which had undergone an eight-day ELCs formation 
period using primary differentiation medium followed by  a further fourteen days with the  
haematopoietic differentiation medium as explained above. Both culture groups were analyzed using 
various techniques such as characterization of ‘embyoid-like’ colonies, haematopoietic colony forming 
unit (CFU) assay, immunocytochemical characterization, RT-PCR, and Western blot immune blotting 
assay, except for flowcytometry antibodies analysis due to the difficulties to collect sufficient amount of 
cells from semi-solid culture medium.  
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Figure 12. A Schematic Culture Plan for 2-D Culture with ELCs Differentiation Step 
5.3. Enhanced Haematopoietic Progenitor Colonies Formation from mESCs Using Conditioned Medium 
Treatment. 
5.3.1. Morphology of mESC Colonies After Pre-Differentiation Media and HepG2 CM Treatment 
Morphologically, mESCs cultured in DMEM formed typical spherical colonies (Figure. 13[i]) 
whereas cultures using control mESCs in pre-differentiation IMDM and CM-mESCs resulted in formation 
of clusters with a flattened morphology (Figure. 13[ii] and [iii]) with more homogeneity and relatively 
larger nucleoli in the component cells, of the CM-mESC cultures, consistent with what has been 
described previously (Keller 2001; Hwang, Randle et al. 2006). Using a comparative time-course, the 
proliferation of CM-mESCs in culture was higher compared with that of control mESCs during the first 
three days of culture (Figure. 14; p≤0.05), wherein the viability of both mESCs and CM-mESCs was >95% 
(Figure. 15A). The capacity for pluripotency was also confirmed for all mESCs cultures with maintenance 
of expression of Oct-4 and SSEA-1  (Figure. 15B) which was observed by immunoflourescence to be 
uniformly distributed across the colonies of mESCs and not restricted to sub-populations of cells within 
the cultures as previously described  (Rathjen, Lake et al. 1999; Hwang, Randle et al. 2006). Expression 
of Oct-4 in all culture conditions was confirmed with RT-PCR and Rex-1 expression in all cultures was 
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also indicative of pluripotent capacity (Figure. 16). Interestingly, the primitive ectoderm marker, FGF-5 
was only expressed in HepG2 CM-mESCs indicative of early differentiation.    
                                                      
Figure 13. Morphological of Control mESCs and CM-mESCs. Shown are examples of mESCs cultured at 
day three in (i) maintenance DMEM where cells congregated in a three-dimensional spherical colony, (ii) 
pre-differentiation IMDM which resulted in a flattened colony and (iii) HepG2-CM which resulted in 
colonies exhibiting the flattest morphology of the three colony types and cells with larger nucleoli. 
Images were capture at 500x magnification under light microscopy.  
 
                         
Figure 14. Growth Evaluation of Control mESCs and CM-mESCs. Summary of growth proliferation in the 
control (mESCs in DMEM) and experimental (CM-mESCs) groups over five days of culture. A higher 
proliferation rate was observed in the CM group over the first 3 days followed by a plateau phase. Data 
shown as mean number of cells ± STD (n=5; *p<0.05 and **p≤0.01). 
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Figure 15. Viability and Maintenance of Pluripotency Capacity of Undifferentiated mESCs in Different 
Culture Conditions at Day Three of Culture (A) A relatively high proportion of ESCs were stained with 
Calcien AM (green) in each culture condition, (i) maintenance DMEM, (iii) pre-differentiation IMDM and 
(v) HepG2-CM indicating good viability of cells. Non viable cells were stained with Ethidium homodimer-
1 (red) shown in each group (ii), (iv), and (vi), respectively, and were relatively fewer in number (B)  
Expression of pluripotency markers, Oct-4 (FITC-green) and SSEA-1 (Rhodamine red- red), was assessed 
by immunofluorescent staining in mESCs cultured at day three in (i), (ii) DMEM; (iv), (v) IMDM; and (vii), 
(viii) HepG2 CM and indicates that all conditions supported the maintenance of these markers. The 
nuclear staining with DAPI is shown in (iii) DMEM, (vi) IMDM, and (ix) HepG2 CM. The inset (i’), (ii’), (iv’), 
(v’), (vii’), and (viii’) show negative controls for on-specific binding of the primary antibodies. Images 
were captured at 100x magnification under fluorescent microscopy (Scales for each image: 200µm). 
 
 
 
 
 
 
 
 
(B) (A) (i’) 
(iv’) 
(ii’) 
(v’) 
(vii’) (viii’) 
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Figure 16. Pluripotency Gene Expression of mESCs in Each Culture Conditions. RT-PCR at day three of 
culture confirmed pluripotency potential with expression of the genes, Oct-3 and Rex-1 in mESCs 
cultured with (1) DMEM, (2) IMDM, and (3) HepG2-CM. The expression of the primitive ectoderm gene 
marker, FGF5 was only observed in CM-mESCs cultured and is suggestive of early differentiation signals. 
Negative control consisted of samples without cDNA. 
 
5.3.2. Formation of ‘Embyoid-like’ Colonies (ELCs) 
 
Formation of ELCs from mESCs cultured in DMEM  showed a similar morphology with normal EB 
shape together with dispersal of differentiated cells at the edge of the colonies at day eight (Figure 17A 
[i]). Generally, ELCs formed from control mESCs culture were larger when compared with CM-mESCs.  In 
contrast, the CM-mESCs formed a homogenous population with irregular and disorganised aggregates 
(Figure 17 A [ii]) as previously described (Hwang, Randle et al. 2006), with more differentiated cells at 
the edge of the colonies as compared with that of the control group. The use of methylcellulose semi-
solid media enables the quantitation of ELCs formed (Keller 2001).   Culture of CM-mESCs resulted in a 
significantly high number of ELCs (p≤0.05) and an almost five-fold enhancement of ELCs formation with 
90% efficiency as compared to the control group at day eight (Figure. 18B). ELCs in control and CM-
mESCs groups were assessed for their gene expression indicative of the three germ layers and early 
haematopoietic differentiation using RT-PCR. The expression of genes for endoderm (Gata-4 and α-feto 
protein), mesoderm (Brachyury-T, Goosecoids, and Flk-1), and ectoderm (Nestin and Sox-2) was detected 
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in ELCs of the control group (Figure 17C [1]). In contrast, there was a higher expression of the mesoderm 
gene Flk-1, but no expression of the endoderm genes Gata-4 and α-feto protein in ELCs of CM-mESCs 
suggesting the up-regulation of mesoderm in the absence of endoderm (Figure 17C [2]). To colaborate 
this enhanced mesoderm pattern, ELCs from CM-mESCs displayed a higher expression of Gata-2 and c-
Kit, indicative of early haematopoietic differentiation (Figure 17C [2]).  
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Figure 17. Formation of ‘Embryoid-Like’ Colonies (ELCs) in Both Culture Groups at Day Eight of Culture. 
(A) Shown are examples of (i) control and (ii) CM-mESCS ELCs (B) A higher number of ELCs formation 
was observed in the CM-mESCs group on day eight shown HepG2 enhanced haematopoietic 
differentiation in culture. Data shown as mean number of colonies + STD (n=5; **p<0.01).(C) RT-PCR 
analysis of genes indicative of the three germs layers at day eight of culture in control mESCs  (1) and 
CM-mESCs (2). Expression of genes of all three germ layers was observed in control ELCs from mESCs 
whereas a higher expression of Flk-1 and loss of endoderm gene expression confirmed better 
differentiation towards mesoderm with some early differentiation towards the haematopoietic lineage 
(Gata-2 and C-Kit). Negative control consisted of samples without cDNA. AFP, alpha-feto protein; Flk-1, 
fetal-liver kinase-1; Bra-T, Brachyury-T; GS, Goosecoid; Sox-1, Sry-related HMG box-1; GAPDH, 
Glyceraldehyde 3-phosphate dehydrogenase. 
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5.3.3. Evaluation of Haematopoietic Lineage in Clonogenic Assays 
 
Cell suspensions from ELCs from both mESC conditions were assessed for haematopoietic 
clonogenic capacity using standard methylcellulose culture over fourteen days.  Early maturation of 
haematopoietic progenitor colonies BFU-E, CFU-E, CFU-GM and CFU-GEMM were observed as early as 
day seven in the CM-mESCs group (Figure 18A). In contrast, the haematopoietic colonies were smaller 
and hardly identifiable in the control mESCs group at day seven of differentiation culture (Figure 18B). 
Further incubation to the standard fourteen days resulted in changes on the  morphology of the coloy 
with a reduction in the reddish colour, associated with a sign of losing haemoglobin capacity in the CM-
mESCs group (Figure 18C) whereas the control mESCS group displayed well-matured haematopoietic 
colonies (Figure 18D). A higher number of haematopoietic colonies was also achieved in the CM-mESCs 
group at day seven as well as at day fourteen of incubation (Figure 19; p≤0.05) with a two-fold 
enhancement comprised of all types of myeloid-erythroid progenitor colonies compared with that of the 
control mESCs. Quatitation of hematopoietiec colonies from CFUs assay indicated almost two-fold 
expansion of erythroid progenitors were obtained from CM-mESCs group (Table 7).  Nucleated 
eythrocytes and macrophages were identified in the CFUs from CM-mESCs at day seven (Figure 20A [i 
and ii]). Expression of early haematopoietic and myeloid-erythroid genes was not detected in control 
mESCs at day seven of CFU culture (Figure 20B [A]) yet were distinct in CFUs from CM-mESCs at day 
seven (Figure 20B [B]). Specifically, the definitive erythroid gene, β-major globin was detected on day 
seven, earlier than that observed with control mESCS, with relatively lower expression of the primitive 
erythroid gene marker, βH1-globin at the same time-point. Over the fourteen days of incubation control 
mESCs (Figure 20B [A’]) and CM-mESCs (Figure 20B [B’]) groups showed a constant expression in all 
haematopoietic and myeloid-erythroid gene markers with lower expression of β-major globin and no 
expression of βH1-globin. This early erythroid maturation of adult-type at day seven was confirmed by 
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detection of Gata1 and β-major globin protein with a lower expression of the primitive erythroid 
marker, ζ-globin (Figure 20C [B]) Gata-1 and β-globin markers were maintained in both groups at day 
fourteen. Overall, the data indicates that CM-mESCs were capable of haematopoietic maturation earlier 
than control cultured mESCs indicating a more efficient differentiation system to mesoderm and the 
haematopoietic lineage. 
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Figure 18. Clonogenic Capacity of Terminally Differentiated mESCs at Day Seven and Fourteen. 
Standard methylcellulose assay was used to determine haematopoietic clonogenic capacity, (i) BFU-E, 
(ii) CFU-E, (iii) CFU-GM and (iv) CFU-GEMM at day seven (A and B)   and day fourteen (C and D) from 
ELCs of CM-mESCs (A and C) and control mESCs (B and D)Morphological changes observed in the CM-
ESCs group at day fourteen of culture were consistent with loss of haemoglobinization within the 
colonies as indicated by the reduction of reddish colour. Scale for each image: 200µm.  
 
A. Day 7: CM-mESCs B. Day 7: Control mESCs 
C. Day 14: CM-mESCs D. Day 14: Control mESCs 
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 Figure 19. A Summary Bar Graph of CFUs from Both mESC Groups at Day Seven and Fourteen of The 
Terminal Differentiation Culture. A higher number of all haematopoietic CFU colonies were observed in 
the CM-mESCs group. Data shown as mean number of colonies + STD (n=5; *p<0.01)  
Table7. Fold Expansion of Erythroid Progenitors from CFUs Assay Over Fourteen Days of Culture. 
 
 
 
 
 
 
 2D 
CONTROL  
2D EXPERIMENTAL 
(ENHANCEMENT WITH HEPG2 CM)  
Average colonies formed per 2x10
4
/ml (per dish)  63  112  
Average  erythroid progenitor (BFU-E and CFU-E) 
colonies per dish  
35  69  
Fold expansion for erythroid progenitors  -  ~2  
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Figure 20. Morphological Evaluation and Gene Expression Enalysis of Haematopietic CFUs. (A)   
Wright-Giemsa staining of hand-picked (i) BFU-E and (ii) CFU-GM colonies at day seven of incubation 
from CM-mESCs confirmed the early maturation of haematopoietic colonies. (B) RT-PCR analysis of 
myeloid-erythroid genes in cells from day seven CFU cultures in control mESCs (A) and CM-mESCs (B) 
indicates early expression of haematopoietic genes only in the experimental condition. Incubation for 
the standard fourteen days resulted in expression of all hematopoietic and myeloid-erythroid markers in 
both control (A’) and experimental groups (B’) with loss of expression of the primitive erythroid marker, 
βH1 globin. Negative control consisted of samples without cDNA. (C) Western blot analysis of CFUs from 
day seven and fourteen of incubation period for control mESCs (A and A’, respectively) and CM-mESCs (B 
and B’, respectively) confirm erythroid maturation at day seven in the experimental group. Negative 
control consisted of samples without protein extract. nE, nucleated erythroid cells; Mac, macrophage; 
SCL, Stem-cell leukaemia. 
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5.4. Discussion 
mESCs cell lines can be maintained indefinitely under undifferentiated stages in the presence of 
LIF or feeder support for the maintenance of pluripotency property. On withdrawal of all factors that 
keep them undifferentiated, mESCs start to differentiate spontaneously in vitro (Itskovitz-Eldor, 
Schuldiner et al. 2000). This unique property of ESCs has given many advantages to regenerative 
medicine and tissue engineering application, especially for a better understanding on the development 
process of ESC differentiation and the mechanism that control cell growth and differentiation in vitro. 
However, it is essential to maintain the undifferentiated stage and self-renewal activity of ESCs for 
pluripotency maintenance and to develop defined culture conditions for lineage specific into 
homogenous population. Assessment of the self-renewal-related transcription factors and markers such 
as Oct-4, SSEA-1, and Rex-1 is important in evaluating the quality of the starting mESCs material. Our 
results indicated that undifferentiated mESCs highly expressed Oct-4, Rex-1 and SSEA-1 with a typical 
three dimensional colony morphology which is in agreement with literature data (Niwa, Miyazaki et al. 
2000; Bloor, Metcalfe et al. 2002; Oka, Tagoku et al. 2002; Dang, Gerecht-Nir et al. 2004). Hence our 
results confirm that mESCs in expansion remained undifferentiated without losing their pluripotency 
properties.  
On the treatment of mESCs with HepG2 CM, enhance cell proliferation activity along with a 
flattened morphology were observed in comparison with untreated mESCs. Growth factors, which 
include IGF-II, produced by the HepG2 cell line influence the expression of adhesion molecules in mESCs 
in a similar way to epithelial-mesenchyme transition during embryogenesis, resulting in shift from 3-
dimensional cell aggregation to 2-dimensional flattened morphology observed in the CM (Khaoustov, 
Risin et al. 2001; Wang, Yates et al. 2005). Our findings are in agreement with previous studies on 
morphological changes, pluripotency property and cell proliferation ability of CM-mESCs by Hwang et al. 
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in 2006. The expression patterns of pluripotent cell markers SSEA-1, Oct-4, and Rex-1 gene markers 
identified CM-mESCs as equivalent to pluripotent cells of the early embryo (Rathjen, Lake et al. 1999). 
Conversion from normal culture condition of mESCs to CM-mESCs culture was found to be accompanied 
by the expression of Fgf-5, suggesting it is equivalence to cells of the primitive ectoderm post 5.25 days 
post coitum (d.p.c) which acts as a substrate for the generation of the primary germ layers of the 
embryo proper and the extra-embryonic mesoderm (Rathjen, Lake et al. 1999).  
Currently, the most established method for ESCs differentiation is EB formation, since in vitro EB 
formation resembles early differentiation during embryogenesis (Leahy, Xiong et al. 1999). Specifically, 
haematopoietic differentiation of mESCs has been demonstrated following EB formation step (Keller et 
al. 2001). Several attempts on using conditioned media to induce mesoderm progenitors have been 
successfully proposed recently (Rathjen, Lake et al. 1999; Lake, Rathjen et al. 2000; Mummery, Ward et 
al. 2002; Calhoun, Rao et al. 2004; Hwang, Randle et al. 2006).  Recent research efforts have focused on 
using conditioned medium collected from cell lines with visceral endoderm functionally to induce 
mesoderm lineage differentiation (Rathjen, Lake et al. 1999; Lake, Rathjen et al. 2000; Mummery, Ward 
et al. 2002).For example, Rathjen and colleagues induced early differentiation of mESCs into an 
apparently homogenous cell population with a high capacity of forming mesoderm in EBs by treatment 
with HepG2-CM (Rathjen, Lake et al. 1999). This finding showed that mESCs treated with HepG2 CM can 
generate mesoderm differentiation in EBs more rapidly, almost two or three times faster than normal 
mESC-derived EBs (Rathjen, Lake et al. 1999). Our results on mesoderm stimulation were in agreement 
with Rathjen’s. The expression of mesoderm gene markers, i.e. brachury and goosecoids were observed, 
which correspond to the primitive streak/nascent mesoderm formation during early development 
process of posterior part in embryo (Herrmann 1991). Studies have also shown that the early primitive 
streak is the origin of the migrating cells that form the extraembryonic mesoderm, where the 
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epithelium-mesenchyme transition is temporally associated with the up-regulation of branchury (Kispert 
and Herrmann 1994). This research work is in agreement with our results showing the temporal 
expression of branchury and goosecoid expression which confirmed the formation of mesodermal layer. 
In our previous studies, differentiation of CM-mESCs into EBs in suspension culture resulted in 
production of a cell population similar to primitive streak/nascent mesoderm formation in vivo (Hwang 
et al. 2006). Our current findings indicate that CM-mESCs grew in methylcellulose-based medium 
forming a colony of cells that exhibited similar properties of EBs and blast-colony forming cells (BL-CFCs), 
which expressed the receptors tyrosine kinase Flk1 and the mesoderm gene T (Brachyury) (Tian and 
Kaufman 2008). A higher expression of Flk-1 marker in the CM-mESCs could be related to the 
enhancement of mesoderm formation triggered by visceral endoderm-like signal from HepG2 CM which 
resulted in activation of early progenitor for haematopoietic lineage, BL-CFCs (Cumano and Godin 2001; 
Tian and Kaufman 2008). 
Our current findings have also shown a promising development of an efficient bioprocess of 
haematopoietic differentiation system from mESCs without following normal process of EB formation 
using HepG2 CM, resulted in early haematopoietic CFU maturation by day seven with a high number of 
haematopoietic progenitors formation.  Relative to the normal three germ layers expression on standard 
formation of embryoid bodies in suspension culture, it is believed that the expression of early 
haematopoietic markers; Gata-2 and c-Kit together with all three germs layers gene markers in both 
culture groups showed a different type of colonies formation which called as ‘embryoid-like’ colonies. 
Therefore, we suggested that the colonies formed in both groups in the methylcellulose-based medium 
are not following the standard formation of EB as the addition of SCF caused in stimulation of early 
haematopoietic stem cell (HSC) progenitors proliferation and prevents HSC apoptosis (Zhu and Emerson 
2002; Kim and Bresnick 2007).  
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A higher expression of c-Kit and Gata-2 in CM-mESCs group could be related to the 
enhancement of haematopoietic differentiation using HepG2 CM and the reaction of SCF in the culture. 
SCF functions by binding to c-Kit, a tyrosine kinase receptor expressed in all HSCs (Kitajima, Masuhara et 
al. 2002; Zhu and Emerson 2002). Our data are consistent with the notion that Gata-2 and c-Kit may play 
a role in the early proliferation and survival of haematopoietic progenitors (Kitajima, Masuhara et al. 
2002; Edling and Hallberg 2007). Negative expression on Gata-4 and α-FP endoderm gene markers from 
ECL of CM-mESCs are consistent with previous report suggesting it would failed to form the extra-
embryonic lineages as a consequence lack the ‘death’ signal, which normally observed in normal EB 
culture resulting in formation of single cavity (Belaoussoff, Farrington et al. 1998; Rathjen and Rathjen 
2003) . According to Rathjen et al. in 1999, mESCs treated with HepG2 CM have lost their ability to form 
visceral endoderm during EB formation and are just restricted to form parietal endoderm. These findings 
are in agreement with the fact that reduced initial endodermal layer formation in EBs gives rise to EB 
disorganization, since it has been demonstrated that disruption of endoderm formation leads to EB 
disorganization. However, these findings require further investigation. Induction of haematopoietic 
differentiation with HepG2 CM treatment on mESCs following the methylcellulose culture promotes 
better haematopoietic differentiation shows one-and-a-half-fold expansion in haematopoietic CFU 
progenitors at day seven and increases significantly up to three-fold expansion by day fourteen. Better 
differentiation towards erythroid progenitors; BFU-E, CFU-E, CFU-GEMM at day seven with a drastically 
enhancement of all erythroid-myeloid colonies at day fourteen were observed in CM-treated mESCs. 
This study shows for the first time of haematopoietic-inducing activity from HepG2 CM and also 
consistent with previous studies on enhancement of mesoderm formation (Hwang, Randle et al. 2006). 
 In vitro mESCs differentiation into haematopoietic lineage using haematopoietic media 
supplemented with monothioglycerol, bovine serum albumin with transferrin and insulin (BIT), and 
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cytokines cocktails i.e. SCF, EPO, IL-3 and IL-6 generates approximately forty to hundred twenty colonies 
after twelve to fourteen days of culture. Our results show that the outgrowth of haematopoietic 
colonies generated almost 50% higher using the HepG2 CM as early as day seven, indicating that it was 
more efficient in comparison with control group. Further comparison with the literature data shows that 
haematopoietic induction of haematopoietic progenitor cells from ESCs co-culture with OP9 stromal 
cells produced a 2.6-fold enhancement of CFU activity but there was no support in formation of 
multilineage differentiation potential that will generate CFU-Mix or CFU-GEMM colonies in vitro (Ji, 
Vijayaragavan et al. 2008). Interestingly, our results showed a 3.2-fold enhancement in CFU activity with 
20% increase in multi-lineage progenitor formation, CFU-GEMM, ≈100% increase in erythroid immature 
progenitor, BFU-E, 50% increase in erythroid mature progenitors, CFU-E and 60% increase in granulocyte 
macrophage progenitor, CFU-GM as compared to the control group. Although direct comparison with 
published data is difficult, our results certainly suggest that this methodology offers improved 
haematopoietic differentiation in terms of culture time and yield.   
Our results conclude that the formation of nucleated erythroid with macrophage cells in BFU-E 
and CFU-GM colonies from Wright-Giemsa staining as well as positive expression of all haematopoietic 
and myeloid-erythroid markers at day seven from CM-mESCs group confirmed the early maturation of 
hematopoietic colonies at day seven (Medvinsky, Taoudi et al. 2008). Interestingly, a high expression of 
definitive erythroid markers, Gata-1 and β-major globin observed in the CM-mESCs group at day seven, 
with a low expression of primitive erythroid marker, βH1-globin, indicate in early maturation towards 
erythroid lineage in culture. The role of Gata-1 in erythroid cell survival and proliferation is well-
documented (Kitajima, Masuhara et al. 2002; Yokomizo, Takahashi et al. 2007). β major-globin is an 
adult haemoglobin gene normally expressed in both circulating primitive erythroblast and differentiating 
definitive erythroblast in the foetal liver (Kingsley, Malik et al. 2006; Palis 2008). βH1-globin is reported 
112 
 
to significantly accumulate in immature primitive erythroid cells (primitive erythroblast) from E7.5 
through E8.5 of mouse gestation (Kingsley, Malik et al. 2006; Palis 2008). These findings support the 
down regulation concept of βH1-globin and up-regulation of βmajor-globin prior to the maturational 
globin switching in primitive erythroblast to definitive erythroblast between E10.5 and E12.5 (Kingsley et 
al. 2006). In contrast, a low expression on early haematopoietic progenitor marker, c-myb in control 
mESCs group at day seven showed that the haematopoietic differentiation is just started and not well-
developed yet in culture.  The c-myb gene is abundantly expressed in immature haematopoietic cells 
(Ness, Kowenz-Leutz et al. 1993; Sandberg, Sutton et al. 2005; Kim and Bresnick 2007; Tober, McGrath 
et al. 2008) and Scl is critical for initial generation of all blood cells (Lecuyer and Hoang 2004; Ismailoglu, 
Yeamans et al. 2008). 
The contribution of cytokine in the differentiation stage of ESCs in vitro to derive various cell 
lineages is well explained (Hwang et al. 2006; Zhu and Emerson 2002). Addition of IL-3 and IL-6 regulates 
the formation of early haematopoietic progenitors while erythropoietin [EPO] signalling is absolutely 
necessary for definitive erythroid differentiation (McGrath and Palis 2005; Palis and Koniski 2005; 
Srivastava, Kaushal et al. 2006). Carotta and colleagues (2004) have described an easy in vitro 
haematopoietic differentiation strategy using serum-free medium with addition of recombinant 
cytokines and hormones to generate mass culture of pure, erythroid progenitors from mESCs. However, 
the mESC-derived erythroid progenitors produced were still immatured and need to be exposed in vivo 
for terminal differentiation into mature, enucleated erythrocytes although the use of define serum-free 
medium with higher concentration cytokines and hormones have been applied in their experiment as 
compared to our differentiation strategy. In addition, our differentiation method using HepG2-CM has 
showed a proper differentiation step by; i) triggering and enhancing mesoderm layer formation as a 
targetted interest of germ layer that give rise to blood lineage during  ELCs production and ii) followed 
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by hematopoietic differentiation that produced a higher production of erythroid progenitors with lower 
concentration of cytokines used in the experiment as compared to Carrotta et al. 2004, hence showed 
that our method offered an efficient, low-cost and straight-forward differentiation strategy for 
eyrthropoiesis. 
Up-regulation of Gata-1 and β-major globin markers expression in CM-mESCs from western blot 
protein analysis suggesting that our method provide an efficient way of enhancing ESCs differentiation 
towards erythroid progenitors using HepG2 CM. Although several soluble factors produced by HepG2 
cell have been characterized, the mechanism by which the HepG2 CM influences mESCs growth and 
differentiation has not been well-defined (Khaoustov, Risin et al. 2001; Wang, Shan et al. 2003). Herein, 
we have demonstrated that CM-mESCs resulted in enhanced haematopoietic differentiation and 
promoted specific-erythroid lineage differentiation. The results presented here support the hypothesis 
that HepG2 CM enhances mesodermal formation from ESCs and may prove to be useful in future 
towards developing an efficient differentiation method related to the lineage-specific of ESCs for 
erythroid cells production.  
 
5.5. Conclusion 
 
We have developed an efficient bioprocess of haematopoietic differentiation system from mESCs 
without following normal process of EB formation using HepG2 CM, resulted in early haematopoietic 
CFU maturation by day seven with a high number of haematopoietic progenitors formation. We have 
also confirmed our previous findings that the conditioned media from the human hepatocarcinoma cell 
line HepG2 induced transition of mESCs into a specific cell type with primitive streak/nascent mesoderm 
profile which enhanced the mesoderm differentiation during ELCs formation. Hence, we suggested that 
114 
 
this method could be potentially effective for generating a specific cell population with a high formation 
of mesoderm layer and could also be useful to stimulate a direct differentiation process of mESCs 
towards haematopoietic lineage due to the potent cell source it produces. Although this strategy is still 
requires further characterization on the active components within the conditioned medium to produce 
a defined culture medium, it could provide a better approach for the up-regulation of specific 
mesodermal differentiation pathways for mESCs that could have application for manufacturing blood 
cells in vitro.    
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Chapter 6. 
In vitro Spontaneous Cardiomyogenic 
Differentiation of mESCs By-passing 
‘Embryoid-Like Colonies’ (ELCs) 
Formation. 
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6.0 Introduction 
 
In vitro differentiation of ESCs can eventually lead to clinical applications due to the special 
properties of having unlimited proliferation whilst maintaining the ability to form all the cells of the 
body, including blood cells. In order to produce physiologically functional cells of interest from ESCs that 
can be used for transplantation, controlled differentiation procedures must be implemented.  
Currently, the most robust method for generating differentiated cells from ESCs is through the 
formation of embryoid bodies, where ESCs spontaneously differentiate and form tissue-like spheroids in 
suspension culture (Keller, Kennedy et al. 2000; Dang, Gerecht-Nir et al. 2004). However, recent studies 
have shown several problems existed from EB formation, such as limitation knowledge on the specific 
culture conditions and requirements for EB culture, especially on the differentiation mechanism(s) and 
cellular interactions occurring during EB formation and the process guiding the development of the 
three germ layers towards the lineage of specific cells within the EBs (Khoo, McQuade et al. 2005). In 
addition, this method is impractical for large-scale cell production (Fok and Zandstra 2005) and 
generates a heterogeneous cell type which is not suitable for cell-specific therapeutic applications. 
Cardiogenic differentiation is derived from mesoderm in direct competition with 
haematopoietic and angiogenic differentiation (Tian and Kaufman 2008; Shiraki, Higuchi et al. 2009). In 
vivo studies on mouse embryogenesis have suggested that smooth muscle cells developed from a 
common mesodermal progenitor termed haemangioblast which also capable of giving rise to 
endothelial and haematopoietic cells (Jezierski, Swedani et al. 2007). Studies on development of ESCs 
differentiation in vitro have identified that a colony of cells called blast colony-forming cell (BL-CFC) 
which derived from EB possess a similar property with haemangioblast during in vivo development.   
Studies have shown that a precursor of cardiac potential, termed cardiovascular colony-forming cells 
(CV-CFCs) arose from BL-CFC containing both cardiac and vascular potential (Kattman, Huber et al. 2006) 
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which supported the previous findings that cardiac lineages developed from a precursor with 
endothelial potential  (Linask and Lash 1983; Lee 1995). Hence, it approved that the BL-CFC, which gives 
rise to haematopoietic and vascular lineages precedes the development of CV-CFC that generates the 
myocardial and endothelial lineages (Kattman, Huber et al. 2006). Further studies on the development 
of blood island in vivo have shown that aggregates of mesodermal cells situated at the periphery 
develop into endothelial cells whereas the inner cells develop into haematopoietic cells (Jezierski, 
Swedani et al. 2007). Moreover, recent embryogenesis studies have described that the haemangioblast 
arises as a transient mesodermal population within the posterior region of the primitive streak (Huber, 
Kouskoff et al. 2004).  
Currently, studies have focused on the development of primitive streak where all the germs 
layers arise during embryogenesis in vivo. Interestingly, recent research works have found that the 
formation of primitive ectoderm and visceral endoderm layers during the primitive streak development 
play important roles on exchanging a vigorous biochemical signal that lead to a subsequent gastrulation 
stage where all the germ layers are eventually formed (Tam and Loebel 2007). Therefore, the use of 
conditioned medium (CM) from the culture of differentiated somatic cells (whilst mimicking the same 
signals during the development process in vivo) has become an alternative differentiation approach to 
direct ESC differentiation into mesoderm in vitro (Rathjen, Lake et al. 1999; Mummery, Ward-van 
Oostwaard et al. 2003; Heng, Cao et al. 2004; Hwang, Randle et al. 2006). Although it is largely 
undefined the use of conditioned medium contains soluble factors that enhanced ESCs differentiation 
process and offers a cheaper option than other techniques.  
Studies using conditioned media from a visceral endoderm-like cell line (END2) have presented 
an efficient improvement on cardiomyogenic precursor cells production during ESCs differentiation 
process which correspond to the role of visceral endoderm in the adjacent mesoderm layer resembling 
in vivo embryo development process (Mummery, Ward et al. 2002; Mummery, Ward-van Oostwaard et 
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al. 2003; Filipczyk, Passier et al. 2007). Other research using liver cell lines have shown some similarities 
on the biochemical signals provided during the pre-gastrulation in embryo which was observed as well 
from visceral endoderm-like cell lines  (Rathjen and Rathjen 2001; Rodda, Kavanagh et al. 2002). Studies 
by Rathjen et al. in 1999 have reported that a conditioned medium derived from human 
hepatocarcinoma cell line, HepG2, induced the transition of ESCs to another type of cell population in 
vitro which was considered as the second pluripotent stage (Rathjen, Lake et al. 1999). Those cells 
showed the same behaviour that corresponds to the epiblast stage in vivo which is known as early 
primitive ectoderm (Rathjen and Rathjen 2001). Interestingly, early inducement of ESCs differentiation 
using HepG2 conditioned medium (HepG2-CM) treatment resulted in selective formation of multipotent 
mesodermal progenitors from EB suspension culture (Rodda, Kavanagh et al. 2002). With respect to this 
background, our group have previously reported that initial treatment of mESCs with HepG2-CM 
promotes specific enhancement of mesodermal formation, hence up-regulate cardiogenic, osteogenic 
and chondrogenic differentiation, depending on EB formation periods (Hwang, Randle et al. 2006). 
Recent research efforts have been proposed to induce specific lineage differentiation of ESCs 
directly without following the EB formation process due to overcome the limitation faced from the 
method. Studies by Takashi et al. in 2003 screened on 880 compounds that are capable to induce 
cardiogenic differentiation using established ESCs clones which expressed embryonic green fluorescent 
protein (EGFP) under the transcriptional control of a cardiac specific promoter, alpha-myosin heavy 
chain (α-MHC). With an addition of ascorbic acid in culture media, this finding has shown an increase 
formation of cardiac myocytes from ESCs differentiation directly in 2-D culture without following EB 
formation step (Takahashi, Lord et al. 2003).  Furthermore, the results have also suggested that 
monolayer culture of ESCs by-passing the EB formation could possibly reduce background 
differentiation, other lineage differentiation and enabled high-throughput screening (Takahashi, Lord et 
al. 2003).  Corresponding to the literature, it is believed that a novel culture method for controlling and 
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enhancing the ESCs differentiation towards specific lineage of interest is highly required. This would 
increase the efficiency of deriving specific lineage cells from ESCs that would also likely require a better 
control over of the cell microenvironment.  
 
6.1. Objectives 
 
The focus of this chapter are: 1) to study the cause of direct differentiation process on mESCs 2-
D culture system without following normal EB formation step using methylcellulose semi-solid culture 
medium, by looking at haematopoietic and cardiogenic spontaneous differentiation; and 2) to develop 
an efficient culture system for directing and enhancing lineage specific of ESCs differentiation which 
focused on haematopoietic and cardiogenic lineage.    
  
6.2. Experimental Plan 
 
Previously, our group has demonstrated that mESCs treated with HepG2 CM differentiate into 
primitive streak/nascent mesoderm like cells by the treatment of HepG2 CM (Hwang et al. 2006) and 
this cell population have shown an enhancement of haematopoietic differentiation especially on 
erythroid progenitor colonies formation with ELCs differentiation step, without following the normal EB 
formation process (Chapter 5). In this chapter, direct in vitro spontaneous cardiogenic differentiation of 
mESCs was observed by-passing the ELCs formation step on specialized methylcellulose semi-solid 
haematopoietic differentiation culture medium. This culture strategy is potentially offered a promising 
novel culture strategy that is more efficient, controllable and reproducible for lineage specific 
differentiation.  The culture process consists of two phases: a) early inducement of mESCs 
differentiation using HepG2 CM in order to acquire potent cell source of mesoderm-like cell and b) 
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direct process of terminal differentiation in methylcellulose semi-solid differentiation culture medium 
from mESCs-treated HepG2 CM cell population by-passing ELCs stage (CM-mESCs-NOELCs).  
One experimental group and one control group were set up as shown in Figure 21. The 
experimental group consisted of CM-mESCs-NOELCs culture where mESCs were cultured in 50:50 HepG2 
CM for three days in prior for inducement of early differentiation into a primitive streak/nascent 
mesoderm like cell population, followed by direct terminal differentiation on specialized methylcellulose 
semi-solid haematopoietic differentiation medium for fourteen days of culture by-passing ELCs 
formation. The control group consisted of normal mESCs cultured in maintenance medium for three 
days, followed by direct terminal differentiation on specialized methylcellulose semi-solid 
haematopoietic differentiation medium for fourteen days without the ELCs step. Both culture groups 
were analyzed using various techniques such as characterization of beating colonies, 
immunocytochemical characterization and RT-PCR, except for the flowcytometry antibodies analysis due 
to the low number of cells collected in each experiment and the difficulties to collect sufficient amount 
of cells from semi-solid culture medium.  
IMDM
[Control]
[Experimental]
   
Figure 21. A Schematic Culture Plan for 2-D Culture By-passing ELCs Differentiation Step 
 
Single cell 
suspension 
Count beating colonies 
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6.3. Enhanced Cardiogenic Differentiation From ESCs Using HepG2 Conditioned Medium By-passing 
The ELCs Formation Step. 
6.3.1. Morphology of Beating Colonies Formation on Methylcellulose Semi-Solid Differentiation 
Medium. 
The initial attempt of this culture was to promote haematopoietic differentiation of mESCs by-
passing ELCs formation step, however, beating colonies formation was observed during the culture 
period on methylcellulose haematopoietic differentiation medium. Interestingly, the beating colonies 
were only observed in the experimental group, CM-mESCs-NOELCs but not in the control group, mESCs 
and there was no formation of haematopoietic colonies existed in both groups during fourteen days 
culture period. This finding corresponds to our previous works in the group where the spontaneous 
cardiogenic differentiation of mESCs were also observed in different culture condition i.e. specified 
osteogenic/chondrogenic culture conditions (Hwang et al. 2006). Spontaneous cardiomyocyte 
differentiation has been observed in both human and murine ESC lines  (Doevendans, Kubalak et al. 
2000; Boheler, Czyz et al. 2002; Kehat, Gepstein et al. 2002; Xu, Police et al. 2002).  
Generally, the morphology of beating colonies observed from the CM-mESCs-NOELCs culture 
formed in small colonies with compact homogenous population, irregular and disorganized aggregates, 
with spontaneous contraction observed within seven days of culture period (Figure 22 (C)). In contrast, 
the control mESC group showed the formation of larger size of EB-like colonies with a decent round 
shape and hardly identified any spontaneous contraction formed in the colonies (Figure 22 (A)). Further 
incubation to the standard fourteen days resulted in changes of the beating colony morphology in the 
CM-mESCs-NOELCs group which exhibited a more compact shape with stronger spontaneous 
contraction (Figure 22. (D)) whilst the colonies in the control mESC group remain in a large EB-like shape 
without any sign of cardiogenic differentiation occurring (Figure 22 (B)). Cardiomyocytes were readily 
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identified due to their spontaneous contraction within days following plating. With continued 
differentiation (longer culture time), the number of beating foci increased and certain group, such as 
CM-mESCs-NOELCs, could possibly contain localized beating cells. During early stages of differentiation, 
cardiomyocytes within beating colonies were small and round-like shape (Figure 22 [C]). With 
maturation, some of the CM-mESC-NOELCs derived cardiomyocytes expressed an elongated shape and 
beating cells were primarily mononucleated and rod-shaped with tight cell-cell contact (Figure 22 [D]), 
consistent with those observed in cardiomyocytes developing in the heart (Westfall, Pasyk et al. 1997).   
  
 
 
 
 
 
 
 
Figure 22. Morphology of Colony in Control mESCs and CM-mESCs-NOELCs Groups. Shown are 
examples of colonies from control mESCs group (A), (B), and experimental CM-mESCs-NOELCs group 
(C),(D) at day seven and fourteen respectively. CM-mESCs-NOELCs group resulted in the formation of 
beating colonies as early as day seven in the culture (C). Further fourteen days of incubation resulted in 
more beating colonies formation with compact colonies formed and stronger spontaneous contraction 
observed from CM-mESCs-NOELCs group (D). Control mESC group remained as an EB-like form with no 
sign towards beating colonies formation during the culture period. 
(A) (B) 
(C) (D) 
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In this study, mESCs and HepG2 conditioned medium-treated mESCs (CM-mESCs-NOELCs) were 
allowed for direct differentiation on haematopoietic methylcellulose-based culture medium for fourteen 
days. The use of methylcellulose semi-solid medium enables the quantitation of colonies formed (Keller 
2001). As shown in Figure 23, enhanced mesoderm formation through the use of HepG2 conditioned 
medium resulted in a three to four-fold increase (p<0.05) in the number of beating colonies in CM-
mESCs-NOELCs group from day seven to day fourteen of culture (Figure 23), where the number of 
beating colonies were shown in Table 8. In contrast, no beating colonies were observed for control 
mESCs group on day seven and day fourteen of culture (Figure 23).  
Table 8. Number of Beating Colonies Formed During Fourteen Days of Incubation Period 
Number of Colonies Per Dish  Control  Experimental  
Day 7  0  20.8 + 4.0  
Day 14  0  74.5 + 2.8 
             Each value indicates the number of colonies per 35 mm dish of 4-dishes plated, n=4(mean + STD) 
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Figure 23. A Summary Bar Graph of Beating Colonies Formation from Control mESCs and CM-mESCs-
NOELCs Groups at Day Seven and Fourteen of The Terminal Differentiation Culture. A significant higher 
number of beating colonies were observed in the CM-mESCs-NOELCs group with no formation of 
beating colonies in control mESCs group. Data shown as mean number of colonies + STD (n=4; *p<0.05). 
 
6.3.2. Immunostaining for Cardiogenic Differentiation 
Immunocytochemistry was performed in both control and experimental group at day seven and 
day fourteen for further confirmation of cardiomyogenesis in methylcellulose differentiation culture. 
Anti-sarcomeric α-actinin was used as common cardiomyogenic marker. The earliest steps in 
cardiomyogenesis involved two process, 1) the assembly of contractile proteins into organized 
structures capable of contraction which requires the polymerization and 2) the assembly of several 
protein into three types of filaments that interact with one another and become organized into 
sarcomeric unit that comprise the myofibrils (Du, Sanger et al. 2003). The formation of myofibril involves 
the precise ordering of multiple subunits into a linear array of sarcomeras (Dabiri, Turnacioglu et al. 
1997). Figure 24 shows anti sarcomeric α-actinin staining in cardiomyocytes from CM-mESCs-ELCs group 
Days/Groups 
N
u
m
b
e
r 
o
f 
b
e
a
ti
n
g
 c
o
lo
n
ie
s/
d
is
h
 
125 
 
detected as early as day seven followed by day fourteen which indicated positive formation of 
cardiomyocytes from the culture. In contrast, there was no expression of anti-sarcomeric α-actinin 
marker observed in the control mESCs group. During the cardiogenic differentiation stages, densely 
packed bundle of myofibrils could be observed from the staining.   
                               
Figure 24. Immunocytochemistry Staining of Beating Colonies from CM-mESCs-NOELCs Group. Shown 
are the beating colonies at day seven (A) and day fourteen (B) of CM-mESCs-NOELCs group. Positive 
expression of cardiomyogenic marker, anti-sarcomeric a-actinin (FITC-green) were observed at day 
seven (a) and day fourteen (b) of culture. The inset (i) and (iii) show positive controls for the antibody, 
while  negative controls for on-specific binding of the primary antibodies was showed by the inset (i’) 
and (ii’). The nuclear staining with DAPI is shown in the inset (ii) and (iv) with blue staining. 
 
6.3.3. Cardiogenic Gene Expression 
In order to investigate cardiomyogenic and haematopoietic differentiation in control and 
experimental group culture, several gene expressions were observed as shown in Figure 25.  A higher 
expression of early cardiomyogenic marker, Gata-4 was observed at day seven in CM-mESCs-NOELCs 
group as compared to the control mESC group. Expression of specific cardiomyogenic marker, alpha-
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myosin heavy chain (α-MHC) was not detacted in control mESCs at day seven of culture (Figure 25) yet  
were distinct in beating colonies from CM-mESCs-NOELCs at day seven (Figure 25). Over the fourteen 
days of incubation CM-mESCs-NOELCS group showed a constant expression of Gata-4 and a-MHC gene 
markers. The expression of Gata-4 in control mESCs was observed in the culture due to the fact that it 
might relates with the formation of endoderm layer during the culture of EB formation. Gata-4 is also 
expressed during the formation of three germ layers in EB culture as a common marker for endoderm 
layer. Previously, we have shown that HepG2-treated mESCs, CM-mESCs formed ‘embryoid-like’ 
colonies, which showed no expression on the endoderm gene, Gata-4 suggesting the absence of 
endoderm layer for up-regulating mesoderm layer during the differentiation process (Chapter 5). 
Therefore, the positive expression of Gata-4 in this result from CM-mESCs-NOELCs  is not related with 
ectoderm formation, suggesting that it would referred as a cardiomyogenic marker which indicated a 
higher potential of the colonies to be driven to cardiogenic lineage differentiation. These results are in 
agreement with the beating colony assay and immunocytochemistry results demonstrating the 
correlation between cardiomyocyte beating colonies and cardiomyocyte marker and gene expression. 
Interestingly, there is no expression of haematopoietic markers, Gata-2 and SCL observed in both 
culture confirmed the differentiation towards haematopoietic lineage was not occurred during the 
culture period.         
Overall, the data indicates that CM-mESCs-NOELCs were more capable of enhancing 
cardiomyogenic differentiation than following the process of by-passing ELCs formation step as 
compared to the control cultured mESCs indicating a more efficient direct differentiation system to the 
cardiomyogenic lineage. 
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Figure 25.  Cardiomyogenic and Haematopoietic Gene Expression Observed from Both Culture Groups. 
RT-PCR analysis at day seven and day fourteen confirmed the cardiogenic differentiation of CM-mESCs-
NOELCs group with a higher expression on Gata-4 and α-MHC cardiogenic gene marker. Expression of 
Gata-4 in control mESCs group due to the formation of endoderm layer and not related with cardiogenic 
differentiation. There was no expression of haematopoietic markers observed from both cultures 
indicated that no differentiation towards haematopoietic lineage.    
 
6.4. Discussion 
 
In Chapter 5, we have demonstrated that early inducement of HepG2 conditioned medium 
during mESC culture stimulates pre-differentiation of mESCs into a cell population with a high capacity 
for haematopoietic differentiation through the formation of ‘embryoid-like’ colonies (ELCs) on 
methylcellulose semi-solid differentiation medium without following normal EB differentiation process. 
Studies have shown that differentiation of mESCs can be induced by removal of LIF or feeder cells to 
produce three germ layers, namely mesoderm, endoderm and ectoderm, through EB-mediated 
spontaneous differentiation. This conventional way of culture strategy has been widely accepted to 
induce further differentiation for specific lineage of interest, such as haematopoietic, cardiogenic and 
osteogenic differentiation (Keller 2001; Mummery, Ward et al. 2002; Hwang, Randle et al. 2006). 
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However, this approach faces several limitations which included the fact that as all three germ layers are 
formed it results in the competition of mesoderm formation with endoderm and ectoderm formation. 
The spontaneous formation of all three germ layers within EBs could reduce the yield of differentiation 
towards specific cell type of interest and could also produced a heterogeneous cells population which 
related to the fact that the mechanism(s) of cellular interaction within during EB formation stage is 
mostly unknown precisely (Khoo, McQuade et al. 2005). Furthermore, EB-mediated differentiation 
strategy involves the formation of spontaneously induced cavitation during the culture process. The 
cavitation process is normally related with programmed cell death, an inevitable and spontaneous 
process, which is very difficult to control. This results in the loss of available cells for terminal 
differentiation even in specialized culture condition for lineage specific differentiation (Coucouvanis and 
Martin 1995; Li, Yau et al. 2000). From those limitations, the need of novel culture strategy by by-
passing the EB formation step is evident, considering the fact that a more efficient, simple, straight 
forward differentiation process and easy manageable bioprocess has to be developed for mESCs 
differentiation process. Herein, in this chapter, we have demonstrated the direct differentiation of 
mESCs into spontaneous cardiomyogenic differentiation in the absent of EB formation although EB-
mediated ESCs differentiation culture strategy has been widely used for triggering ESCs differentiation 
(Keller 2001; Mummery, Ward et al. 2002; Hwang, Randle et al. 2006; Placzek, Chung et al. 2009).  
Recently, several approaches on directing ESCs differentiation without following EB formation 
towards lineage of interest have been investigated which mainly focused on the formation of 
mesoderm-mediated type cell lineage (Hwang, Randle et al. 2006; Karp, Ferreira et al. 2006). 
Specifically, Langer et al. in 2006 demonstrated hESCs differentiation into the osteogenic lineage 
without EB formation, which resulted in increased bone nodule activity as compared with five days EB-
mediated osteogenic differentiation.  However, studies have reported that mESCs do not differentiate 
directly into lineages of interest without prior EB formation (Shimko, Burks et al. 2004). Studies have 
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recently focused on the use of conditioned medium as an alternative strategy for enhancing ESC 
differentiation into the desired cell lineage (Hwang, Polak et al. 2008). Mummery et al. in 2002 reported 
that upon the treatment with the visceral endoderm-like cell line, END-2 conditioned medium on ESCs 
culture resulted in ESCs aggregation and spontaneously differentiation to beating colonies characteristic 
of cardiogenic differentiation. Furthermore, it has been also presented that avian precardiac explants-
conditioned medium induced cardiogenic differentiation, presumably by mimicking the cues from the 
explanted endoderm and mesoderm (Rudy-Reil and Lough 2004). Previously, our group has 
demonstrated that the conditioned medium from the human hepatocarcinoma cell line, HepG2 induced 
the rapid and enhanced formation mesoderm-mediated cell population from mESCs (Hwang, Randle et 
al. 2006). Our result on mesoderm stimulation was in agreement with our previous group findings.  In 
another approach on cell-mediated mesoderm differentiation, our group has previously reported that 
osteogenic differentiation could be successfully achieved directly without undergoing EB formation after 
the enhancement of mESCs with HepG2 conditioned medium which resulted in a significant increase of 
bone nodule forming activity in comparison with normal osteogenic differentiation of mESCs.  
Specifically, the direct differentiation approach for this study is similar our previous attempts by 
Hwang et al. in 2006 on direct osteogenic differentiation by-passing EB step. The culture process 
involved two phases; 1) inducement of mESCs differentiation into primitive streak/nascent mesoderm-
like cells by using HepG2 CM in order to produce a potent cell source for specific lineage differentiation; 
and 2) direct terminal differentiation towards lineage of interest by using specified differentiation 
culture without following EB/ELCs formation. Our recent findings have shown that HepG2 CM not only 
resulted in formation of a high capacity of mesoderm-mediated cell population and stimulated the 
osteogenic differentiation by-passing the EB step as reported previously, but also enhanced cardiogenic 
differentiation without undergoing EB/ELCs formation. 
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Cardiomyocytes are easily identified due to their spontaneous contraction after few days plating 
on culture medium. During the culture period,the number of spontaneously beating foci increases and 
all the colonies may contain localized beating cells (Zhou, French et al. 2010).Immunostaining expression 
on anti- sarcomeric α-actinin, which specific for a-skeletal muscle actinin and a-cardiac muscle actinin 
confirmed the cardiomyogenic differentiation from the beating colonies formation in the culture 
(Goncharova, Kam et al. 1992).  In this chapter, we achieved enhanced spontaneous cardiomyogenic 
differentiation from mESCs-treated with HepG2 CM without following ELCs step, i.e. from CM-mESCs-
NOELCs group and the addition of any strong cardiogenic stimulators. Specifically, CM-mESCs-NOELCs 
were cultured on methylcellulose differentiation culture medium with existence of specialized growth 
factors to induce direct haematopoietic differentiation, such as erythropoietin (EPO), stem cells factor 
(SCF), interleukin-3 (IL-3) and interleukin 6 (IL-6). However, cardiomyogenic differentiation was observed 
from CM-mESCs with the formation of beating colonies on the specialized haematopoietic 
differentiation medium due to the fact that HepG2 CM influenced direct mesoderm-mediated cell 
population in culture. Previously, Rathjen and colleagues have used HepG2 CM for early inducement of 
mESCs differentiation resulted in a high capacity of cell-forming mesoderm, which lead to an increase in 
the number of beating colonies (Rathjen, Lake et al. 1999). Our results on mesoderm enhancement and 
cardiomyogenic differentiation were in agreement with Rathjen’s. Furthermore, in vivo studies on early 
development of embryogenesis have shown that mesoderm layer gives rise to cardioblasts, which 
differentiate into cardiomyocytes. The process towards cardiomyogenic lineage has been suggested as a 
primary event in mesodermal differentiation (Arai, Yamamoto et al. 1997). 
 In addition, the spontaneous cardiomyogenic differentiation occurred in specialized 
haematopoietic differentiation medium might be triggered from the reaction of growth factors used in 
the culture medium. Recent studies on embryo development in mice have shown that EPO, an essential 
growth factor that promotes survival, proliferation and differentiation of mammalian erythroid 
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progenitor cells could also trigger cardiomyocyte proliferation probably in a non-cell-autonomous 
manner when injecting marked EPOR−/−ESCs into wild type blastocysts of chimeric mice (Wu, Richards 
et al. 1999). Further analyses on ESCs injected in the chimeric mice have shown that EPOR−/−ESCs could 
contribute widely to the normal structure and development of cardiomyocytes in vivo. Moreover, similar 
studies on the embryogenesis have found erythropoietin receptor (EPOR) expressed in the developing 
mice heart in a temporal and cell type-specific manner, which is initially detected by embryonic day 10.5 
and persists until day 14.5 (Kertesz and Wu 1999; Wu, Richards et al. 1999). This finding supports our 
spontaneous cardiomyogenic differentiation observed from CM-mESCs-NOELCs group, which focused on 
the effect of specialised hematopoietic growth factors in differentiation medium. Specifically, our study 
have produced about 4-fold increase in the number of beating colonies from CM-mESCs-NOELCs group  
on the specified methylcellulose haematopoietic differentiation culture medium without following EB 
formation from  day seven to day fourteen of culture. CM-mESCs-NOELCs group generating 
approximately 2.6 and 9.3 beating colonies/cm
2
 at day seven and day fourteen respectively on 35mm 
petri dish. Interestingly, the control mESCs group did not show any formation of beating colonies during 
the culture period. In comparison, cardiomyocytes differentiation of mESCs enhanced by gene mutation 
after thirteen days of culture by plating individual five days-EBs, generated approximately 3.4 beating 
colonies/cm
2 
(Zhou, French et al. 2010).  
This controlled and enhanced cardiomyogenic differentiation was further characterized by early 
cardiomyogenic genes, Gata-4 and α-MHC molecular expression and the positive expression on 
cardiomyogenic marker, anti-sarcomeric α-actinin. Interestingly, a high of expression Gata-4 and a-MHC 
in CM-mESCs group than the control mESCs group was observed in this study. Gata-4 is well known as an 
early indicator for cardiomyogenesis in the mammalian development together with a-MHC (Grepin, 
Nemer et al. 1997; Brewer, Alexandrovich et al. 2005; Stary, Pasteiner et al. 2005). In many previous 
works, Gata-4 and α-MHC genes were strongly expressed in the early stage after inducing visceral 
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endodermal signals to ESC-culture using HepG2 or END-2 cell line, resulting in the enhancement of 
cardiomyogenesis (Rathjen, Lake et al. 1999; Rathjen and Rathjen 2001; Filipczyk, Passier et al. 2007). 
With agreement to the previous studies, our current findings on deriving spontaneous cardiomyogenic 
differentiation from mESCs with enhancement using HepG2 CM by-passing the EB/ELCs step are more 
effective than the control group. Negative expression of haematopoietic gene markers in control and 
experimental culture group confirmed that there was no sign of differentiation towards haematopoietic 
lineage. This result is in agreement with the recent studies that mESCs do not differentiate directly into 
haematopoietic lineage without prior EB/ELCs formation. The culture by-passing ELCs step gave poor 
efficiency of haematopoietic commitment, thus, it is important to recapitulate the normal process 
occurred during haematopoietic development in vivo to improve the differentiation efficiency toward 
haematopotic lineage (Chang, Nelson et al. 2006).    
 
6.5. Conclusion. 
 
Herein, we have proposed a novel culture strategy for directing spontaneous cardiomyogenic 
differentiation of mESCs by avoiding the EB formation process completely which enabled in vitro direct 
cardiomyogenesis in culture. We have also achieved an early differentiation of cardiomyogenic at day 
seven of culture with a significant increase of beating colonies formation over fourteen days culture 
period which reached up to four-fold expansion without following EB step from CM-mESCs-NOELCs 
group. Removing the EB/ELCs formation step provides an efficient strategy for direct cardiomyogenic 
differentiation which could offer an easy and straight forward differentiation process than the 
conventional EB mediated differentiation culture method. In addition, cardiomyogenic differentiation 
could be enhanced by the use of early differentiated mESCs which induced by HepG2 CM treatment. By 
taking advantage of the ease of directing and enhancing in vitro cardiogenic differentiation, the culture 
133 
 
strategy described here would be useful to provide a better culture strategy for cardiac repair and 
cardiac tissue engineering application.    
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Chapter 7. Bioprecessing For Three- 
Dimensional (3-D) Blood Cells- and 
Cardiac Cells- Like Formation Using 
Alginate Hydrogel Encapsulated mESCs 
treated with HepG2-CM and Cultured in 
HARV Bioreactor 
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7.0. Introduction.  
 
In response to urgent needs for blood, ex vivo manufacture of blood cells from haematopoietic 
stem or progenitor cells has been developed extensively from isolation of various cell types i.e. cord 
blood, bone marrow, or peripheral blood and culturing  them on conventional 2-dimensional (2-D) tissue 
culture flasks or expending them in different type of three-dimensional (3-D) culture system, which 
involved the use of scaffold that are made from natural and synthetic biomaterials in bench-scale (Banu, 
Rosenzweig et al. 2001; Liu and Roy 2005; Feng, Chai et al. 2006; Taqvi and Roy 2006; Ma, Chan et al. 
2008). However, the main problem of using somatic hematopoietic stem cells is the difficulty of 
expending them, which limits the possibility of using these cells for high scale industrial production of 
major blood components (Slukvin 2010). Specially, recent ex vivo blood manufactured studies have 
shown the potential use of ESCs for blood production in vitro because of their unique unlimited 
proliferation property. Several ESCs differentiation culture approaches have been documented involving 
three dimensional scaffold systems with appropriate humoral and chemical factors to stimulate 
hematopoietic differentiation during the culture process (Liu and Roy 2005; Taqvi and Roy 2006). Roy 
and colleagues in 2006 have demonstrated the effect of three-dimensional (3-D) scaffold culture system 
on mESCs hematopoietic differentiation using synthetic poly (L-lactic acid) (PLLA) based scaffold with 
addition of OP9 cell co-culture differentiation method providing suitable environment for 
haematopoietic differentiation, which resulted in improvement of hematopoietic progenitor cells (HPCs) 
production. Similar studies from the same group have also reported that the beneficial effects of 3-D 
scaffolds on haematopoiesis using the commercially available Cytomatrix system resulted in a higher 
efficiency of HPCs generation by forming higher frequencies of both colony formation and myeloid cell 
production (Liu and Roy 2005).  
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The use of scaffolds have been applied to ESCs cultures increasingly as it is known to provide a 
closely resemble of the 3-D microenvironment by offering the physical support that enable cell-cell and 
cell-material interactions, which facilitated a more tissue-like structure (Sasaki, Takagi et al. 2002; Taqvi 
and Roy 2006).  Although scaffolds have been extensively applied in 3-D culture system to support tissue 
growth by serving as the extracellular matrix for the cells, recent studies have shown that synthetic 
scaffolds did not represent the natural matrix molecules associated with each cell type and tissue in vivo 
(Rosso, Marino et al. 2005). Moreover, this culture process, which normally conducted in static culture 
system even has some drawbacks although improvement on scaffold manufacture have been made 
recently in order to produce “smart” scaffold, which is capable to release particular factors and control 
the temporal expression of various molecules released from the polymer and could possibly help to 
induce differentiation of ESCs within the scaffolds (Rosso, Marino et al. 2005). It has been well reported 
that mass transfer limitations involved during in vitro static culture of 3-D scaffolds resulted in limitation 
on cell growth, which also could inhibited the cell to proliferate and form normally into 3D tissue-like 
construct (Ishaug-Riley, Crane-Kruger et al. 1998; Holy, Shoichet et al. 2000). During the static culture 
system, cell growth and tissue formation are usually confined on top surface area of scaffold resulting in 
poor distribution of cells inside the scaffolds; hence disable them to proliferate into a well-structure of 
3-D tissue-like form. For instance, it has been reported that some cells (bone marrow stem cells) which 
were initially seeded at internal part of the 3D porous scaffolds could migrate by chemotaxis towards 
outer surface where nutrient concentration is higher. In contrast, the remaining cells grew inside the 
scaffolds showed less ability to differentiate towards lineage of interest and lower expression of specific 
genes of the desired cells lineage (Glowacki, Mizuno et al. 1998). Studies have shown that nutrient 
transportation process into the centre point of 3-D scaffolds is mainly depends on diffusion, which could 
not satisfy the metabolic requirement of cells grew inside the 3-D scaffolds for a longer culture period 
(Mueller, Mizuno et al. 1999).  Moreover, several limitations have been also discussed when dealing 
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with static culture system, which include the lack of mixing resulting in critical concentration gradients 
for pH, dissolved oxygen, cytokines and metabolites; problem to do online monitoring during the culture 
process;  and repeated handling required to feed cultures or obtain data on culture performance. These 
factors could contribute to the low process reproducibility and could also limit the productivity by the 
number of cells that can be supported by a given surface area (Collins, Miller et al. 1998; Cabral 2001). 
These limitations could be reduced by bioreactors application in culture system.         
The use of bioreactor is an alternative approach to standard flask cultures of cells in vitro and 
become essential in tissue engineering, as it provides an in vitro culture system mimicking in vivo 
conditions for the growth of cells to form three dimensional tissue substitutes. Current modification on 
improving culture condition by using bioreactors have offered many benefits for developing an efficient 
in vitro culture condition for the cell growth as they enable systematic studies of the responses of living 
tissues to various mechanical and biochemical cues. Advanced bioreactors are required when a large 
number of cells are needed, accessory cells are used and high cell densities are desired. Recent studies 
have shown that the use of bioreactors in culture system could drastically reduce the amount if space 
and handling steps involved and could also increased the volumes of tissue-engineered product in 
comparison with in vitro flask-based culture strategy. The main aim of using bioreactors in culture 
system is to provide a better culture environment for cell expansion that could increase the productivity 
of cells, which supported by a given surface area for cell growth, and to ease the handling process during 
the maintenance of cells in culture, thus, it could reduced the process of labour intensive.  
In recent years, among various types of bioreactors, NASA’s Johnson Space Centre has 
developed a new bioreactor technology that shows promise in addressing the shortcomings of 
conventional cell culture apparatus for 3-D culture. This technology is designed to stimulate the effects 
of microgravity in cell in a ground-based culture system. The bioreactor, rotating wall vessel (RWV) from 
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Synthecon is a cylindrical vessel that maintains cells in suspension by slow rotation about its horizontal 
axis with a coaxial tubular silicon membrane for oxygenation. Rotating wall vessel (RWV) bioreactors 
such as High Aspect Ratio Vessel (HARV) bioreactor have been widely used in culture of cells seeded on 
scaffolds or microcarriers (Song, Fan et al. 2010; Song, Liu et al. 2010) or without scaffold in blood cell 
formation in vitro (Sytkowski and Davis 2001; Ritz, Lelkes et al. 2006). The RWV bioreactor is designed to 
reduce the damage effect of turbulence and minimise the shear stress by creating a unique environment 
for the culture media to rotate at the same angular velocity as the vessel wall with laminar fluid flow. 
Gentle mixing of media in the RWV bioreactor is induced by particle sedimentation, resulting in 
adequate nutrition and oxygenation delivery during the cells growth, thus, it offers an efficient culture 
condition that could support the 3-D tissue growth and ideals for mammalian cell culture (Hammond 
and Hammond 2001). Delivery of oxygen is accomplished via a coaxial silicone membrane, which 
allowed the passive exchange of gasses to and from the medium and avoided bubbles formation that 
could create cell-damaging turbulence. The free-falling of microcarrier inside the bioreactor resulting 
from gravity that could be balanced by the centrifugal forces from the rotation of the outer cylinder, 
which rotated at a controlled rate, thus establishing suspension culture environment for microcarrier 
(Pollack, Meaney et al. 2000; Hammond and Hammond 2001). The sedimentation of 3-D cell aggregates 
in the vessel confers additional benefits in terms of mass transfer. The constant movement of 
aggregates in the media insures that nutrient, oxygen, and waste transfer will not be limited by diffusion 
as they are in static culture system (Hammond and Hammond 2001).  
Another important factor that normally accompanied with bioreactor application in 3-D culture 
system is the use of microcarrier for cell growth and 3D tissue-like formation. Several types of 
biomaterials have been used for ex vivo blood production such as natural or synthetic polymers and 
hydrogels in order to provide cues and extracellular matrix environment for the cell growth and 
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differentiation (Liu and Roy 2005; Taqvi and Roy 2006; Annabi, Nichol et al. 2010; Geckil, Xu et al. 2010; 
Song, Fan et al. 2010; Song, Liu et al. 2010). Many applications on using natural and synthetic polymer 
have been developed to promote 3D culture environment in vitro. Among all, porous scaffolds have 
been widely used by most researchers for constructing 3D bone marrow-like structure in vitro in order 
to mimic the stem cells niches of bone marrow haematopoiesis in vivo. However, the problem of using 
this biomaterial is the structure of the porous scaffold itself, which normally formed as in a non-
homogenous shape such as cylindrical or disc type, thus giving rise to very complex motion in 
bioreactors. This culture environment may not suitable for online monitoring culture system as it could 
be very difficult to model and evaluate the influence of mechanical stress on the scaffolds resulting in 
poor consistency in data collection. Hence, hydrogels with spherical shape could be considered as 
another option for promoting 3-D culture condition in vitro as it offers a simple shape with morphology 
of sphere-like form, which is easy to produce and control the size constantly. This offers benefit for 
online monitoring culture studies, which allows for further analysis on evaluating the motion and effect 
of culture environment on hydrogels in bioreactor. Studies on model and experimental validation of 
such particles motion in bioreactors have been presented in order to optimise suspension culture for 3D 
culture system (Pollack, Meaney et al. 2000; Hammond and Hammond 2001). Among all types of 
biomaterial used to form hydrogel, alginate has been widely chosen by researchers for cell 
encapsulation, drugs or growth factor delivery and stem cell bioprocessing (Hammond and Hammond 
2001; Masuda, Takegami et al. 2003; De Ceuninck, Lesur et al. 2004; Gu, Amsden et al. 2004; Hwang, 
Polak et al. 2008; Siti-Ismail, Bishop et al. 2008; Song, Fan et al. 2010; Song, Liu et al. 2010), due to the 
fact that it offers great biocompatibility (low undesirable immune response), significant mechanical 
resistance, and good biodegrability (Becker, Kipke et al. 2001; King, Sandler et al. 2001).      
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Studies have shown that gelatin incorporation with alginate can help the structure of 
cell/hybrids to keep mechanical stability after prolonged culture (Balakrishnan, Mohanty et al. 2005). 
Magyar and colleagues in 2001 have formed discoid colonies and cystic EBs from mESCs encapsulated in 
hydrogel, and demonstrated that alginate encapsulation provides ESCs with adequate 3-D residential 
space to grow up like in vivo. Our group has previously developed a 3-D simplified, integrated, and 
reproducible bioprocess culture system for mESCs differentiation towards several types of specific 
lineage of interest, i.e. osteogenesis (Randle, Cha et al. 2007; Hwang, Polak et al. 2008) and 
chondrogenesis (Hwang, Polak et al. 2008) using encapsulation with alginate/gelatin hydrogel and 
rotating wall vessel (RWV) bioreactor system (HARV, Cellon, Bereldange, Luxembourg). With respect to 
those previous works, herein, we established a novel culture strategy for 3-D hematopoietic 
differentiation of mESCs using alginate encapsulation and HARV bioreactor system.  
7.1. Objectives 
The focus of this chapter are : 1) to develop a novel three-dimensional (3D) single step 
bioprocessing culture system for mESC hematopoietic differentiation in HARV bioreactor with early 
inducement of differentiation using HepG2-CM to enhance mesodermal development and alginate 
encapsulation, resulting in efficient and reproducible culture strategy for ex vivo blood production, and 
2) to  optimise the selective production of hematopoietic or cardiomyogenic differentiated cells by 
monitoring the effect of different culture medium on spontaneous differentiation of mESCs.   
7.2. Experimental Plan 
In this study, each previous culture strategies were integrated into a single step culture process 
using alginate encapsulation and HARV bioreactor for developing a novel 3-D culture system of 
haematopoietic and/or cardiomyogenic differentiation from mESCs. Undifferentiated mESCs were 
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encapsulated with alginate solution mixed with gelatin prior to the gelation process of alginate bead and 
followed by the reaction of calcium solution to form the spherical-like beads shape.  Encapsulated cells 
subsequently were transferred to 50-ml vessels of High Aspect Ratio Vessel (HARV) bioreacto (Cellon, 
Bereldange, Luxembourg), and these vessels were rotated at the speed of 25 rpm. Each reactor 
contained five-hundred beads, which contained 20 000 cells per bead and rotation rate of the culturing 
vessel varied following cell growth kinetics previously tested, in order to avoid increasing shear stress 
forces inside, in that the beads were getting heavier with the cells growing through the culturing period. 
The beads were dissolved at each time point for sample collecting using depolymerisation buffer 
consisting of 50 mM tri-sodium citrate dehydrate (Fluka, Poole, UK), 77 mM sodium chloride (BDH 
Laboratories Supploes, Poole, UK) and 10 mM HEPES (Sigma)(Magyar, Nemir et al. 2001). 
Maintenance mESCs medium or HepG2-CM was applied in each vessel for the first 3 days to get 
cell expansion that could also enabled to keep their pluripotency at the same time, and spontaneous 
differentiation was triggered using IMDM (Gibco) containing 15% of FBS (Gibco), 2 mM L-Glutamine 200 
mM (Gibco), 150 µM MTG (Sigma), and 40 ng/ml mSCF (R and D Systems), which have been modified 
from ELCs formation based on the standard protocol for two dimensional (2D) culture of mESCs 
hematopoietic differentiation (Stem cells Technologies, 2003). To perform hematopoietic 
differentiation, 10 mg/ml of bovine insulin, 5.5 mg/ml human transferin, and 5 ng/ml sodium selenite 
(ITS liquid media supplement; SIGMA), 50 mg/ml ascorbic acid (SIGMA), 40ng/ml mSCF, 3 unit/ml hEPO, 
and 10 ng/ml mIL-3 were additionally added in ELCs formation medium (Hiroyama et al. 2008) as for the 
hematopoietic differentiation medium. The culture timeline for hematopoietic differentiation is 
described in Table 9. Growing cells in beads were photographed using a Leica DM IL inverted phase 
microscope (Leica, Weitzlar, Germany) and analysis^D sofware (Olympus, Munich, Germany), and 
beating colonies in semi solid media were filmed using CamStudio, a free screen recording software 
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(CamStudio.org, Essex,UK).  The beads were dissolved in alginate bead dissolution buffer in order to 
collect the cells for further analysis.  
 
Table 9. Culture timeline for hematopoietic differentiation 
Group Maintenance with LIF Spontaneous 
differentiatio
n with 40 
ng/ml mSCF 
Hematopoietic 
differentiation (ITS 
medium supplement, 
L-ascorbate, 40 ng/ml 
mSCF, 3U/ml hEPO, 
10 ng/ml mIL-3. 
Total days in 
culture 
Normal 
growth 
medium 
HepG2-
conditioned 
medium 
(A) Control 
mESCs  
3 
days 
x 8 days 10 days 21 
Experimental 
(B) CM-mESCs  
(C) CM-mESCs-
NOELCs 
 
x 
x 
 
3 days 
3 days 
 
8 days 
x 
 
10 days 
18 days 
 
21 
21 
 
 
 
Figure 26. A Schematic Culture Plan for 3-D Single-Step Hematopoietic Differentiation (Adapted from 
(Hwang, Cho et al. 2009)). 
 
7.3. Enhanced mESCs Growth Proliferation and Differentiation with HepG2-CM Treatment in 3-D 
HARV Bioreactor Culture System 
7.3.1. Morphology and viability of encapsulated mESCs in 3-D HARV Culture System 
Morphology and viability of cells from control mESCs, CM-mESCs and CM-mESCs-NOELCs groups 
cultured within alginate hydrogel beads in 3-D haem
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microscopy analysis and live and dead cell viability assay. The light microscopy studies on day 3 and day 
20 of culture period showed that mESCs encapsulated in the alginate hydrogel beads formed colonies 
and the agglomerations appeared to grow in all groups over the culture period. Overall observation on 
the beads on day 20 of culture revealed the difference in the cellular colony morphology between 
control mESCs group and the HepG2-CM treated mESCs group. Cellular colonies in the control mESCs 
culture appeared to be less compact of the cellular colonies and scattered compared to the HepG2-CM 
treated mESCs groups, i.e. CM-mESCs and CM-mESCs-NOELCs groups, which exhibited denser colonies 
(Figigure 29). However, CM-mESCs-NOELCs showed more cell aggregates with denser colony compared 
to CM-mESCs group which could be related to the spontaneous differentiation towards cardiomyogenic 
lineage, which formed bypassing ELCs formation (Figure 27).   
Following the light microscopy analysis, samples of cells from control mESCs, CM-mESCs and 
CM-mESCs-NOELCs groups was qualitatively visualized using a two fluorescence cell viability assay that is 
based on the simultaneous determination of live and dead cells that measure intracellular esterase and 
plasma membrane integrity. Calcein AM is cleaved by intracellular esterases to label live cells brightly 
with green fluorescence. Ethidium homodimer (EthD-1) enters cells that have lost plasma membrane 
integrity, producing bright red fluorescent labeling of dead cells. As shown in Figure 28, over the 20 days 
of hematopoietic differentiation culture in HARV bioreactor, most of the cells within alginate hydrogel 
beads in all culture groups showed intensified green fluorescent indicating live cells with very few red 
fluorescent, which exhibited the non-viable cells.In agreement with the light microscopy analysis, the 
control mESCs group likely showed smaller viable colonies than the other two HepG2-CM treated mESCs 
groups, as culture time passed i.e. on day 20.In contrast, CM-mESC-NOELCs group exhibited a bigger size 
of colonies and more compact compared to CM-mESCs group due to the spontaneous differentiation 
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towards cardiogenic lineage. The population of dead cells was gradually increased relatively, but the size 
of cell aggregation was also increased.      
 
 
 
 
Figure 27. Morphological observation of the encapsulated mESCs by the light microscope in 3-D 
culture of HARV bioreactor. (A), (B) and (C) represented the mESCs for control, CM-mESCs and CM-
mESCs-NOELCs groups on day 3 of culture respectively. (D), (E) and (F) showed the cell aggregates for 
control, CM-mESCs and CM-mESCs-NOELCs groups on day 20 of culture respectively. 
 
 
 
(A) (D) 
(B) (E) 
(C) (F) 
145 
 
                                                                                       
                                                                                  
                                                                                                                                                         
 
Figure 28. Viability study of differentiated cells in 3-D culture of HARV bioreactor. A high cell density 
was observed within the hydrogels. Calcein AM (green) staining indicated good viability of cells within 
the culture on day.  Non-viable cells were stained with Ethidium homodimer-1 (red).  (A), (B) and (C) 
represented the light microscopy image for control, CM-mESCs and CM-mESCs-NOELCs groups on day 
20 of culture respectively, whereas (D), (E) and (F) showed the fluorescent image for control, CM-mESCs 
and CM-mESCs-NOELCs groups on day 20 of culture respectively. The inset (D-a), (E-a) and (F-a) 
exhibited the fluorescent image for live cells, whereas (D-b), (E-b) and (F-b) showed the fluorescent 
image for dead cells. 
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7.3.2. mESCs Growth Proliferation study in 3-D HARV Bioreactor Culture System 
The growth kinetics of encapsulated ESCs in from each culture groups during haematopoitic 
differentiation culture were demonstrated by MTS assay. Samples of beads from each culture groups 
were directly treated with MTS solution and were incubated for 3 hours before continue with 
absorbance reading by ELISA reader at 490nm. The OD values of each culture group were calculated and 
a graph of cell numbers for each time point was plotted as shown in Figure 29.  The HepG2 treated 
mESCs groups, i.e. CM-mESCs and CM-mESCs-NOELCS mESCs showed a higher growth rate than the 
control mESCs group by day 6 of the culture period. This result corresponds to the 2-D culture growth 
proliferation study that showed a higher growth rate achieved from HepG2-CM treated mESCs group 
compared to control mESCs group (Chapter 5). 
 In particular, CM-mESCs group exhibited a higher increase of cell’s growth proliferation 
compared to control group, thus resulting as a better expansion with a significant increase during the 
early stage of haematopoietic differentiation from day 3 to 9. CM-mESCs-NOELCs showed a slightly 
higher expansion compared to CM-mESCs group resulting as the fastest growth rate among all groups. 
This result is corresponds to the live and dead analysis result as described previously.  However, in 
general, the growth rate of the encapsulated HepG2-treated mESCs groups were increased slowly after 
day 11, which is likely due to the preparation for cell differentiation process towards haematopoietic 
and spontaneous cardiomyogenic lineages and the spatial restriction in the alginate hydrogel beads 
after the density of cells reached about 2.5x10
5
 cells/bead. CM-mESCs and CM-mESCs-NOELCs groups 
also showed a similar final cell density in a bead on day 21 at almost 3.0x10
5
 cells/bead compared to 
control mESCs group that showed a density of cells below than 2.5x10
5
 cells/bead. Statistical analysis 
were done by one way ANOVA between all groups in HARV culture (p<0.05) (Figure 29). 
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Figure 29. Growth Kinetics of 3-D Encapsulated mESCs During Culture Process. A higher increase of 
cell’s growth proliferation observed in HepG2-Treated mESCs (CM-mESCs and CM-mESCs-NOELCs) 
compared to control mESCs group indicated that a better expansion achieved from both Hep-G2-mESCs 
Treated groups. (p≤0.05). 
 
7.3.3. Bioprofile analysis of culture medium in HARV bioreactor 
In order to evaluate the growth kinetics of control group and two groups of HepG2-CM treated 
mESCs (CM-mESCs and CM-mESCs-NOELCs) within alginate beads indirectly, the consumption of 
nutrient in the haematopoietic differentiation medium from each culture group in the HARV bioreactor 
was evaluated by measuring time-course concentration of glucose, glutamine, lactate and ammonium, 
and by detecting the changes of pH from the culture media during the whole haematopoietic 
differentiation period.   In this study, the hematopoietic differentiation medium was refreshed every 
two days just after measuring the concentration of nutrients in cultured media using a bio-profiler. Day 
3 represents the last day of mESCs expansion in control maintenance medium and HepG2-CM before 
the culture media were changed to differentiation medium for stimulating differentiation. All cultures 
for medium-profiling were carried out separately from the other studies. Statistical analysis was done 
for all culture groups by one way ANOVA (p≤ 0.05). 
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7.3.3.1.Nutrient consumption rates (Glucose and glutamine) 
Glucose concentration was measured from control mESCs and both HepG2-CM treated mESCs 
groups on day 3, which showed no particular difference among all culture groups. The measurement of 
day 3 showed that glucose concentration in each medium was rapidly reduced from 22.4 mM to almost 
zero, after the starting point of haematopoietic differentiation in all culture groups, resulting that most 
of the glucose was consumed during the culture period (Figure 30).  
In terms of glutamine concentrations, glutamine levels of all culture groups showed very low 
levels from the onset of haematopoietic differentiation to the end of culture, which dropped drastically 
from 4.3 mM to around 0.5 mM and 0.0 mM indicating that most of the glutamine supplied in medium 
was also successfully consumed during the culture period (Figure 30).  
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Figure 30. Comparison of Glucose and Glutamine Consumption During Haematopoietic 
Differentiation. 
7.3.3.2. pH variations level  
pH rates in the media of all culture groups were indicated at approximately 7.5 at the beginning 
of culture and were gradually decreased as the culture time passed although the fresh medium was 
supplied every two days. Overall the pH level in all groups i.e. control mESCs, CM-mESCs, and CM-
mESCs-NOELCs, which cultured in HARV were maintained at lower levels approximately between 7.25 to 
7.35 without huge variations during haematopoietic differentiation (Figure 31).  
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Figure 31. pH Variations During Haematopoietic Differentiation. 
7.3.3.3. Metabolite concentration profiles (lactate and ammonia) 
In an opposite pattern with pH, glucose and glutamine level, lactate accumulation in all groups 
were increased drastically from approximately between 0.13 mM and 0.15 mM to around 55 mM and 60 
mM. In general, there was no huge variation of lactate levels were observed in all groups during 
haematopoietic differentiation culture period (from day 9 until day 21) (Figure 32). 
In terms of ammonia (NH4
+
) accumulation, the same kinetic pattern with lactate concentration 
was also observed in the medium of all groups starting from approximately 2.75 mM and went up in 
between 3.50 mM to 4.00 mM (Figure 32). The increase pattern of lactate and ammonia level in all 
groups indicated that both types of metabolite were released through metabolism of cells within 
alginate hydrogel beads into medium, which correspond to the high consumption rates of glucose and 
glutamine profiles as explained above.  
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Figure 32. Comparisons of Lactate and Ammonia Accumulation During Haematopoietic 
Differentiation. 
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7.3.4. Analysis studies on Differentiation Process of Encapsulated mESCs in 3-D HARV Bioreactor 
Culture System  
Samples of encapsulated mESCs from each groups cultured in HARV bioreactor were collected at 
certain time points during the differentiation process and were analysed for early detection of 
hematopoietic gene markers expression by RT-PCR. 
7.3.4.1. Gene Expression Profiles 
Following the evaluation of cell growth and metabolic activity in HARV bioreactor culture 
system, haematopoietic differentiation was also characterised by distinct cellular phenotypes, such as a 
component of specific myeloid-erythroid and transcription factor gene expression profiles. In this study, 
a series of gene expression level were presented in order to determine the direct haematopoietic 
differentiation of encapsulated mESCs in control, CM-mESCs and CM-mESCs-NOELCs groups, which 
performed by observing the expression of pluripotency, mesoderm and myeloid-erythroid gene markers 
at different time point and culture stage using RT-PCR. Samples from each culture group were tested up 
to day 15 as the expression of haematopoietic differentiation markers were started to observe from the 
control mESCs group on day 15 of culture.   
7.3.4.1.1. Pluripotency gene expression profiles  
As shown in figure 33, the expression of pluripotency gene markers, Oct-4 and Rex-1 were 
clearly detected in all groups of encapsulated mESCs in 3D HARV culture at day 1 with negative 
expression on primitive ectoderm marker, Fgf-5, indicating that the mESCs in all culture groups 
remained their pluripotency although in 3D culture system. Following the terminal haematopoietic 
differentiation process, the expression of Oct-4 and Rex-1 were decreased gradiently on day 4 with 
slightly expressed in control mESCs group although the expression of these gene markers were not 
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obviously showed from HepG2 CM-treated mESCs, i.e. CM-mESCs and CM-mESCs-NOELCs groups 
following the culture period. In contrast, the expression of Fgf-5 was clearly detected on day 4 of control 
mESCs group and day 9 of both HepG2 CM-treated mESCs groups although the expression of this marker 
was only highly observed on day 15 from CM-mESCs and CM-mESCs-NOELCs group with no further 
expression showed on day 9 and day 15 from control groups, resulting in loosing of pluripotentcy 
property when the differentiation process started in all culture groups. The expression of housekeeping 
gene marker was constantly observed in all culture groups over the culture period. 
 
 
 
 
 
Figure 33. Pluripotency Gene Markers Expression During The Culture Period. (M) referred to the 
maintenance phase of culture.  
7.3.4.1.2. Mesoderm gene expression profiles  
As shown in Figure 34, the expression of mesoderm gene markers were clearly observed from 
CM-mESCs and CM-mESCs-NOELCs as compared to control mESCs group indicating that early 
enhancement towards mesoderm differentiation was better achieved from both HepG2-treated mESCs 
groups during the culture period of encapsulated mESCs in 3D HARV culture system. A gradiently 
increased expression of mesoderm genes were detected from CM-mESCs and CM-mESCs-NOELCs group 
started with Brachyury-T expression observed at day 4 followed by Flk-1 and Goosecoids expression on 
mESCs 
(M) 
D.1 D.4 D.9 D.15 D.1 D.4 D.9 D.15 D.15 -ve -ve -ve D.1 D.4 D.9 
CM-mESCs CM-mESCs-NOELCs 
Differentiation Differentiation Differentiation (M) (M) 
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day 9 and day 15 of culture, although the expression pattern of Brachyury-T and Goosecoids observed 
from  CM-NOEB mESCs group were started to reduce their expression on day 15. A higher expression of 
all mesoderm markers were detected from CM-mESCS on day 15 indicating that this group promotes a 
progressive differentiation pattern towards mesoderm layer by maintaining the enhancement of 
mesoderm gene expressions over the culture period. The expression of Flk-1 gene marker was only 
maintained observed from control mESCs group along the culture period showing a lower differentiation 
ability towards mesoderm without enhancement with HepG2-CM treatment, which indicate that this 
conditioned medium improved the mesoderm differentiation corresponds to our previously data of 2D 
culture system in Chapter 5 . A housekeeping gene marker, Gapdh was constantly detected over the 
culture time point.   
 
 
    
 
 
Figure 34. Mesoderm Gene Markers Expression During The Differentiation Process. (M) referred to the 
maintenance phase of culture.  
7.3.4.1.3. Early Haematopoietic and cardiomyoenic gene expression profiles  
Figure 35 showed the expression of early cardiomyogenic gene marker, Gata-4 and 
haematopoietic gene markers specific for myeloid-erythroid progenitors detected from all culture 
groups indicating that the encapsulated mESCs differentiated into two type of lineages, i.e. 
(M) 
D.1 D.4 D.9 D.15 D.1 D.4 D.9 D.15 D.15 -ve -ve -ve D.1 D.4 D.9 
Differentiation Differentiation Differentiation (M) (M) 
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haematopoietic and cardiomyogenic lineage in 3D HARV culture system. The expression of early 
cardiogenic gene marker, Gata-4 was prominently expressed from the CM-mESCs-NOELCs culture group, 
which observed as early as early as day 4 in the differentiation culture and increased the expression 
throughout the culture period, especially on day 15 that showed the highest expression among all day of 
culture time point. Gata-4 expression were also observed from CM-mESCs and control mESCs group with 
lower expression than the CM-mESCs-NOELCs group indicating that early inducement of encapsulated 
mESCs with HepG2 CM in the CM-mESCs-NOELCs group promotes a better way of spontaneous 
cardiomyogenic differentiation as compared to the other two groups. This finding is corresponds to our 
previous data in Chapter 6 that explained the differentiation process bypassing EB step triggered the 
spontaneous differentiation towards cardiomyogenic lineage in 2D culture system. CM-mESCs showed a 
similar expression pattern of Gata-4 with CM-mESCs-NOELCs with lower expression of Gata-4 started at 
day 4, having a slight increase of the expression on day 9 before it starting to decrease the expression on 
day 15. Control mESCs showed the lowest expression of Gata-4, which also detected a bit later in the 
culture started at day 9 and constantly expressed on day 15 as compared to the other groups due to the 
reason that the encapsulated mESCs from the control group was not treated with the Hep2 CM.  
The expression of haematopoietic gene markers specific for myeloid-erythroid progenitors were 
highly expressed from the CM-mESCs culture when all of the myeloid-erythroid gene markers were 
clearly observed on day 9 and were increased in the expression on day 15 of the differentiation culture. 
This finding is corresponds to our previous data in Chapter 5 that explained the enhancement of 
hematopoietic differentiation from CM-mESCs group in 2D culture system.  Interestingly, the expression 
of EKLF (Erythroid Krüppel-like factor; KLF1) that play roles on early detection towards terminal 
erythroid differentiation was also observed from each culture group (Drissen, von Lindern et al. 2005; 
Hodge, Coghill et al. 2006; Siatecka and Bieker 2011). However, the expression was highly detected from 
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CM-mESCs culture as early as day 9 followed by a gradient increase on day 15 indicating that cell-
potentially differentiate toward erythroid lineage were highly formed in this culture as compared to 
other groups through the signal expression of this gene.       
  In contrast, the lower expression of haematopoietic gene markers were detected from CM-
mESCs-NOELCs culture with a high expression of early haematopoietic gene marker, Gata-2 was only 
observed on day 9 as compared to the other gene markers, indicating that the differentiation towards 
haematopoietic lineage was inhibited by the spontaneous cardiomyogenic differentiation in the culture. 
The lowest expression of haematopoietic gene markers was shown from control mESCs culture as all 
expression of haematopoietic gene markers were only detacted on day 15 and all haematopoietic gene 
markers were constantly expressed lower as compared to the other groups during the culture period 
showing that only the mESCs culture treated with Hep2 CM promotes a better way of lineage specific 
differentiation. The expression of a housekeeping gene, Gapdh, was constantly expressed over the 
culture time point.          
 
 
    
 
 
 
Figure 35. Early Hematipoietic and Cardiomyogenic Gene Markers Expression During Differentiation 
Process. 
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7.3.4.2. Flowcytometry Analysis on Erythropoiesis Studies 
Due to the interest of this study on production of red blood cells, encapsulated mESCs were 
analysed using flowcytometry technique with specific erythroid markers, in order to examine the 
potential of differentiating and maturing the RBCs inside the beads using the single-step of 
differentiation 3D protocol in this study. Hence, following the high expression of ELKF, an early erythroid 
gene marker and other hematopoietic gene markers expressed using RT-PCR gene analysis, two groups; 
CM-mESCs and control mESCs group were tested for erythroid monoclonal antibodies staining using 
flowcytometry analysis as these groups showed positive expression on all hematopoietic gene markers 
without any expression on other lineage as observed from CM-mESCs-NOELCs group.   Flowcytometry 
was used to assess the dynamics of different cell populations during the culture. Flowcytometry uses the 
principles of light scattering, light excitation, and emission of flourochrome molecules to generate 
specific-multi parameter data from the cells. The cultured cells were analysed for phenotypic expression 
of surface proteins specific for subpopulations of hematopoietic cells. 
In this study, the cells were cultured up to 21 days (3 weeks) in HARV bioreactor followed by 
staining process on specific eyrthroid monoclonal antibodies before continue evaluating with 
flowcytometry machine. Harvesting the mESCs from the beads might harming the cells due to the longer 
exposure of the bead on desolving buffer solution, hence it is important to get an optimum exposing 
time point to minimise the risk of losing cell during the decapsulation step.   Due to the impossibility to 
predict the results, the two specific erythroid monoclonal antibodies prior the erythropoiesis detection: 
CD71 and TER-119 were used, but further studies using additional antibodies would cover all the 
differentiated types of cells in the hematopoietic system and need to be further investigated. The two 
antibodies used were selected depending on the interest towards producing matured erythrocytes from 
the culture; below there is a detail of the types of cells they identify. 
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• CD71: The antibody that recognizes the transferrin receptor, which is essential for iron transport 
into proliferating cells. CD71 is expressed on marrow stromal cells (MSCs) from bone marrow, 
on activated T and B lymphocytes, macrophages, and all proliferating cells. It is upregulated on 
lymphocytes during proliferative responses to antigens or mitogens but is not expressed on 
resting lymphocytes. CD71 is present on reticulocytes and erythroid progenitors in fetal liver, 
cord blood, and peripheral blood, yet it is lost as these differentiate to mature erythrocytes 
(Phillips, Le et al. 1984; Lokan, James et al. 1987). 
• TER119:  This antibody is a glycophorin A-associated protein. This antigen is expressed on 
mature erythrocytes and erythroid precursor cells in adult blood, lymphoid tissue and bone 
marrrow, and in the embryonic yolk sac and fetal liver (Ikuta, Kina et al. 1990; Ogawa, Matsuzaki 
et al. 1991; Kina, Ikuta et al. 2000). 
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Figure 36. The Flowcytometry Analysis Profile of The Encapsulated mESCs Cultured in HARV Bioreactor 
from Day 0 to Day 21. The low expression of both erythroid markers observed in both culture groups 
indicated that maturation of terminal differentiated cell towards enucleated erythrocytes were not 
achieved in the culture. 
 
Table 10. Flow data during the culture process. The table shows the percentage of cells stained by 
matured erythroid markers after decapsulation process of encapsulated mESCs.  
 
 
 
 
Groups CD71 TER 199 
Day 0  2.60 1.90 
Day 21 - mESCs 0.66 0.26 
Day 21 - CM-mESCs 0.89 0.21 
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Day 0 represented the early stage of mESCs before undergoing encapsulation process. Freshly 
2D culture of mESCs was tripsinised and the suspension of cells was stained with erythroid marker prior 
to the encapsulation process. As shown in Figure 36, a small population of cells was observed to express 
both CD71 and TER-119 erythroid markers from Day 0 mESCs indicating that there was autofluorescent 
occurred during the cell staining process, resulting to a false positive cell population (Table 10).  Cellular 
autofluorescence is a common obstacle in flow cytometry, interfering with detection of low level 
fluorescence.  Autofluorescence is detected from the cells contain molecules, which become fluorescent 
when excited by UV/Visual radiation of suitable wavelength. This fluorescence emission, arising from 
endogenous fluorophores, is an intrinsic property of cells and is called auto-fluorescence. 
Autofluorescence is different from fluorescent signals obtained by adding exogenous markers like FITC, 
GFP, or PE. It is usually strongest with short wavelength excitation (UV or Blue) and short wavelength 
emission (Blue and Yellow) (Mosiman, Patterson et al. 1997).   
                Over the 21 days of culture period, the population of cells that expressed both markers was 
decreased in control and CM-mESCs groups indicating that the differentiation and maturation of 
terminal differentiated cells towards mature erythroid cells were not successfully achieved during from 
encapsulated mESCs in suspension 3D culture of HARV bioreactor (Figure 38 and Table 9). In other point, 
preliminary study on the the immunocytochemistry expression of both CD71 and TER-119 erythroid 
markers was conducted earlier by staining the cells directly with the markers using cytospin technique.  
The cell staining was evaluated qualitatively under a fluorescent microscopy. Although there was 
expression on both markers observed in the both culture during the differentiation period (data shown 
in Appendix 3), the expression was probably due to the non-specific binding caused by polyclonal 
antibody markers used in the experiment. Antigen affinity-purified polyclonal antibodies maximize the 
opportunity of antigen binding in tissue, due to multiple epitope recognition but without the drawback 
of conventional polyclonal antibodies that caused the non-specific binding (R and D system). Hence, 
161 
 
using the flowcytometry analysis with monoclonal antibodies showed more specific binding on the 
targeted markers and analysed the data obtained quantitatively. However, although the differentiation 
and maturation of erythroid cells were not successfully achieved in the beads culture observed from 
control mESC and CM-mESCs groups as shown by specific monoclonal antibodies staining from the 
flowcytometry analysis, the positive expression from direct immunocytochemistry staining showed by 
the polyclonal antibodies of the samples still could be used an early indicator for the cells that could 
potentially differentiate into lineage of interest, i.e. erythroid. It has been agreed that further study 
need to be conducted to explain this phenomenon in detail. Therefore, based on these findings, we have 
carried on few initial analyses to get more ideas on the lineage specific of cells obtained from our 3D 
culture protocol.      
 
7.3.5. Analysis Studies on Differentiation Process of De-capsulated mESCs Beads and Re-plated on 
Petri Dish 
 
Samples of encapsulated mESCs from each groups cultured in the bioreactor were collected at the 
end of differentiation process time point i.e. on the day of 21 in HARV bioreactor and were decapsulated 
to harvest the mESCs. The cells were plated on 35mm bacteria grade petri dish for clonogenic ability of 
CFU assay and the colonies were collected for cytospin Wright-giemsa staining and 
immunocytochemistry staining, RT-PCR analysis and Western blot study.       
7.3.5.1. Clonogenic ability of CFU assay  
Following the 3D HARV culture process, cells suspension from decapsulated mESCs were 
harvested and were plated on methylcellulose semi-solid medium with addition of specific 
haematopoietic growth factors i.e. mSCF, mIL-3, hIL-6, and hEPO in order to see the ability of 3D 
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encapsulated mESCs cultured in HARV bioreactor able to produce haematopoietic progenitor colonies. 
Incubation to the standard 14 days resulted in formation of all types of hematopoietic progenitor 
colonies BFU-E, CFU-E, CFU-GM and CFU-GEMM, which were observed in control and both experimental 
groups. As shown in Figure 37, control mESCs group showed the formation of myeloid progenitors, 
which identified by the formation of CFU-GM colonies that most prominently detected during the 
culture. In contrast, CM-mESCs group exhibited a better culture for erythroid progenitor’s as shown by 
formation of BFU-E colonies that mostly observed during the culture period. A well-matured of reddish 
colour’s colonies was observed from the BFU-E, which associated with a sign of maintaining 
haemoglobin capacity in the CM-mESCs culture group whereas the control mESCs group displayed poor 
formation of red progenitor colonies, which related to the low capacity of colonies to maintain 
hemoglobin maturation.  Formation of beating colonies was only observed in the CM-mESCs-NOELCs 
group, which formed dominantly in the culture together with the hematopoietic progenitor colonies.    
                           
Figure 37. Clonogenic capacity of terminally differentiated mESCs at day 14 of the 3-D culture. (A) 
Shown are examples of (i) CFU-GM colonies, most prominently identified in the control group, (ii) BFU-E 
colonies, observed mostly in the CM-mESCs group and (iii) “Beating colonies” observed only in the CM-
mESCs-NOELCs group. 
 
As shown in Figure 38, a higher number of hematopoietic colonies was achieved from the CM-
mESCs group over the 14 days of incubation (p≤0.01) with a 3-fold enhancement comprised of all types 
of haematopoietic progenitor colonies compared with that of the control mESCs. The highest formation 
(A) (B) (C) 
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of erythroid progenitors i.e. BFU-E and CFU-E formation were collected from the CM-mESCs group, 
which represented 79.5% of culture with approximately 3-fold enhancement compared with that of the 
control, mESCs (30.2%) and CM-mESCs-NOELCs (9.6%) groups (Table 11). In contrast, control mESCs 
group showed the highest formation of myeloid colonies, i.e. CFU-GM represented 69.5% ± 3.4 of the 
culture with almost 4-fold enhancement as compared with that of the CM-mESCs (18.8 % ± 4.6) and CM-
mESCs-NOELCs (9.1 % ± 5.0) groups (Table 11). This result showed that HepG2-treated mESC groups i.e., 
CM-mESCs could enhanced the haematopoietic differentiation towards erythroid lineage as compared 
to the control group, while CM-mESCs-NOELCs group showed different phenotype of differentiation 
towards  spontaneous cardiomyogenic differentiation. This group showed the highest number of 
beating colonies collected from the culture, represented 81.2 % ± 8.3 of the colonies with only 19.8 % of 
hematopotietic progenitor colonies were formed (Table 11). These findings were corresponded to the 
previous 2D culture results on the enhancements of heamatopoietic differentiation (chapter 5) and 
spontaneous cardiomyogenic differentiation (chapter 6)  using HepG2 conditioned medium, which also 
showed a greater amount of each type of colonies harvested from 3D system as compared to 2D 
conventional culture. However, the formation of mixed culture of heamatopoietic colonies together 
with beating colonies in CM-mESCs-NOELCs groups is an interesting new finding and further studies 
need to be conducted to explain this phenomenon in detail.   
Table 11. Percentage(%) of hematopoietic progenitor colonies from 3D culture system with CFU assay 
Groups BFU-E CFU-E CFU-GEMM CFU-GM Beating Col. Total 
mESC 20.3 ± 3.2 9.9 ± 2.7 0.3 ± 0.5 69.5 ± 3.4 0 ± 0 100 
CM-mESCs 54.7 ± 8.5 24.8 ± 4.4 1.7 ± 1.6 18.8 ± 4.6 0 ± 0 100 
CM-mESCs-NOELCs 6.7 ± 3.7 2.9 ± 2.4 0.1 ± 0.3 9.1 ± 5.0 81.2 ± 8.3 100 
Each value indicates the percentage of colonies per 35 mm dish of 4-dishes plated, n=4 (mean + STD) 
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Figure 38. A Summary bar graph of colony unit formation in all culture groups at day 14 of the 
terminal differentiation in 3-D culture. A significant higher number of all hematopoietic progenitor 
colonies was observed in CM-mESCs harvested cells as compared to the other groups. A high number of 
early (BFU-E) and more committed (CFU-E) erythroid colonies was observed in the 3-D CM-mESCs group. 
Beating colonies were only observed in the CM-mESCs-NOELCs group of 3D culture. (p≤0.01). 
 
 
7.3.5.2. Cytospin Wright-Giemsa staining 
Haematopoietic progenitor colonies from control mESCs and CM-mESCs groups were stained 
with Wright-Giemsa Staining that normally used to study the different morphology of blood cells 
through histological technique. The colonies were collected from methylcellulose semi-solid culture and 
were resuspended in PBS to wash them before diluting them to prepare a cell suspension of 1X 10
5
 
cell/mL. The cells were loaded up into appropriate wells of the cytospin case and were centrifuged at 
130rpm for 5 min to allow more cells to anneal on the slide in the case. The slide was dried up for 1-2 
hours at room temperature before continue placing it in the Wright-Giemsa stain for 10 seconds, 
followed by washing process with de-ionised water for 1-2 minutes and air dry thoroughly before 
evaluation under light microscope. As shown from the Figure 39, macrophages were identified in the 
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CFUs from the Wright-Giemsa staining at day 14 of culture without any formation of nucleated 
erythroblast observed, confirmed the CFUs result on the formation of CFU-GM colonies, which most 
prominently formed from the control mESCs group (Figure 39 [A] and [B]). The macrophage morphology 
from the staining were identified based on the criteria as follows: (i) a large cell, slightly smaller size in 
mouse with 20-30 µm in diameter (ii) the nucleus is oval and stains a purple color; (iii) the cytoplasm is 
ample, a pale-grey color with occasional bluish zones, with some azurophilic (pinkish-purple) granules 
present; and (iv) colorless vacuoles present, occasionally in large numbers. In contrast, nucleated 
eythroblast and macrophages were identified in the CFUs from CM-mESCs at day 14 (Figure 40 [A] and 
[B]), confirmed the formation of BFU-E that mostly observed from the culture. The standard Wright-
Giemsa staining of BFU colonies normally appear with a formation of macrophage and immature 
nucleated erythroblast cells as similarly shown in Figure 40 (A) and (B). The immature nucleated 
erythroblast morphology was identified as follows: (i) relatively large cell, slightly smaller in mouse with 
a diameter of 9-15 µm; (ii) a high nuclear ratio compare to cytoplasmic area, the nucleus occupies 
almost three-fourths of the cell body and it is generally a round structure which stains a deep violet-
blue; and (iii) the cytoplasm often a narrow ring around the nucleus, comprising only one-tenth of the 
volume of the cell, and the color varies from sky-blue to pinkish purple. The staining pictures were 
identified based on the blood histology images of an atlas on laboratory animal hematology (J.H. 
Sanderson and Christine E.Phillips, 1981). 
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Figure 39. CFU-GM colonies of Control mESCs Group (A and B). Shown are cytospin staining of CFU-GM 
colonies exhibited the macrophages cells, which were mostly observed in the staining.   
  
Figure 40. BFU-E Colonies of CM-mESCs Group (A and B). Formation of macrophages and nucleated 
erythrocytes was observed prominently from the cytopin staining of BFU-E.  
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7.3.5.3. Immunocytochemistry staining on cardiomyogenic differentiation 
The beating colonies from the CM-mESCs-NOELCs group cultured at day 14 were stained with 
early cardiomyogenic marker, anti-sarcomeric α-actinin for the immunocytochemistry study as the low 
amount of haematopoietic colonies from from the CFU assays in the same culture were too low and not 
possible to run the cytospin staining. Beating colonies formed on the methylcellulose semi-solid medium 
were washed gently to remove the medium and were fixed with parafolmaldehyde before continue with 
the antibody incubation for the staining process. The process followed by washing step before 
evaluating the slide under fluorescent microscope. As shown in Figure 41, positive expression of 
cardiomyogenic marker, anti-sarcomeric α-actinin (FITC-green) was observed in the culture, hence 
confirmed the spontaneous differentiation towards cardiomyogenic lineage in CM-mESCs-NOELCs 
culture. However, further study on the influence of hematopoietic cytokines and pseudo-3D 
environment of methylcellulose culture on the spontaneous cardiomyogenic differentiation need to be 
explained in detail.       
                    
Figure 41. Immunocytochemistry Staining of Beating Colonies From CM-mESCs-NOELCs. Shown are the 
beating colonies day 14 (A) of CM-mESCs-NOELCss group. Positive expression of cardiomyogenic marker, 
anti-sarcomeric α-actinin (FITC-green) were observed in the culture. The inset (i) show positive controls 
for the antibody, while the negative control for on-specific binding of the primary antibodies was 
showed by the inset (i’). The nuclear staining with DAPI is shown in the inset (ii) with blue staining. 
(A) (i) 
(ii) 
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7.3.5.4. Gene expression analysis of CFUs 
Studies on the expression of early haematopoietic and cardiomyogenic gene markers were run 
by RT-PCR analysis. Samples of CFUs were harvested from each culture groups at day 14 and were 
quantified their RNAs before continue with cDNA formation and reverse transcriptase PCR step. As 
shown on Figure 42, CFUs from control mESCs groups only showed positive expression of early 
haematopoietic markers, Gata-2 and SCL with negative expression on cardyomyogenic, Gata-4 and α-
myosin heavy chain (α-MHC) and specific definitive erythroid gene marker, β-major globin. In contrast, 
CFUs from CM-mESCs group exhibited higher expression of Gata-2 with positive expression on SCL and 
β-major Globin, hence indicated a better culture environment for hematopoetic differentiation towards 
erythroid lineage. However, there was no expression on cardyomyogenic markers observed, which 
confirmed that haemepatopoietic differentiation was successfully achieved from this culture group. In 
other case, expression of Gata-4 and α-MHC were highly detected from CFUs of CM-mESCs-NOELCs 
culture supports the previous results on the spontaneous differentiation towards cardiomyogenic 
lineage although there were some expression of Gata-2 and SCL observed at the lowest level from the 
culture, hence proved that cardiomyogenic differentiation were dominantly formed during the culture 
period although the formation of mixed lineage colonies were observed from this group. However, there 
was a negative expression on β-major globin gene marker showed that differentiation towards erythroid 
lineage was not occurred in the group.  Overall, the data showed that CM-mESCs group was the best 
group for hematopoietic differentiation compared to control mESCs and CM-mESCs-NOELCS indicating a 
more efficient differentiation system towards haematopoietic lineage specifically on erythroid 
progenitors.  
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Figure 42. Gene Expression Studies of CFUs from 3-D encapsulated mESCs cultured in HARV System. 
RT-PCR analysis of haematopoietic and cardiomyogenis genes at day 14 CFUs culture of control mESCs 
(A), CM-mESCs (B) and CM-mESCs-NOELCs (C) groups indicated that hematopoietic differentiation was 
successfully achieved from the CM-mESCs group and cardiomyogenic differentiation was only detected 
from the CM-mESCs-NOELCs group. The expression of definitive erythroid marker, β-major globin 
observed from CM-mESCs showed that specific haematopoietic differentiation towards erythroid 
lineage was also occurred in this group. Negative control consisted of samples without cDNA. 
 
7.3.5.5. Western Blot Analysis of CFUs  
Following the gene expression studies, samples of CFUs from each culture groups were 
examined for western blot antibodies analysis for further identification on erythropoietic differentiation. 
The CFUs from all groups were collected at day 14 and were quantified their proteins before continue 
with antibodies blotting step. As shown in figure 43, expression of early erythroid marker, Gata-1 and 
definitive erythroid marker, β-globin were observed from CM-mESCs culture proved that erythropoietic 
differentiation and haemoglobin development were successfully achieved only from this group, hence 
indicated that CM-mESCs provided an efficient  culture condition for specific differentiation towards 
erythroid lineage. However, there was no expression on primitive erythroid marker, ζ-globin from the 
A C B -ve 
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culture on day 14 indicated that the primitive eryhtoid cells might hardly to be maintained in vitro up to 
14 days of incubation period as their formation normally in a short-term before shifted to become 
definitive erythroid cells. In other case, negative expression of erythroid markers were observed from 
control mESCs and CM-mESCs-NOELCs groups indicated that erythropoiesis were occurred in both 
groups, hence supports the previous data on poor formation of reddish colonies that contained 
haemoglobin from the cultures.    
 
 
 
     
Figure 43. Western Blot Analaysis of CFUs from 3-D encapsulated mESCs culture in HARV System. 
Analysis of erythroid antibody markers at day 14 CFUs culture of control mESCs (A), CM-mESCs (B) and 
CM-mESCs-NOELCs (C) groups indicated that hematopoietic differentiation toward specific erythroid 
lineage was successfully achieved from the CM-mESCs group. Negative control consisted of samples 
without proteins. 
 
7.4. Comparison Studies on CFUs Formation From 2-D and 3-D Culture Systems 
 
Following the CFUs assay, a graph of all types of hematopoietic colonies were plotted to 
compare the clonogenic ability of each culture groups in 2-D and 3-D culture system (Figure 44). Overall, 
CM-mESCs group showed the highest population of heamatopoietic colonies after 14 days of culture 
with two times higher of all progenitors formation were observed in 2-D and three times higher of the 
CFUs were formed in 3-D culture condition as compared to the control mESCs group (Figure 44). 
Interestingly, the CM-mESCs group was also exhibited the highest differentiation towards erythroid 
A -ve B C 
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progenitors which represented two times higher of BFU-E and CFU-E formation were collected from 2-D 
culture and three times higher of those colonies formation were obtained in 3-D culture as compared to 
the control mESCs group. Moreover, the erythroid progenitor colonies formation in CM-mESCs culture 
showed 61.2% of the colonies population was formed in 2D culture and 79.5% of erythroid colonies was 
achieved from 3-D culture after 14 days of incubation period (Table 12). Hence, this finding indicated 
that the CM-mESCs provided a better differentiation culture condition towards hematopoietic colonies 
as well as enhanced the specific differentiation towards erythroid progenitors with more colonies 
formation were obtained from 3-D culture system as compared to 2-D culture. In contrast, control 
mESCs group showed more formation of CFU-GM with 69.5% of colonies population were obtained in 3-
D culture and 38.3% colonies were collected in 2-D culture system. Hence, the result indicated that 
control mESCs provided a hematopoietic culture condition that promotes myeloid differentiation with a 
high formation of CFU-GM was observed during the culture period. In other points, the CM-mESCs-
NOELCs group showed a different trend of lineage formation with 81.2% of beating colonies was 
observed as well as 19.8% of hematopoietic colonies was also formed from 3-D culture indicated that 
the 3-D culture environment enhanced the mixed lineage formation as compared to the 2-D culture with 
100% of pure population of beating colonies were obtained from the CM-mESCs-NOELCs group (Table 
12). Overall, the 3-D system provided a better culture environment for hematopoietic differentiation 
which observed from a higher formation in almost all types of hematopoietic progenitors collected from 
HepG2 treated groups (CM-mESCs and CM-mESCs-NOELCs) as compared to the same groups in 2-D 
system. However, the formation of multipotential progenitor cells, CFU-GEMM was obtained a slightly 
higher in 2-D culture as compare to 3-D culture observed from the CM-mESCs and control mESCs groups 
indicated that 2-D culture system is more suitable for generating the multipotential progenitors. 
Moreover, the pure formation of beating colonies was only observed from 2-D culture of CM-mESCs-
NOELCs group as compared to the 3-D culture system indicated that the differentiation process in 2-D 
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system is restricted only for one lineage of cell type. However, the formation of mixed lineages of 
hematopoietic and cardiomyogenic colonies observed in 3-D culture from CM-mESCs-NOELCs is an 
interesting finding that needs to be studied further.    
 
 
 
 
 
 
 
Figure 44. A Schematic of bar graph of 2-D and 3-D culture for CFUs formation in each culture groups 
at day 14 of culture. Summary of bar graphs indicated that the CFU formations were highly obtained 
from 3-D cultured cells compared to 2-D cultured mESCs with a higher formation of erythroid 
progenitors colonies (BFU-E and CFU-E) in CM-mESCs groups and Beating colonies formation in CM-
mESCs-NOELCs observed from 3-D culture system (p≤0.01). 
 
Table 12. Percentage of CFUs from each culture group at day 14 of incubation period. 
Groups BFU-E CFU-E CFU-GEMM CFU-GM Beating Col. Total 
2D mESC 36.9 ± 2.4 19.5 ± 2.2 5.3 ± 1.5 38.3 ± 3.1 0 100 
2D CM-mESCs 39.9 ± 2.8 21.3 ± 3.1 7.2 ± 2.9 31.6 ±2 .3 0 100 
2D CM-mESCs-NOELCs 0 0 0 0 100 ± 2.7 100 
3D mESC 20.3 ± 3.2 9.9 ± 2.7 0.3 ± 1.5 69.5 ± 3.4 0 100 
3D CM-mESCs 54.7 ± 8.5 24.8 ± 4.4 1.7 ± 1.6 18.8 ± 4.6 0 100 
3D CM-mESCs-NOELCs 6.7 ± 3.7 2.9 ± 2.4 0.1 ± 0.3 9.1 ± 5.0 81.2 ± 8.3 100 
Each value indicates the percentage of colonies per 35 mm dish of 4-dishes plated, n=4 (mean + STD) 
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7.5. Discussion 
Advanced ex-vivo blood manufacture has been developed extensively with modification on the 
conventional culture system that enables certain types of blood cells to be created from different cell 
resources in combination with biomaterials and bioreactor culture vessels. This approach is potentially 
can provide a basis for systematic, controlled in vitro studies of blood cells growth and function. To 
dates, many research efforts on producing blood cells-like have been developed extensively by studying 
various cell sources with application on the 3-D biomimic scaffold using 2-D culture system in laboratory 
scale (Banu, Rosenzweig et al. 2001; Liu and Roy 2005; Feng, Chai et al. 2006; Taqvi and Roy 2006; Ma, 
Chan et al. 2008). However, the 2-D culture system has not been shown to generate a proper 3-D tissue 
successfully that equivalent to the in vivo tissue development due to several limitations especially on the 
lack of nutrient mass transport and mechanical forces that are important to induce the differentiation 
process and the growth of cells. In order to overcome these problems, the use of bioreactor has been 
applied recently in cell culture technique to enhance the 3-D growth of cells as well as to provide a 
better culture environment that mimicking the in vivo cells production. Therefore, we have developed a 
culture system that produced 3-D blood cells-like using mESCs, HepG2-conditioned medium, hydrogel 
alginate beads encapsulation and HARV bioreactor. Up to our concern, our study is the first one 
demonstrating the 3-D blood cells-like formation from individual cell suspension of encapsulated mESCs 
in a bioreactor system with a conditioned medium treatment, thus this culture effort could be used 
potentially to improve the production of blood cells manufacture ex vivo widely. 
In mouse development process in vivo, at about 4.5 days post coitum (d.p.c), inner cell mass in 
the blastocyst experiences very complicated developmental program closely in contact with visceral 
endoderm layer. This developmental stage leads to the formation of second pluripotent cell population 
which is called the primitive ectoderm in the late epiblast stage, where a rapid cell population occurs 
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before the gastrulation process (Snow and Bennett 1978; Pelton, Sharma et al. 2002). Correspondently 
with the in vivo condition, cells in the CM-mESCs and CM-mESCs-NOELCs groups affected by initial 
visceral endodermal signals from HepG2-CM resulted in a faster growth rate as compared to control 
mESCs until they reached a maximum cell number, which was achieved almost 3x10
5 
cells/bead after 
day 11 during the culture process. This cell growth tendency was reported correspondently to the 
growth rate of the cells observed in two-dimensional culture (Hwang, Randle et al. 2006). In terms of 
cell’s morphology in the 3-D, the HepG2-CM treated cells (i.e. CM-mESCs and CM-mESCs-NOELCSs) 
showed relatively bigger size on the cell agglomeration compared to control mESCs affected from the 
conditioned medium treatment on the cells resulted in the higher cell proliferation, hence leads to the 
bigger colonies formation. This finding is also corresponds to our live and dead results that showed an 
increase of cell aggregation size with culture time.  
In this study, mESCs were prepared in suspension followed by encapsulation process with 1.1% 
alginate mixed with 0.1% gelatin. The encapsulated mESCs were cultured in suspension environment 
within the rotating wall vessels bioreactor, i.e. HARV bioreactor that controlled in vitro suspension 
culture condition by producing laminar flow and minimizing shear and turbulence stresses on cells 
during the culture process whilst providing sufficient nutrient and oxygenation that supports 3-D tissue 
growth(Hammond and Hammond 2001).  The hydrogel encapsulation technique was adopted because 
hydrogels, which are mostly consisting of water, have high diffusivity. It is well-known that effective 
mass transfer would be achieved in hydrogels even with a poorly mixed external environment. The 
gradient of physicochemical parameters between hydrogel and surrounding medium would become 
higher in the bioreactor culture due to the well mixing as the rates of nutrient consumption and 
metabolite accumulation become faster as cells grow. Observation of locally changed medium-colour in 
a tissue culture flask is consistent with this situation, and also supports the necessity of good-mixing 
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using a bioreactor. Although a culture of large cellular constructs is generally known to require a 
‘capillary network” as part of the structure through induced angiogenesis or vascularisation (Placzek et 
al. 2009), a well-mixed culture condition offers an external force for mass transport such as convection 
could also reduced the diffusion limitation faced in 2-D conventional static culture condition. This is 
demonstrated by the higher viability of cell colonies found in the HARV culture up to 21 days of culture 
period as shown by the live and dead results.  
Terminal differentiated cells formed within alginate beads consisted of viable and metabolically 
active cells, which were evaluated by measuring pH change, glucose consumption, lactates and 
ammonia production in haematopoietic medium during cultures. It has been reported that the pH and 
metabolites profiles can provide a kind of metabolite parameters to be used to modulate cell 
metabolism such as ECM synthesis and tissue growth as well as morphology for developing optimal 
culture condition for cell growth (Obradovic, Carrier et al. 1999; Zhao, Pathi et al. 2005).  Mammalian 
cells utilize glucose and glutamine as one of major energy sources. Glucose uptake was from culture 
medium and then is converted to lactate as a by-product through glycolysis under anaerobic condition, 
yielding 2 mol of adenosine triphosphate (ATP) per mole of glucose, or producing CO2 and H2O through 
the tricarboxylic acid (TCA) cycle in aerobic condition, yielding 36 mol of ATP per mole of glucose. 
Lactate is mostly produced by glycolysis of glucose, and only a small amount is derived from glutamine 
(Zielke, Sumbilla et al. 1980; Glacken, Fleischaker et al. 1986). Glutamine is utilized by catabolism 
through the TCA cycle, producing ammonia as a by-product. The amount of ammonia can be used as an 
indicator of glutamine utilization and TCA cycle activity (Miller, Wilke et al. 1987; Siano and Mutharasan 
1991). 
  Although numerous studies about ESC expansion and differentiation have been undertaken thus 
far, the optimal requirements of the basic medium for ESC culture are still not clear. In vivo, the normal 
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concentration of glucose which circulates through blood vessels is approximately 1000 mg/l. However, 
supraphysiological glucose levels such as 4500 mg/l have been frequently employed for ESC derivation 
and maintenance in vitro. It was demonstrated that modified MEMα (Minimum Essential Medium 
alpha) and IMDM (Iscove’s Modification of Dulbecco’s Medium) containing 4500 mg/l of glucose 
improved the efficiency of ESC derivation remarkably in conjunction with the maintenance of their 
pluripotency, compared with the different media containing 1000 mg/l of glucose (Dulbecco’s Modified 
Eagle Medium)(Ogawa, Kanashima et al. 2001; Kim, Amano et al. 2009). On the other hand, the greatest 
rate of ESCs differentiation was found not at a high glucose level (4500 mg/l) but at a physiologically 
normal glucose level (1000 mg/l)(Khoo, McQuade et al. 2005). In this study, ESCs were expended in 
HepG2-CM formulated with high glucose DMEM, and differentiated in the haematopoietic medium 
based on low glucose IMDM. IMDM was developed to support cells with high concentrations of various 
amino acids, vitamins and sodium pyruvate etc. It was shown in the results of the medium profiles in 
this study that glucose levels reached 0 mM after the medium was changed to haematopoietic medium 
and maintained at extremely low levels throughout the entire haematopoietic differentiation period. 
This situation can be simply reasoned by a low level of initial glucose concentration in the 
haematopoietic medium (about 5 mM (1000 mg/l)), causing the early depletion of the glucose contents. 
On the other hand, it has demonstrated that the early embryo development of human and mouse, pre-
implantation of blastocysts, as enhanced in the physiological glucose level, and furthermore, it showed 
high dependency on pyruvate or glutamine instead of glucose (Conaghan, Handyside et al. 1993; Quinn 
1995). The other study also suggested that ESCs in differentiation phase can survive in 0 mM of glucose 
adapting to other substrates present in the medium for metabolism such as pyruvate and glutamine 
(Khoo, McQuade et al. 2005). 
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  In this study, the trends of the variances in glutamine levels showed a consistency to the reports 
above during haematopoietic differentiation. Our study of 3-D haematopoiesis has shown a rapid 
decrease in glucose concentration in the media observed from control mESCs, CM-mESCs and CM-
mESCs-NOELCs due to initial low concentration of glucose in haematopoietic differentiation medium, 
indicating a rapid cell growth and active metabolism occurred in cells from the cultures. In other points, 
different high concentration in glutamine level observed from all group of cultures might be due to a 
higher tendency of HepG2-CM treated cells, i.e. CM-mESCs-NOELCs and CM-mESCs to proliferate more 
as compared to control mESCs, corresponding to the growth proliferation study. The higher proliferation 
cells leads to the higher consumption of glutamine showed by a rapid reduction of glutamine 
concentration to ground level from CM-mESCs-NOELCs due to the highest growth rates affected from 
the HepG2-CM treatment and could also related to the spontaneous cardiomyogenic formation 
occurred in this group. This followed by CM-mESCs that showed a slightly similar trend of rapid 
glutamine reduction which was also affected from the HepG2-CM treatment that leads to 
haematopoietic differentiation. The lowest glutamine consumption was showed by control mSCs group 
due to the lowest number of growth proliferation achieved during the culture.   
Corresponding to the result of glutamine consumption, lactate and ammonium production 
during haematopoietic differentiation period was also higher than in the early maintenance culture 
phase. Lactate and ammonium profile showed a fast increase in their concentration at day 3 before 
slowly increased the level to reach a relatively constant concentration in all culture groups during the 21 
days of culture. The highest concentration of lactate and ammonium represented by CM-mESCs-NOELCs 
followed by CM-mESCs and control mESCs group which also corresponded to the growth proliferation 
study that related to the higher secretion level of both metabolites in cultures.  
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In addition, medium pH is another key parameter in cell culture as it also affects cell viability, 
cell growth and metabolic activity. In our study, the pH of haematopoietic differentiation media in all 
culture groups decreased with culture time which could also related to an increasing lactate and 
ammonia concentration corresponding to the fact that ammonia and lactate production alters 
intracellular and external pH in culture media (Barngrover, Thomas et al. 1985). However, the pH change 
is still within the proper pH range (7.0-7.4) observed from the culture media indicated that there was no 
strong influence on the cell growth and function. From these results, we suggest that the more concise 
control of culture condition should be necessary to achieve optimal culture system with regards on the 
nutrient consumption profile and cellular metabolism in a bioreactor.  
Recently, many research approaches on development of 3-D blood cells-like using mESCs, 3-D 
scaffold systems, application on bioreactor systems and appropriate growth factors in the culture 
system, showing the potential use of ESCs for blood cells manufacture ex vivo (Banu, Rosenzweig et al. 
2001; Dang, Gerecht-Nir et al. 2004; Liu and Roy 2005; Feng, Chai et al. 2006; Taqvi and Roy 2006; Ma, 
Chan et al. 2008; Fridley, Fernandez et al. 2010). However, in spite of these successful approaches for 3-
D haematopoietic differentiation of ESCs, attempts to direct the differentiation of ESCs into desired cell 
type through intermediate EB formation have been limited. To dates, limited knowledge exist 
concerning the culture conditions and requirements for culturing EBs, differentiation mechanism and 
cellular interactions within EBs resulting in difficulty to control homogenous differentiation. In other 
words, little is known about the process guiding the development of three germ layers and specific 
lineage of cells within the EB. Current approaches for the differentiation through intermediate EB 
formation give rise to a mixture of different cell types due to spontaneously formed three germ layers 
(Khoo, McQuade et al. 2005). In our previous study, we have developed a haematopoietic 
differentiation culture system without forming normal EB step with the formation of ‘embryoid-like 
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colonies’ (ELCs) (Chapter 5). Therefore, to develop a better and an efficient culture system for ex vivo 
blood cell manufacture, our culture system was designed to trigger early differentiation of alginate 
encapsulated mESCs with subsequent haematopoietic differentiation by culturing the cells in HepG2-CM 
and haematopoietic medium in a HARV bioreactor in order to achieve a 3-D blood cells-like formation. 
The early differentiation process of forming the 3-D blood cells-like in the alginate beads with those 
differentiation factors was characterized by gene expression studies during the maintenance and 
differentiation stages of 21 days culture period.   
The expression of representative markers for the evaluation of the early developmental 
progress such as Oct-4, Rex-1 and FGF-5 were relatively compared in all culture groups based on the 
expression level observed in our 2-D study previously (Chapter 5). Oct-4 is one of the POU family 
transcription factors which is considered a major regulator for maintenance of pluripotency in ESCs 
(Nichols, Zevnik et al. 1998; Niwa, Miyazaki et al. 2000). Oct-4 level gradually decreases in the induction 
of spontaneous differentiation in ESCs (Palmqvist, Glover et al. 2005). Rex-1 and FGF-5 are known to be 
expressed in the specific stage of embryogenesis. In particular, it was reported that Rex-1 is expressed in 
day 4.5 of blastocyst in mouse developmental process, and then down-regulated 1-2 days later in the 
embryonic ectoderm (Rosner, Vigano et al. 1990; Rogers, Hosler et al. 1991). Whilst FGF-5 expression in 
mouse development is first apparent in day 5 of post-implantation epiblast (Haub and Goldfarb 1991) 
suggesting that Rex-1 is down regulated but FGF-5 is up-regulated after day 4.5 of mouse 
embryogenesis. Amplification of FGF-5 gene however has not been detected in undifferentiated ESCs 
(Hamazaki, Oka et al. 2004; Zhang, Guo et al. 2005). According to the findings above, the expression of 
FGF-5 and Rex-1 in vitro and in vivo represents a temporally distinct sub-population of differentiating 
ESCs within the Oct-4 positive pool (Pelton, Sharma et al. 2002).     
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In this study, the lower expression of Oct-4 and Rex-1 as well as a higher expression of Fgf-5 
genes during the transition of maintenance to differentiation stage indicated that mESCs from CM-
mESCs and CM-mESCs-NOELCs groups were shifted from the pluripotent stage into the intermediate 
pluripotent stage by HepG2-CM which could be effectively followed by the specific lineage 
differentiation. Thus, this finding corresponded to the behavior of mESCs that similarly reported in the 
above studies as well as observed in Chapter 5 and 6 (Rathjen, Lake et al. 1999; Rathjen and Rathjen 
2001; Pelton, Sharma et al. 2002; Rodda, Kavanagh et al. 2002; Hwang, Randle et al. 2006).  
In vivo, after the stage of epiblast which has been severely influenced by visceral endodermal 
signaling, the future mesodermal lineage fraction tends to get farther from the epithelial monolayer and 
traverse the primitive streak along the posteriodital axis of the embryo, an area of localized ECM 
breakdown (Ciruna, Schwartz et al. 1997; Ciruna and Rossant 2001). Rodda et al. reported that mESCs 
differentiated to primitive extoderm-like cells by HepG2-CM, and then three germ layers differentiation 
progressed in the absence of visceral endoderm when cultured in the germ layers formation medium. 
This environment would situate a loss of contact between cell and epithelial layer of ECM, which is 
similar with in vivo situation when the potential mesodermal fraction starts migrating from posterior 
epiblast. This speculation can well link to the selective mesoderm formation in the colonies derived from 
HepG2-CM treated mESCs (Rodda, Kavanagh et al. 2002). These findings suggested an efficient method 
to control lineage-specific differentiation introducing HepG2-CM to ESC-culture. In this study, the 
enhancement expression of mesodermal development markers in HepG2-CM treated cells (CM-mESCs 
and CM-mESCs-NOELCs) is correspondent with the previous findings above, and this selective 
mesodermal development in our 3-D culture can have an easy link to the specific haematopoietic 
differentiation including cardiomyogenic spontaneous differentiation which also agreed with the result 
of our previous works in Chapter 5 and 6.  
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A stronger Gata-4 expression in CM-mESC-NOELCs group than CM-mESCs and control mESCs 
groups is also one of the interesting findings in this study. Gata-4 is well known as an early marker of 
cardiomyogenesis in the mammalian development process with Nkx2.5 and other parietal endoderm 
markers such as SPARC and S100A4 (Grepin, Nemer et al. 1997; Brewer, Alexandrovich et al. 2005; Stary, 
Pasteiner et al. 2005; Stary, Schneider et al. 2006).  In many previous works, Gata-4 was strongly 
expressed in the early stage after introducing visceral endoderm signals to ESC-culture using HepG2 or 
END-2 cell line, resulting in the effective cardiomyogenesis (Rathjen, Lake et al. 1999; Rathjen and 
Rathjen 2001; Filipczyk, Passier et al. 2007). With agreement to the previous studies, HepG2-CM 
treatment in the CM-mESCs-NOELCs 3-D culture could potentially derived ESCs to cardiomyogenic 
lineage effectively than CM-mESCs and control mESCs group with their early and higher expression of 
Gata-4.  
As one of the clues in vivo, it was reported that Flk-1 was not expressed in the cells of primitive 
streak but was up-regulated as they exited the streak (Ema, Yokomizo et al. 2006). With regard to this 
finding, Kattman et al. examined that ESCs were not expressing Branchury-T but Flk-1 in the early in vitro 
development were well-derived towards cardiomyogenic lineage cells. This in vitro situation could 
reflect the onset of Flk-1 expression in vivo as the cells exit the primitive streak leading to 
cardiomyogenis (Kattman, Huber et al. 2006). On contrast with this result, the development stage where 
the both Branchury-T and Flk-1 were expressed could be specified as the onset of embryonic blood cell 
development and presumed as the progeny for the both hematopoietic and vascular component 
formation (Huber, Kouskoff et al. 2004; Kouskoff, Lacaud et al. 2005; Kattman, Huber et al. 2006). In 
spontaneous cardiomyogenic formation of this study, CM-mESCs-NOELCs was directly situated in the 
haematopoietic medium prior to the heamtaopoietic differentiation study when Gata-4 and 
mesodermal markers was observed to be expressed in the culture. The expression of Flk-1 was also 
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observed which is correspondent to the environment for cardiomyogenic development in vivo. 
However, the strong expression of Flk-1 as well as expression of Brachyuri-T would link to the 
maturation process for the blood formation as stated above in vivo.  
An early and higher expression of Gata-2 observed in CM-mESCs-NOELCs is corresponding to the 
above findings on the blood formation. Gata-2 is a member of the Gata family of transcription factors, 
and is indispensable for the development of haematopoietic system. Gata-2 expression occurs early in 
haematopoiesis and is essential for proliferation and expansion of haematopoietic stel cells and 
progenitors (Tsai, Keller et al. 1994; Kitajima, Masuhara et al. 2002; Edling and Hallberg 2007; Koga, 
Yamaguchi et al. 2007).  
In other points, in vivo studies on embryoid bodies of ESCs found that Gata-2 and Smad5 
cooperate to induce EKLF expression in a progenitor population  Early in haematopoiesis, Gata-2 and 
Smad5 activate EKLF in a co-operative fashion. This integration of the BMP-4 signaling pathway, which 
essential for mesoderm development with the Gata-2 target gene network is achieved at the upstream 
enhancer of EKLF, where functional Gata and Smad binding sites are found in close proximity to one 
another resulted in the expression of EKLF. This followed by a switch to Gata-1 that replaces Gata-2 and 
binds to the EKLF upstream enhancer, hence regulating EKLF expression at high levels upon erythroid 
lineage commitment. This stage- and lineage-dependent control of EKLF expression defines a crucial role 
for EKLF as a regulator of lineage fate decisions during haematopoiesis (Lohmann and Bieker 2008). Our 
gene profiles on the expression of Gata-2 and EKLF detected from all culture groups in this study are 
corresponding to the above findings, with a higher expression of both gene markers were observed from 
CM-mESCs group indicating that enhancement towards haemotopoietic differentiation were 
successfully achieved in this group as compared to others.  
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An early expression of c-myb, SCL and c-kit were also observed from HepG2-CM-treated groups, 
thus, supported the early inducement of differentiation towards haematopoietic lineage from these 
cultures, with a higher expression of the gene markers detected from CM-mESCs group indicating that a 
better culture condition for haematopoietic differentiation. C-myb expression is an early indicator for 
haematopoietic differentiation as it plays a pivotal role in human primary haematopoietic 
stem/progenitor cell lineage commitment. This transcription factor is highly expressed in immature 
haemtaopoietic cells and down regulated during differentiation (Ness, Kowenz-Leutz et al. 1993; 
Sandberg, Sutton et al. 2005; Kim and Bresnick 2007; Tober, McGrath et al. 2008; Bianchi, Zini et al. 
2010). Stem cell leukemia (SCL, also known as TAL1 (T-cell acute lymphoblastic leukemia 1) is a tissue-
specific basic helic-loop-helix (bHLH) factor that plays a central function in haematopoietic development. 
SCL is down-regulated in maturing cells suggesting that loss of SCL may be an important event in the 
differentiation of pluripotent haematopoietic cells (Lecuyer, Herblot et al. 2002; Lecuyer and Hoang 
2004; Ismailoglu, Yeamans et al. 2008). 
Contribution of cytokine cocktails in the haematopoietic differentiation of ESCs are well-
explained (Zhang, Park et al. 2005; Srivastava, Kaushal et al. 2006; Irion, Clarke et al. 2010; Zhou, French 
et al. 2010). Addition of Stem Cell Factor (SCF), Interleukin-3 (IL-3) and Interlaukin-6 (IL-6) regulate the 
formation of early haematopoietic progenitors while EPO signaling is necessary for erythroid progenitor 
differentiation and maturation.   SCF (also known as kit ligand, mast cell growth factor, or steel factor) is 
a haematopoietic cytokine that trigger its biologic effects by binding to its receptor, c-kit. c-kit is a 
tyrosine kinase receptor that expressed in all HSCs (Broudy 1997; Kitajima, Masuhara et al. 2002; Zhu 
and Emerson 2002). Hence, our findings in this study are corresponding to the above reports as well as 
our previous results in Chapter 5.  
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Following to an interesting finding in this study on the expression of EKLF gene marker which 
potentially could be related to the erythroid lineage development, the expression of CD71 and TER119 
were used to track erythroid differentiation in vitro from the encapsulated mESCs culture. During the 
differentiation of mESCs in vitro, EKLF expression is activated prior to the terminal erythroid 
differentiation(Adelman, Chattopadhyay et al. 2002).  The expression of immature erythroid marker, 
CD71
 
and mature eyrthroid marker, TER-119 were not successfully achieved during the culture process, 
indicating that maturation process was not occurred in the culture groups. CD71 is atransferrin receptor, 
which is essential for iron transport into proliferating cells. CD71 is present on reticulocytes and 
erythroid progenitors in fetal liver, cord blood, and peripheral blood, yet it is lost as these differentiate 
to mature erythrocytes (Judd, Poodry et al. 1980; Phillips, Le et al. 1984; Lokan, James et al. 1987). TER-
119 is a glycophorin A-associated protein, which expressed on mature erythrocytes and erythroid 
precursor cells in adult blood, lymphoid tissue and bone marrrow, and in the embryonic yolk sac and 
fetal liver (Ikuta, Kina et al. 1990; Kina, Ikuta et al. 2000; Ogawa, Kanashima et al. 2001). In vivo studies 
on mouse embryo have shown that early erythroid progenitors expressed(Zielke, Sumbilla et al. 1980) 
moderate levels of CD71 and are TER-119
−
. As the cells continue to divide and differentiate TER-199 
expression is induced and CD71 expression is down regulated (Eshghi, Vogelezang et al. 2007). In 
addition, high levels of CD71 expressed on nucleated cells and greatly reduced levels on the cells that 
had extruded their nuclei (young primitive reticulocytes). Whilst the expression of TER-119 was higher in 
enucleated than in nucleated cells (reticulocytes) (Fraser 2007). Corresponding to the in vivo mouse 
embryo, studies have shown that the process of erythroblast enucleation occurs very frequently and is 
also important for erythroid homeostasis. Among others, macrophages contribute essentially to 
erythroblast enucleation (Hanspal and Hanspal 1994). Since enucleation occours in pure erythroblast in 
vitro cultures as well, it is reasonable that enucleation of erythroblast is a cell-autonomous process 
However, in the absence of supporting cells the enucleation of erythroblast is less efficient and also 
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partially blocked (Dolznig, Kolbus et al. 2005). Hence, the expression of ELKF in this study is 
corresponding with the previous reports on the expression of Gata-2 and EKLF towards the onset of 
haemotpoietic progenitor’s formation, and was not related to the eyrthroid differentiation.  
  The failure of erythroid formation in encapsulated mESCs culture might be due to the low 
concentration of EPO that stimulate the differentiation towards erythroid progenitor in our 3-D culture. 
Studies on the cytokine inducement have shown that IL-3 and SCF have synergetic effects with EPO on 
the proliferation and differentiation of erythroid progenitors (Wang, Yates et al. 2005). Recent works on 
the 3-D erythroid cell growth and differentiation in rotating wall vessel bioreactor using murine 
erythroleukemia cells have reported that an amount of 20 U/ml of EPO concentration were used in the 
culture to induce the differentiation (Sytkowski and Davis 2001). In other point, Liu and Roy in 2005 have 
used an amount of 1000U/ml of mIL-3 and 10 µg/ml of mSCF with other cytokine cocktails to trigger the 
haematopoietic differentiation of mESCs in their 3-D culture system. In our study, the concentration of 
cytokines added in our 3-D differentiation culture strategy were based on the modification of cytokines 
concentration that were used in our 2-D standard protocol studies that contained 3U/ml of EPO, 10 
ng/ml of mIL-3 and 40 ng/ml of mSCF, which showed lower concentration as compared to the literatures 
reported above. Hence, the failure erythroid formation in encapsulated mESCs observed from our 
studies could be related to the lower concentration used in the culture media, thus this finding supports 
the above reports. However, the higher expression of haematopoietic gene markers observed in this 
study, although at the lower concentration of cytokines was used is an interesting finding indicating that 
the haematopoietic differentiation might not only depend on the cytokines concentration but the 3-D 
culture environment might also promote the differentiation. Taqvi and Roy in 2006 have reported that 
their 3-D culture system can influence haematopoietic differentiation of ESCs without any addition of 
cytokine. Thus, our findings are in agreement with this report. 
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  By exposing the encapsulated mESCs on methylcellulose media for clonogenic ability have 
shown a significant increase on the hematopoietic colonies formation especially from CM-mESCs group 
due to the cytokine supplements in the semi-solid media. Interesting, the formation of beating colonies 
were also formed from haematopoietic colony assay observed from CM-mESCs-NOELCS group indicating 
that the spontaneous cardiomyegenic was triggered by the influence of haematopoietic cytokines in the 
media. The contribution of cytokine in the differentiation stage of ESCs in vitro to derive various cell 
lineages is well-documented (Hwang et al. 2006; Zhu and Emerson 2002). Addition of IL-3 and IL-6 
regulates the formation of early haematopoietic progenitors while erythropoietin [EPO] signalling is 
absolutely necessary for definitive erythroid differentiation (Srivastava et al. 2006; McGrath and Palis 
2005).  Studies on the embryo development in mice have shown that EPO could also trigger 
cardiomyocyte proliferation (Wu et al. 1999). These results are in agreement with our previous findings 
in Chapter 5 and 6. However, the formation of mixed lineage observed from CM-mESCs-NOELCs culture 
is an interesting finding that needs to be study further to explain this phenomenon in detail.   
Formation of macrophage and nucleated erythroid from the CFUs colonies collected in control 
mESCs and CM-mESCs culture respectively using Wright-Giemsa staining indicated that the encapsulated 
mESC cultured in 3-D HARV bioreactor were capable on differentiating towards haematopoietic 
colonies. In other points, the expression of anti-sarcomeric α-actinin as common cardiomyogenic 
marker detected from the CM-mESCs culture confirmed the beating colonies was prominently formed 
from the culture. Anti-sarcomeric α-actinin is specific for a-skeletal muscle actinin and a-cardiac muscle 
actinin. It stains Z lines and dot in stress fibers of myotubes in skeletal and cardiac muscle. 
Immunofluorescent labeling of a large variety of cells with anti a-actinin reveals an extensive association 
of the proteins with the actin containing stress fibers and, in particular, with their membrane-bound 
termini (Goncharova, Kam et al. 1992). 
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Positive expression on cardiomyegenic gene markers i.e. Gata-4 and α-Myosin Heavy Chain (α-
MHC) confirmed the cardyomyegenic differentiation in CM-mESCs-NOELCs culture. Enhancement on 
cardyomyogenis has shown a strong expression on Gata-4 and α-MHC genes after inducing visceral 
endodermal signals to ESC-culture using HepG2-or END2 cell line (Filipczyk et al. 2007; Rathjen and 
Rathjen 2001; Rathjen et al. 1999). In contrast, the expression of heamatopoeitic markers, Gata-2 and 
SCL as well as definitive erythroid marker, β-major globin were observed in the CM-mESCs group 
indicated that this group are more prominent for haematopoietic differentiation especially on the 
erythroid progenitor formation.  Up-regulation of Gata-1 and β-major globin markers expression in CM-
mESCs from western blot protein analysis suggested that this culture group provide an efficient way of 
enhancing ESCs differentiation towards erythroid progenitors. The role of Gata-1 in erythroid cell 
survival and proliferation is well-documented (Kitajima, Masuhara et al. 2002; Yokomizo, Takahashi et al. 
2007). β major-globin and β-globin is an adult haemoglobin gene normally expressed in both circulating 
primitive erythroblast and differentiating definitive erythroblast in the foetal liver (Kingsley, Malik et al. 
2006; Palis 2008). The results presented here support the above reports and correspond to our 2-D 
results in Chapter 5 and 6, thus confirmed the hypothesis on the enhancement of haematopoietic and 
spontaneous cardiomyogenic differentiation from 3-D culture of alginate encapsulated mESC treated 
with HepG2-CM and culture in rotating wall vessel bioreactor, which showed more differentiation 
occurred towards both lineages as compare to control group. 
 
7.6. Conclusions 
The development of a novel 3-D bioprocess for haematopoietic differentiation as well as 
spontaneous cardiomyegeic differentiation using alginate/gelatin mixture have provided a 
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physiochemically stable for differentiating ESCs during 21 days of culture period. Three-dimensional 
alginate encapsulated mESCs were initially treated with HepG2-CM followed by terminal differentiation 
in HARV bioreactor. This study verified that mESC-differentiation can be controlled in the 3-D culture 
using HepG2-CM as shown in previous 2-D works. Various culture groups such as control mESCs, CM-
mESCs and CM-mESCs-NOELCs were compare with the protocol used in this 3-D culture approach. 
Selective generation of haematopoietic and spontaneous cardiomyogenic differentiation cells from 
mESC was also firstly achieved through enhancing masodermal lineage development. This bioprocess 
also presented scalability of ESC-based cells generation culturing 500 beads (producing 3x10
5
 cells per 
beads in 21 days) in 55ml-size of single bioreactor vessel. Furthermore, the encapsulationwith alginate 
hydrogel used in this study would link to the applicability of injectable manipulation in the clinical 
procedure. Although there are still many questions and hurdles to solve in the clinical use of ESCs, the 
results in this chapter can be a guide line for the development of a novel bioprocess to enhance quality, 
productivity ad reproducibility of blood manufacturing ex-vivo. In addition, the formation of mixed 
lineage formed in CM-mESCs-NOELCs culture need to be studied further in order to have a better 
understanding the on controlling the differentiation pathway.  
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Chapter 8.       
Overall Conclusions and Future Plans 
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8.0. Conclusions 
In this thesis, we have developed a novel culture strategy for deriving in vitro haematopoiesis as well as 
spontaneous cardiomyogenesis from mESCs and a bioprocess for the formation of 3-D blood-cell likes 
for ex vivo blood cells manufacture, as well as spontaneous cardiac-like cell formation for angiogenesis 
and vascularization application. For the application of ESCs to blood and cardiac cell-like formation, the 
efficient derivation of haematopoietic and cardiomyogenic lineage cells from pluripotent ESCs is a 
prerequisite. Regarding ESCs early differentiation strategy into three germ layer; endoderm, mesoderm 
and ectoderm, well organized induction of mesoderm formation from undifferentiated ESCs is an 
important intermediate step for further terminal differentiation towards haematopoietic lineage cells. 
Formation of ‘embryoid-like colonies’ during spontaneous haematopoietic differentiation which showed 
relatively similar gene profile analysis of normal EB on the three germ layers gene marker expression 
with addition on the expression of early haematopoietic gene marker were also observed in the culture, 
thus, this showed enhancement differentiation towards haematopoietic lineage. A rapid induction of 
mesoderm formation was detected by the increased expression of brachyury, Flk-1 and goosecoid 
transcripts. This corresponds to the previous finding from our group on the early differentiation of mESC 
towards the production of a cell population with a similar gene expression profile to primitive streak/ 
nascent mesoderm by inducement with conditioned medium from the HepG2 cell line (human 
hepatocarcinoma) that exhibited similar biological function with visceral endoderm, which play a key 
role in mesoderm formation during embryogenesis since it induces and enhances mesoderm formation. 
Following the enhancement of early differentiation of mESCs into mesoderm, mESCs were allowed to 
form ELCs for 8 days, and then dissociated ELC-derived cells to differentiate into haematopoietic lineage 
cells in the presence of haematopoietic supplements. Early maturation on the CFUs colonies were 
observed from the HepG2 treated cells at day 7 with enhancement on all of haematopoietic colonies 
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formation especially the erythroid progenitors  indicated that haemoglobinization in the colonies 
occurred early during the culture period. Further incubation period showed more formation of the 
hematopoietic progenitors with a reduction on the reddish colonies, thus indicated that the colonies 
losing haemoglobin capacity to maintain for a longer culture time point. Herein, we have developed a 
new culture strategy to enhance haematopoietic differentiation especially towards erythroid 
progenitors with an early maturation on the colonies resulted in reduction of culture time. Following the 
early maturation of CFUs on hematopoietic differentiation of mESCs, the need to develop a more 
efficient culture method leads to the investigation of direct differentiation of mECSs by by-passing ELCs 
formation, which was suggested from the previous finding that HepG2-CM treated mESCs showed early 
inducement on gene expression profile for mesoderm formation. Therefore, mESCs early differentiation 
was induced by culture in HepG2-CM. Subsequently, haematopoietic differentiation was induced by 
haematopoietic media without ELCs formation. Removing the ELCs formation resulted in the beating 
colonies formation without any haematopoietic colonies observed from the HepG2-CM treated mESCs, 
which is possibly due to the spontaneous cardiomyogenic differentiation although in the presence of 
haematopoietic cytokines in the media. Finally, using this novel differentiation strategy, direct 3-D 
haematopoiesis or cardiomyogenesis of mESCs through encapsulation in alginate hydrogel and culture in 
HARV bioreactors was achieved was achieved which enabled the formation of 3-D blood or cardiac cell-
like. Although the formation of mixed lineages of haematopoietic and cardiomyogenic cells were 
observed in one culture group and need to be elucidated further, hence, this novel bioprocess could still 
provide an efficient, scalable, automatable, single-step culture system for application on ex vivo blood 
cells manufacture and angiogenesis study that could be potentially used in therapeutic application.    
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8.1. Future Plans 
This thesis presented a novel culture strategy and bioprocess established for mESCs differentiation. 
However, from a therapeutic point of view, application on this culture strategy and bioprocess for ex 
vivo blood cells manufacture and angiogenesis study requires further characterization and development.   
  First, requirement on the characterization of the active factors from the HepG2-conditioned 
medium (HepG2-CM) that induce the differentiation of ESC and enhance mesoderm formation needs to 
be identified in order to produce a defined culture medium, thus rendering its usage clinically relevant. 
It is crucial to identify the biological molecules that trigger the ESCs differentiation since cell line-derived 
conditioned media may cause transmission of pathogen and vary in quality depending on the cell’s 
physiological status. Using proteomics technology, the combination of two-dimensional electrophoresis 
coupled to mass spectrometry with matrix-assisted laser desorption ionization (MALDI) has become a 
powerful tool for this analysis. Hence, a defined medium that contain active factors developed from 
HepG2-CM, which characterized using proteomics analysis is highly important in order to direct the 
differentiation towards specific lineage of cells by up-regulating the mesoderm formation.    
Second, cell sorting for purification of cells may be required in order to purify the haterogeous 
cell population formed specifically on haematopoietic or cardiomyogenic cells. Application on 
Fluorescence Activated Cell Sorting (FACS) could be used to selects the cell of interest from the 
heterogenous population based on the intensity of fluorescence which the cells emits. Prior to the 
analysis, a selection of suitable monoclonal antibodies is required in order to indentify the desired cell 
type.      
Third, different type of material used for hydrogels production may be required to study to see 
the potential of other material on forming direct single-step differentiation with our 3-D system. Finally, 
this culture strategy should be tested and modified in term of the difference in culture condition for the 
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practical application of this culture system to human ESC-based biotechnology as this system is 
established using mESCs. For future clinical therapy application, mESCs is inadequate to use as a 
transplantation or disease model because of the genetic variability between human and mice. 
Moreover, the use of animal sources may result in cross- species contamination with foreign pathogens 
and compromise their use in clinical application (Choumerianou, Dimitriou et al. 2008). Recent research 
reports describe the development of TeSR1, a serum-free, animal product-free medium that support the 
derivation and long-term feeder-independent culture of human ESCs has been produced (Ludwig et al. 
2006). However, there is no further similar application has been designed for mESCs culture up to date. 
The TeSR1 culture medium is a modification, with certain proteins and growth factors, makes TeSR1 
suitable for use in routine research for standard human ESCs cultures (Ludwig, Bergendahl et al. 2006). 
Additionally, feeder-independent human-ESCs culture conditions have been described that include 
protein components solely derived from recombinant sources or purified from human material and the 
derivation of 2 new human ESC lines in these defined culture medium (Ludwig, Levenstein et al. 2006). 
 In other point, chromosomal abnormalities are commonly occurred in embryonal carcinomal 
cells and mouse ESCs, and karyotypic changes often enhances their proliferative capacity while 
shortening the population doubling time (Choumerianou, Dimitriou et al. 2008). In comparison, most 
human ESC lines appeared to have a normal karyotype although studies have shown that epigenetics 
changes might occur during the culture process which associated with prolonged culture of ESCs 
(Drapper, Smith et al. 2004; Eggan, Reode et al. 2002). Therefore, it is crucial to maintain established cell 
lines under stringent culture conditions and be checked often for the acquisition of chromosomal 
abnormalities, although the incidence of such instability is not fully understood.   
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Appendix 
195 
 
Appendix 1  
A standard curve was plotted by measuring the level of the endogenous mitochondrial dehydrogease of 
mESCs after 4 hours of seeding with serial cell seeding density using the CellTiter 96® Aqueous non-
radioactive cell proliferation assay according to previously described method in the section of 4.4.1.3. 
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Appendix 2 
Calibration curve is plotted using serially diluted bovine serum albumin (Sigma, UK) and Bio-Rad DC 
protein assay kit (Bio-Ras, USA) or BCA 
TM
 protein assay kit (Pierce, USA) according to the manufacturer’s 
instruction. 
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Appendix 3 
Immunocytochemistry fluorescent staining of polyclonal antibodies erythroid markers, CD71 and TER-
119 from 3-D HARV encapsulated mESCs culture using direct staining with cytospin technique. Results 
showed positive expression on both markers in all culture groups. However, the expression of both 
erythroid markers was reduced when detected using monoclocal flowcytometry antibodies analysis. 
Thus, it is predicted that the expression was caused by the unspecific staining used from polyclonal 
antibodies. 
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Appendix 4 
Unstained samples for encapsulated mESCs suspension were analyzed at day 0 and day 21 of 
differentiation culture.  
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Appendix 5 
Three-dimensional static culture analysis of control mESCs and CM-mESCs groups indicate that the 
expression of erythroid markers, CD71 and TER-119 were reduced during the culture period, thus, this 
result showed the differentiation towards erythroid lineage in static culture were also not successfully 
achieved as well as in HARV culture system described in Chapter 7.3.4.2.     
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